<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="review-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Pharmaceutics</journal-id><journal-id journal-id-type="iso-abbrev">Pharmaceutics</journal-id><journal-id journal-id-type="pmc-domain-id">2103</journal-id><journal-id journal-id-type="pmc-domain">pharmamdpi</journal-id><journal-id journal-id-type="publisher-id">pharmaceutics</journal-id><journal-title-group><journal-title>Pharmaceutics</journal-title></journal-title-group><issn pub-type="epub">1999-4923</issn><publisher><publisher-name>Multidisciplinary Digital Publishing Institute  (MDPI)</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12473785</article-id><article-id pub-id-type="pmcid-ver">PMC12473785.1</article-id><article-id pub-id-type="pmcaid">12473785</article-id><article-id pub-id-type="pmcaiid">12473785</article-id><article-id pub-id-type="pmid">41012512</article-id><article-id pub-id-type="doi">10.3390/pharmaceutics17091176</article-id><article-id pub-id-type="publisher-id">pharmaceutics-17-01176</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>3D Bioprinted Neural Tissues: Emerging Strategies for Regeneration and Disease Modeling</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Choi</surname><given-names initials="T">Taekyung</given-names></name><xref rid="af1-pharmaceutics-17-01176" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0009-0003-6432-6392</contrib-id><name name-style="western"><surname>Park</surname><given-names initials="J">Jinseok</given-names></name><xref rid="af1-pharmaceutics-17-01176" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Lee</surname><given-names initials="S">Suvin</given-names></name><xref rid="af1-pharmaceutics-17-01176" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-1244-7793</contrib-id><name name-style="western"><surname>Jeon</surname><given-names initials="HJ">Hee-Jae</given-names></name><xref rid="af1-pharmaceutics-17-01176" ref-type="aff">1</xref><xref rid="af2-pharmaceutics-17-01176" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-6806-4201</contrib-id><name name-style="western"><surname>Kim</surname><given-names initials="BH">Byeong Hee</given-names></name><xref rid="af1-pharmaceutics-17-01176" ref-type="aff">1</xref><xref rid="af2-pharmaceutics-17-01176" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-8161-683X</contrib-id><name name-style="western"><surname>Kim</surname><given-names initials="HO">Hyun-Ouk</given-names></name><xref rid="af1-pharmaceutics-17-01176" ref-type="aff">1</xref><xref rid="af3-pharmaceutics-17-01176" ref-type="aff">3</xref><xref rid="af4-pharmaceutics-17-01176" ref-type="aff">4</xref><xref rid="c1-pharmaceutics-17-01176" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Lee</surname><given-names initials="H">Hyungseok</given-names></name><xref rid="af1-pharmaceutics-17-01176" ref-type="aff">1</xref><xref rid="af2-pharmaceutics-17-01176" ref-type="aff">2</xref><xref rid="c1-pharmaceutics-17-01176" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name name-style="western"><surname>Tomuta</surname><given-names initials="I">Ioan</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-pharmaceutics-17-01176"><label>1</label>Department of Smart Health Science and Technology, Kangwon National University (KNU), Chuncheon-si 24341, Republic of Korea; <email>chlxorud0805@kangwon.ac.kr</email> (T.C.); <email>man4331@kangwon.ac.kr</email> (J.P.); <email>binee0630@kangwon.ac.kr</email> (S.L.); <email>jeon22@kangwon.ac.kr</email> (H.-J.J.); <email>kbh@kangwon.ac.kr</email> (B.H.K.)</aff><aff id="af2-pharmaceutics-17-01176"><label>2</label>Department of Mechanical and Biomedical Engineering, Kangwon National University (KNU), Chuncheon-si 24341, Republic of Korea</aff><aff id="af3-pharmaceutics-17-01176"><label>3</label>Department of Bioengineering, Division of Chemical Engineering and Bioengineering, College of Art, Culture and Engineering, Kangwon National University (KNU), Chuncheon-si 24341, Republic of Korea</aff><aff id="af4-pharmaceutics-17-01176"><label>4</label>Institute of Fermentation and Brewing, Kangwon National University (KNU), Chuncheon-si 24341, Republic of Korea</aff><author-notes><corresp id="c1-pharmaceutics-17-01176"><label>*</label>Correspondence: <email>kimhoman@kangwon.ac.kr</email> (H.-O.K.); <email>ahl@kangwon.ac.kr</email> (H.L.); Tel.: +82-33-250-6272 (H.-O.K.); +82-33-250-6309 (H.L.)</corresp></author-notes><pub-date pub-type="epub"><day>10</day><month>9</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>9</month><year>2025</year></pub-date><volume>17</volume><issue>9</issue><issue-id pub-id-type="pmc-issue-id">497664</issue-id><elocation-id>1176</elocation-id><history><date date-type="received"><day>09</day><month>7</month><year>2025</year></date><date date-type="rev-recd"><day>03</day><month>9</month><year>2025</year></date><date date-type="accepted"><day>05</day><month>9</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>10</day><month>09</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>27</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-28 18:25:14.327"><day>28</day><month>09</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; 2025 by the authors.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="pharmaceutics-17-01176.pdf"/><abstract><p>Three-dimensional (3D) bioprinting has emerged as a versatile platform in regenerative medicine, capable of replicating the structural and functional intricacies of the central and peripheral nervous systems (CNS and PNS). Beyond structural repair, it enables the construction of engineered tissues that closely recapitulate neural microenvironments. This review provides a comprehensive and critical synthesis of current bioprinting strategies for neural tissue engineering, with particular emphasis on comparing natural, synthetic, and hybrid polymer-based bioinks from mechanistic and translational perspectives. Distinctively, it highlights gradient-based modulation of Schwann cell behavior and axonal pathfinding using mechanically and chemically patterned constructs. Special attention is given to printing modalities such as extrusion, inkjet, and electrohydrodynamic jet printing, examining their respective capacities for controlling spatial organization and microenvironmental cues. Representative applications include brain development models, neurodegenerative disease platforms, and glioblastoma scaffolds with integrated functional properties. Furthermore, this review identifies key translational barriers&#8212;including host tissue integration and bioink standardization&#8212;and explores emerging directions such as artificial intelligence-guided biofabrication and organ-on-chip integration, to enhance the fidelity and therapeutic potential of neural bioprinted constructs.</p></abstract><kwd-group><kwd>3D bioprinting</kwd><kwd>bioinks</kwd><kwd>neural tissue engineering</kwd><kwd>brain model</kwd></kwd-group><funding-group><award-group><funding-source>National Research Foundation of Korea (NRF) grant funded by the Korean government through the Basic Research Laboratory (BRL) Program</funding-source><award-id>RS-2025-00512586</award-id></award-group><award-group><funding-source>National Research Foundation of Korea (NRF) grants funded by the Korea government (MSIT)</funding-source><award-id>RS-2024-00423107</award-id></award-group><award-group><funding-source>Korea Institute for Advancement of Technology (KIAT) grant funded by the Korea Government</funding-source><award-id>RS-2022-KI002563</award-id></award-group><funding-statement>This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government through the Basic Research Laboratory (BRL) Program (RS-2025-00512586). This work was also supported by a National Research Foundation of Korea (NRF) grants funded by the Korea government (MSIT) (No. RS-2024-00423107). This work was supported by Korea Institute for Advancement of Technology (KIAT) grant funded by the Korea Government (MOTIE, Korea, RS-2022-KI002563, The Competency Development Program for Industry Specialist).</funding-statement></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="sec1-pharmaceutics-17-01176"><title>1. Introduction</title><p>The nervous system is a highly intricate network responsible for regulating sensory processing and cognitive function. Damage or dysfunction in the central and peripheral nervous systems (CNS and PNS) can lead to significant neurological impairments [<xref rid="B1-pharmaceutics-17-01176" ref-type="bibr">1</xref>]. The global prevalence of neurological disorders is increasing, owing to the rapidly aging population. Consequently, there is a significant increase in the incidence of neurodegenerative diseases, spinal cord injuries, and peripheral nerve injuries (PNIs) [<xref rid="B2-pharmaceutics-17-01176" ref-type="bibr">2</xref>,<xref rid="B3-pharmaceutics-17-01176" ref-type="bibr">3</xref>,<xref rid="B4-pharmaceutics-17-01176" ref-type="bibr">4</xref>].</p><p>Traumatic brain injury and spinal cord damage&#8212;both affecting the CNS&#8212;pose persistent therapeutic challenges [<xref rid="B5-pharmaceutics-17-01176" ref-type="bibr">5</xref>]. PNIs, often caused by trauma or surgical complications, also remain prevalent in clinical practice. Effective treatment remains difficult owing to limited regenerative capabilities, neural structural complexity, and insufficient treatment options. Current interventions, such as surgical nerve grafting and pharmacological therapies, often fall short of restoring full function, highlighting the need for improved and customized drug delivery systems.</p><p>To address these limitations, strategies that accurately reproduce the neural microenvironment are essential. The demand for physiologically relevant in vitro models continues to increase. Neural tissue engineering (NTE)&#8212;a multidisciplinary field that integrates biomaterials, cell therapy, and advanced manufacturing technologies&#8212;has emerged as a promising approach to meet these challenges. In particular, three-dimensional (3D) bioprinting technology has recently emerged, enabling precise control of cell distribution, spatial regulation of tissue structure, and biochemical signaling pathways. This opens new avenues for creating complex, bioinspired neural tissue structures [<xref rid="B6-pharmaceutics-17-01176" ref-type="bibr">6</xref>].</p></sec><sec id="sec2-pharmaceutics-17-01176"><title>2. Neural Tissue</title><sec id="sec2dot1-pharmaceutics-17-01176"><title>2.1. Neural Tissue Engineering</title><p>The nervous system consists of specialized cells called neurons, which form an intricate network for transmitting electrical impulses and information. Through this network, the nervous system regulates various physiological functions. The nervous system is anatomically divided into the CNS and PNS. The CNS, comprising the brain, cerebellum, and spinal cord [<xref rid="B7-pharmaceutics-17-01176" ref-type="bibr">7</xref>,<xref rid="B8-pharmaceutics-17-01176" ref-type="bibr">8</xref>], coordinates sensory and motor functions and processes incoming neural signals. Conversely, the PNS consists of nerves that extend from the CNS. The PNS transmits sensory information to the CNS and conveys motor commands to peripheral tissues and organs.</p><p>Injury to the nervous system can disrupt neuronal signal transmission and compromise the integrity of the blood&#8211;nerve barrier (BNB), leading to significant functional impairment [<xref rid="B9-pharmaceutics-17-01176" ref-type="bibr">9</xref>]. While the PNS retains some capacity for axonal regeneration and recovery, the CNS lacks intrinsic regenerative ability. Recovery in the CNS is limited to injuries &lt; 1 cm in length [<xref rid="B10-pharmaceutics-17-01176" ref-type="bibr">10</xref>]. Consequently, NTE has emerged as a multidisciplinary field, aiming at promoting neuronal regeneration and functional restoration. NTE combines several biomaterials, cell-based therapies, and advanced bioprinting technologies to reconstruct damaged neural tissue.</p><p>Compared to other tissues such as skin, cartilage, and bone, nerve tissue exhibits significantly lower regenerative capacity and greater functional complexity [<xref rid="B11-pharmaceutics-17-01176" ref-type="bibr">11</xref>]. In particular, the CNS demonstrates limited self-repair capabilities owing to the presence of inhibitory molecules, reduced neurogenesis, and highly intricate synaptic architecture [<xref rid="B12-pharmaceutics-17-01176" ref-type="bibr">12</xref>]. Furthermore, the precise spatial organization of neurons and glial cells, the need for electrical conductivity, and the maintenance of functional synaptic connectivity pose unique challenges. Therefore, NTE must meet design criteria distinct from those of other tissues in the body, including controlled anisotropy, targeted delivery of neurotrophic factors, and reproduction of the native electrophysiological environment.</p><p>NTE has recently expanded into multiple applications (<xref rid="pharmaceutics-17-01176-f001" ref-type="fig">Figure 1</xref>A), with a primary focus on evaluating cerebral recovery [<xref rid="B13-pharmaceutics-17-01176" ref-type="bibr">13</xref>]. Precision-engineered biomaterial constructs, such as Nerve Guidance Conduits (NGCs), are being developed [<xref rid="B14-pharmaceutics-17-01176" ref-type="bibr">14</xref>]. Pathological research and drug response validation are advancing via NTE technologies and the accurate simulation of the nervous system enabled via organ-on-chip platforms. Three-dimensional bioprinted brain tissue models are utilized in drug screening owing to their superior performance compared to those of two-dimensional (2D) cell cultures and animal models [<xref rid="B15-pharmaceutics-17-01176" ref-type="bibr">15</xref>]. The field of Artificial intelligence (AI) research is experiencing significant growth. AI integration forecasts biological responses, automates image analysis, and enhances bioprinting parameters [<xref rid="B16-pharmaceutics-17-01176" ref-type="bibr">16</xref>].</p><p><xref rid="pharmaceutics-17-01176-f001" ref-type="fig">Figure 1</xref>B shows the key advancements in NTE. This timeline highlights the progression of NTE, beginning with early strategies such as Schwann cell-induced conduits (2004), followed by the development of biodegradable semiconductor materials (2009), stem cell-based therapies (2011), and gelatin-based hydrogels for the controlled release of growth factors (2014) [<xref rid="B17-pharmaceutics-17-01176" ref-type="bibr">17</xref>]. Recent advancements include functionalized nanofiber scaffolds introduced in 2021, which demonstrate the ongoing significant development and research activity within the field. Current technologies include Schwann cell application [<xref rid="B18-pharmaceutics-17-01176" ref-type="bibr">18</xref>], neural conduit creation via electrospinning [<xref rid="B19-pharmaceutics-17-01176" ref-type="bibr">19</xref>], nerve regeneration studies involving mechanical and electrical stimulation [<xref rid="B20-pharmaceutics-17-01176" ref-type="bibr">20</xref>], and the application of stem cells and growth factors [<xref rid="B21-pharmaceutics-17-01176" ref-type="bibr">21</xref>]. Traditional 2D cell culture methods fail to replicate the 3D complexity of brain networks [<xref rid="B22-pharmaceutics-17-01176" ref-type="bibr">22</xref>,<xref rid="B23-pharmaceutics-17-01176" ref-type="bibr">23</xref>]. Animal models are limited based on ethical considerations, interspecies variability, and restricted access to human neuro tissue [<xref rid="B24-pharmaceutics-17-01176" ref-type="bibr">24</xref>,<xref rid="B25-pharmaceutics-17-01176" ref-type="bibr">25</xref>]. To address these challenges, researchers are meticulously developing 3D brain tissue models via precise cellular organization [<xref rid="B26-pharmaceutics-17-01176" ref-type="bibr">26</xref>,<xref rid="B27-pharmaceutics-17-01176" ref-type="bibr">27</xref>]. NTE leverages 3D bioprinting to replicate biologically relevant structures.</p></sec><sec id="sec2dot2-pharmaceutics-17-01176"><title>2.2. Limitations of Conventional Fabrication Methods in Neural Tissue Engineering</title><p>In NTE, traditional fabrication methods&#8212;such as solvent casting, freeze-drying, and electrospinning&#8212;have been widely employed to produce porous scaffolds that facilitate neural cell adhesion. However, these approaches have significant limitations in replicating the intricate architecture and functional complexity of neural tissues. Solvent casting, often combined with powder extrusion, is commonly used to fabricate porous polymer scaffolds. However, this method limits precise control over pore shape and distribution, leading to uneven cell distribution and reduced nutrient transport efficiency. Residual solvents can cause cytotoxicity, rendering this approach unsuitable for highly sensitive neural tissue environments [<xref rid="B28-pharmaceutics-17-01176" ref-type="bibr">28</xref>]. Freeze-drying is a widely effective method for producing scaffolds with high porosity and biodegradability, but the resulting structures often lack mechanical strength and fail to reproduce the unique microenvironment of neural tissue, such as axial anisotropy [<xref rid="B29-pharmaceutics-17-01176" ref-type="bibr">29</xref>]. Electrospinning produces nanofiber-based scaffolds that mimic the architecture of the extracellular matrix (ECM). A report shows that aligned electrospun fibers are effective in inducing neural stem cell differentiation and guiding neurite outgrowth. However, most electrospinning technologies yield 2D or pseudo&#8211;3D con-structs, with limited capability to control multilayered cell arrangements or vertical cell distribution [<xref rid="B30-pharmaceutics-17-01176" ref-type="bibr">30</xref>]. To address the limitations of existing fabrication methods, 3D bioprinting&#8212;capable of precisely depositing bioinks in digitally programmed layers&#8212;is gaining attention as a next-generation approach for effectively reproducing the complex microenvironment of neural tissue. These techniques can integrate various cell types, growth fac-tors, and anisotropic physical properties within a single construct.</p></sec><sec id="sec2dot3-pharmaceutics-17-01176"><title>2.3. Role of Three-Dimensional Bioprinting in Neural Tissue Engineering</title><p>3D bioprinting technology is becoming increasingly significant in NTE, enabling precise structural control, enhanced cell-scaffold interactions, and the creation of functional tissue models. <xref rid="pharmaceutics-17-01176-f002" ref-type="fig">Figure 2</xref> shows the progression of 3D bioprinting technology over recent decades. Initial studies investigated glial and retinal cell viability and neurite outgrowth employing inkjet-based printing techniques [<xref rid="B31-pharmaceutics-17-01176" ref-type="bibr">31</xref>]. Subsequent work explored traumatic brain injury therapy via GelMA/HA-based hydrogels [<xref rid="B11-pharmaceutics-17-01176" ref-type="bibr">11</xref>], marked the first formal application of biomaterials and tissue-specific patterning in NTE. The technology was further enhanced to incorporate neural-based cell printing as well as fabricate tissue and scaffold prototypes, followed by integrating high-resolution laser printing to enhance structural precision [<xref rid="B32-pharmaceutics-17-01176" ref-type="bibr">32</xref>,<xref rid="B33-pharmaceutics-17-01176" ref-type="bibr">33</xref>]. Since 2014, research on fabricating nerve guidance conduits incorporating cells for peripheral nerve regeneration has garnered interest [<xref rid="B34-pharmaceutics-17-01176" ref-type="bibr">34</xref>,<xref rid="B35-pharmaceutics-17-01176" ref-type="bibr">35</xref>]. Scaffold development using Schwann cells has become a central focus in PNS regeneration [<xref rid="B36-pharmaceutics-17-01176" ref-type="bibr">36</xref>]. Recent research has intensified on applying 3D bioprinting to peripheral nerve conduits and tissues, while 4D bioprinting has emerged as a strategy for creating dynamically adaptive constructs [<xref rid="B37-pharmaceutics-17-01176" ref-type="bibr">37</xref>]. Recently, high-resolution brain cell scaffolds have been fabricated using digital light processing-based porous hydrogels [<xref rid="B38-pharmaceutics-17-01176" ref-type="bibr">38</xref>]. Additionally, a multilayered blood&#8211;brain barrier (BBB) model has been effectively developed and applied to drug permeability investigations [<xref rid="B39-pharmaceutics-17-01176" ref-type="bibr">39</xref>]. Consequently, 3D bioprinting technology is advancing beyond the creation of rudimentary structures towards the development of tissues with physiological function and dynamic responsiveness.</p></sec></sec><sec id="sec3-pharmaceutics-17-01176"><title>3. Fundamentals of Three-Dimensional Bioprinting for Neural Tissues</title><sec id="sec3dot1-pharmaceutics-17-01176"><title>3.1. Bioprinting Technologies</title><p>3D bioprinting employs computer-aided design and manufacturing technologies to precisely deposit biomaterials at specified locations, enabling the fabrication of complex 3D biological structures [<xref rid="B40-pharmaceutics-17-01176" ref-type="bibr">40</xref>]. Scaffolds for nerve tissue regeneration must meet various characteristics, including biocompatibility, biodegradability, appropriate porosity, and sufficient mechanical strength [<xref rid="B41-pharmaceutics-17-01176" ref-type="bibr">41</xref>], while also providing an environment that effectively supports cell adhesion and viability. Conventional scaffold manufacturing methods&#8212;including solvent casting, particle leaching, phase separation, and freeze-drying&#8212;offer limited control over microporosity. Furthermore, residual organic solvents can impair cell survival [<xref rid="B42-pharmaceutics-17-01176" ref-type="bibr">42</xref>]. To address these limitations, additive manufacturing technology has been adopted, enabling more precise structural design and the fabrication of complex tissues [<xref rid="B43-pharmaceutics-17-01176" ref-type="bibr">43</xref>]. Currently, bioprinting technology is primarily divided into four main categories: extrusion-based, inkjet-based, electrohydrodynamic (EHD) and laser-assisted. Each method operates on distinct principles and presents specific advantages and limitations [<xref rid="B44-pharmaceutics-17-01176" ref-type="bibr">44</xref>].</p><p>As summarized in <xref rid="pharmaceutics-17-01176-t001" ref-type="table">Table 1</xref>, each bioprinting technology presents distinct advantages and disadvantages from both mechanistic and translational perspectives. Extrusion-based bioprinting allows the use of bioinks with diverse viscosities, making it suitable for scalable and clinically relevant constructs; however, the application of high pressure can generate excessive shear stress that compromises cell viability. Inkjet-based bioprinting enables the fabrication of high-resolution structures under biocompatible printing conditions, but its applicability is restricted to low-viscosity bioinks, which limits scalability for larger tissue constructs. Laser-assisted bioprinting provides excellent precision and patterning capabilities, but it is costly, and cell viability can be affected by the duration of laser exposure. EHD bioprinting offers nanoscale resolution and fine droplet control, providing opportunities for fabricating complex tissues, but it suffers from low throughput, high voltage risks, and complex setup requirements.</p><sec id="sec3dot1dot1-pharmaceutics-17-01176"><title>3.1.1. Extrusion-Based Bioprinting</title><p><xref rid="pharmaceutics-17-01176-f003" ref-type="fig">Figure 3</xref>A shows an extrusion-based bioprinting method. In this approach, bioink is extruded via a nozzle to fabricate a desired structure. Pneumatic or mechanical systems&#8212;including screw- or piston-driven mechanisms&#8212;are typically utilized to control extrusion. This technique accommodates various bioink viscosities, and single- or multi-nozzle configurations can be employed to extrude multiple inks simultaneously [<xref rid="B45-pharmaceutics-17-01176" ref-type="bibr">45</xref>,<xref rid="B46-pharmaceutics-17-01176" ref-type="bibr">46</xref>]. Nevertheless, this technique generally offers relatively low printing resolution [<xref rid="B47-pharmaceutics-17-01176" ref-type="bibr">47</xref>], and the shear stress generated during extrusion can adversely affect cell viability [<xref rid="B48-pharmaceutics-17-01176" ref-type="bibr">48</xref>]. Despite these limitations, it remains technically simple and cost-effective, making it the most widely adopted bioprinting technique to date. With careful nozzle control and optimized bioink formulation, it can achieve sufficient reproducible results even in complex structures such as neural tissues.</p></sec><sec id="sec3dot1dot2-pharmaceutics-17-01176"><title>3.1.2. Inkjet-Based Bioprinting</title><p>The inkjet-based bioprinting method (<xref rid="pharmaceutics-17-01176-f003" ref-type="fig">Figure 3</xref>B) creates structures via ejecting discrete droplets of bioink onto defined positions. It is best suited for bioinks with low viscosity [<xref rid="B49-pharmaceutics-17-01176" ref-type="bibr">49</xref>,<xref rid="B50-pharmaceutics-17-01176" ref-type="bibr">50</xref>]. Two principal droplet-generation mechanisms are employed. The primary technique is thermal inkjet, which applies heating to produce vapor bubbles within the bioink, thereby expelling droplets. The alternate technique is the piezoelectric inkjet method, which utilizes piezoelectric actuators to eject bioink via voltage stimulation. This technique generally offers higher cell viability and enables the fabrication of high-resolution structures. However, nozzle clogging occurs with high-viscosity bioinks, limiting the range of suitable inks [<xref rid="B49-pharmaceutics-17-01176" ref-type="bibr">49</xref>]. While well-suited for neural tissue printing requiring precise positional control, it remains constrained owing to the limited mechanical strength of the resulting constructs.</p></sec><sec id="sec3dot1dot3-pharmaceutics-17-01176"><title>3.1.3. Electrohydrodynamic (EHD) Bioprinting</title><p>Electrohydrodynamic (EHD) bioprinting is an emerging high-resolution printing technology that uses electrostatic forces to eject ultra-fine bioink droplets from a nozzle (<xref rid="pharmaceutics-17-01176-f003" ref-type="fig">Figure 3</xref>C). Unlike conventional extrusion-based bioprinting that depends on mechanical pressure to extrude ink, EHD bioprinting applies a high-voltage electric field (typically 0.1&#8211;10 kV) between the nozzle and the substrate [<xref rid="B51-pharmaceutics-17-01176" ref-type="bibr">51</xref>]. This electric field forms a Taylor cone at the nozzle tip, from which charged droplets are ejected, enabling nanoscale patterning with exceptional spatial resolution and precision in scaffold fabrication [<xref rid="B52-pharmaceutics-17-01176" ref-type="bibr">52</xref>]. One of the primary advantages of EHD bioprinting is its ability to process low-viscosity bioinks with minimal mechanical shear stress, thereby supporting high cell viability. However, the process is highly sensitive to various variables such as voltage, nozzle&#8211;substrate distance, flow rate, ink conductivity, and viscosity. High voltage can induce electrical stress on encapsulated cells, potentially compromising their survival and function [<xref rid="B53-pharmaceutics-17-01176" ref-type="bibr">53</xref>]. Maintaining sterility and structural uniformity across large constructs also remains a significant challenge.</p></sec><sec id="sec3dot1dot4-pharmaceutics-17-01176"><title>3.1.4. Laser-Assisted Bioprinting</title><p>Laser-based bioprinting is a nozzle-free, non-contact technique capable of producing high-resolution structures (<xref rid="pharmaceutics-17-01176-f003" ref-type="fig">Figure 3</xref>C). In this method, a pulsed laser is used to apply heat to a thin metal film. The resulting rapid vaporization generates a pressure wave that propels the biological material onto the substrate, forming the desired structure [<xref rid="B54-pharmaceutics-17-01176" ref-type="bibr">54</xref>]. This approach accommodates bioinks of various viscosities and facilitates the fabrication of fine structures, which is advantageous for controlling cell alignment and spatial distribution. However, cells may be damaged during the laser irradiation process owing to heat or emitted residual materials, potentially affecting their viability [<xref rid="B55-pharmaceutics-17-01176" ref-type="bibr">55</xref>,<xref rid="B56-pharmaceutics-17-01176" ref-type="bibr">56</xref>]. Therefore, when handling sensitive nerve cells, precise control of laser intensity and pulse duration is essential. Additionally, <xref rid="pharmaceutics-17-01176-f003" ref-type="fig">Figure 3</xref>D,E shows the various bioprinting techniques utilized [<xref rid="B57-pharmaceutics-17-01176" ref-type="bibr">57</xref>,<xref rid="B58-pharmaceutics-17-01176" ref-type="bibr">58</xref>].</p></sec></sec><sec id="sec3dot2-pharmaceutics-17-01176"><title>3.2. Bioinks for Neural Tissue Engineering</title><p>Post-stacking shape and structural stability largely depend on the rheological properties of bioink. Key parameters include shear-thinning behavior, viscoelasticity, and viscosity [<xref rid="B59-pharmaceutics-17-01176" ref-type="bibr">59</xref>]. Most bioinks are polymer-based, including natural, synthetic, composite, and hybrid types. Shear-thinning is essential for minimizing cell damage. It reduces printing viscosity to enhance ink flow, then increases viscosity to strengthen the construct [<xref rid="B60-pharmaceutics-17-01176" ref-type="bibr">60</xref>]. Viscoelasticity governs the balance between ink flow and structural integrity [<xref rid="B61-pharmaceutics-17-01176" ref-type="bibr">61</xref>]. Generally, a higher storage modulus than that of the loss modulus usually enhances structural stability. However, excessively high values can clog nozzles or cause irregular printing [<xref rid="B62-pharmaceutics-17-01176" ref-type="bibr">62</xref>]. Bioink properties significantly influence cellular activity. Advances in formulation are yielding bioinks optimized for specific applications, incorporating natural polymers, synthetic polymers, and nanoparticles [<xref rid="B63-pharmaceutics-17-01176" ref-type="bibr">63</xref>].</p><p>As summarized in <xref rid="pharmaceutics-17-01176-t002" ref-type="table">Table 2</xref>, various types of bioinks exhibit distinct properties from mechanical and translational perspectives. Natural polymers such as collagen, alginate, and dECM provide excellent biocompatibility that supports neural survival and differentiation, but their limited mechanical strength, rapid degradation, and variability restrict long-term stability. Synthetic polymers such as PEG, PCL, and PLA allow precise control over mechanical and degradation properties and provide high reproducibility, but they lack the biological cues necessary for neural tissue development. Hybrid polymers aim to combine the advantages of natural and synthetic systems by integrating bioactivity with mechanical robustness, and more recently, conductive polymers such as PEDOT:PSS have been incorporated to provide electrical functionality for neural stimulation; however, issues related to cytotoxicity, degradation byproducts, and manufacturing complexity must be resolved before clinical application.</p><sec id="sec3dot2dot1-pharmaceutics-17-01176"><title>3.2.1. Natural Polymers</title><p>Natural polymers were the first materials used in neural tissue engineering. Derived from biological sources, these polymers demonstrate physicochemical and structural properties similar to those of native tissues. They exhibit excellent high biocompatibility and biodegradability. Collagen-based hydrogels, a representative example, enhance neural survival and proliferation and are primarily used as neural induction conduits [<xref rid="B64-pharmaceutics-17-01176" ref-type="bibr">64</xref>,<xref rid="B65-pharmaceutics-17-01176" ref-type="bibr">65</xref>]. Hyaluronic acid (HA), a key component of the extracellular matrix, promotes nerve outgrowth and cell differentiation, making it valuable in treatments for both PNS and CNS [<xref rid="B66-pharmaceutics-17-01176" ref-type="bibr">66</xref>]. Chitosan-based hydrogels enhance cell adhesion and nerve outgrowth, being primarily applied in PNS and CNS regeneration [<xref rid="B67-pharmaceutics-17-01176" ref-type="bibr">67</xref>]. Alginic acid, a natural polysaccharide derived from brown algae and certain bacteria, is effectively used in peripheral nerve regeneration [<xref rid="B68-pharmaceutics-17-01176" ref-type="bibr">68</xref>].</p><p>Recently, decellularized extracellular matrix (dECM)-based bioinks have attracted increasing attention. dECM preserves the ECM components and bioactive factors of the source tissue, facilitating cell-specific adhesion and functional differentiation while providing a tissue-specific biochemical and structural environment [<xref rid="B69-pharmaceutics-17-01176" ref-type="bibr">69</xref>]. dECM derived from the PNS or CNS promotes maturation of neurons, Schwann cells, and synapse formation [<xref rid="B70-pharmaceutics-17-01176" ref-type="bibr">70</xref>]. When combined with bioprinting technology, dECM is increasingly applied to customized neural tissue modeling and regenerative therapy platforms. While natural polymers exhibit high biocompatibility and promote neural cell growth, they often lack sufficient mechanical strength and structural stability. For example, both collagen and HA support cell proliferation but degrade rapidly, compromising long-term structural integrity. Chitosan exhibits good cell adhesion but limited solubility. These limitations reduce their scalability and clinical translation, driving growing interest in hybrid bioinks.</p></sec><sec id="sec3dot2dot2-pharmaceutics-17-01176"><title>3.2.2. Synthetic Polymers</title><p>Synthetic polymers serve as customizable bioinks, allowing precise control over mechanical strength and physical characteristics. These polymers are fabricated using diverse technologies and platforms. Their composition, including biodegradability, can be finely regulated [<xref rid="B76-pharmaceutics-17-01176" ref-type="bibr">76</xref>], overcoming the limitations of natural polymers. Key synthetic materials include polycaprolactone (PCL), polyethylene glycol (PEG), and polylactic acid (PLA). Most polymers are fabricated using 3D printing or electrospinning techniques [<xref rid="B77-pharmaceutics-17-01176" ref-type="bibr">77</xref>]. PCL demonstrates exceptional structural stability and facilitates precise regulation of biocompatibility and degradation rates, making it a preferred material in brain tissue engineering [<xref rid="B71-pharmaceutics-17-01176" ref-type="bibr">71</xref>]. PCL nanofibers generated using electrospinning effectively direct axon regeneration and enhance neuronal development [<xref rid="B30-pharmaceutics-17-01176" ref-type="bibr">30</xref>]. The viscoelasticity of PEG-based hydrogels can be optimized by modifying crosslink density, facilitating the fabrication of diverse neuronal scaffolds [<xref rid="B72-pharmaceutics-17-01176" ref-type="bibr">72</xref>].</p></sec><sec id="sec3dot2dot3-pharmaceutics-17-01176"><title>3.2.3. Hybrid Polymers</title><p>Hybrid polymer-based bioinks integrate the beneficial properties of both natural and synthetic polymers. They exhibit biological activity similar to that of natural polymers while offering mechanical strength comparable to synthetic polymers [<xref rid="B72-pharmaceutics-17-01176" ref-type="bibr">72</xref>]. Modifying the physical properties of composite bioinks is relatively straightforward, and they effectively maintain cellular viability and structural integrity. For example, poly(3,4-ethylenedioxythiophene) (PEDOT) can be combined with polystyrene sulfonate (PSS) to create electrically conductive hydrogels [<xref rid="B73-pharmaceutics-17-01176" ref-type="bibr">73</xref>]. Another method involves leveraging the ionic interactions between alginate and chitosan to enhance structural stability [<xref rid="B74-pharmaceutics-17-01176" ref-type="bibr">74</xref>]. Hybrid bioink formulations regulate biodegradation rates and enhance the efficiency of cell adhesion and growth factor distribution. They effectively facilitate the fabrication of complex tissue architectures. The potential synergy among graphene, carbon nanotubes, and cellulose nanofibers has been investigated in several studies. This approach facilitates the development of effective, biocompatible bioinks for living organisms [<xref rid="B75-pharmaceutics-17-01176" ref-type="bibr">75</xref>].</p></sec></sec><sec id="sec3dot3-pharmaceutics-17-01176"><title>3.3. Key Design Considerations for Neural Bioprinting</title><sec id="sec3dot3dot1-pharmaceutics-17-01176"><title>3.3.1. Biocompatibility and Cell Viability</title><p>In brain tissue engineering, bioinks and scaffolds must exhibit biocompatibility for effective 3D bioprinting applications. Maintaining cellular viability is essential for effective regeneration. Recent studies have explored the use of conductive hydrogels and nanomaterials. One effective strategy for achieving this involves integrating a small quantity of graphene oxide (GO) into gelatin methacryloyl (GelMA) hydrogels [<xref rid="B78-pharmaceutics-17-01176" ref-type="bibr">78</xref>]. This modification enhances its mechanical strength and electrical conductivity. Cellular viability improves when exposed to UV light [<xref rid="B78-pharmaceutics-17-01176" ref-type="bibr">78</xref>]. A scaffold composed of PCL/chitosan nanofibers integrated with gold nanoparticles has been developed. This material demonstrates minimal influence on neuronal development, attachment, or survival, indicating its biocompatibility and non-toxicity [<xref rid="B79-pharmaceutics-17-01176" ref-type="bibr">79</xref>]. These findings highlight the critical role of bioink formulation and nanomaterial incorporation for supporting neuronal cell survival and function.</p></sec><sec id="sec3dot3dot2-pharmaceutics-17-01176"><title>3.3.2. Mechanical and Rheological Properties</title><p>Nerve tissue is classified as soft tissue with distinct mechanical properties. The mechanical strength and rheological behavior of scaffolds mimicking nerve tissue significantly affect cell adhesion, differentiation, and survival [<xref rid="B80-pharmaceutics-17-01176" ref-type="bibr">80</xref>]. Recent studies have focused on regulating properties by combining conductive polymers with nanomaterials. A scaffold composed of polypyrrole (PPy) and silk fibroin (SF) is effective in promoting Schwann cell proliferation and neural regeneration through electrical stimulation [<xref rid="B81-pharmaceutics-17-01176" ref-type="bibr">81</xref>,<xref rid="B82-pharmaceutics-17-01176" ref-type="bibr">82</xref>]. Incorporating carboxylated graphene oxide into a PPy/poly-L-lactic acid (PLLA) composite enhances tensile strength, meeting the mechanical requirements of neural tissue [<xref rid="B83-pharmaceutics-17-01176" ref-type="bibr">83</xref>]. These findings demonstrate that regulating mechanical and rheological properties improves scaffold performance in neural tissue engineering.</p></sec><sec id="sec3dot3dot3-pharmaceutics-17-01176"><title>3.3.3. Bioactivity and Electrical Conductivity</title><p>Electrical signal transmission is a fundamental function of nerve tissue. Therefore, scaffold electrical conductivity is an essential factor for neural cell growth and functional recovery. Recently, extensive research has focused on using conductive hydrogels and nanomaterials to enhance these properties [<xref rid="B84-pharmaceutics-17-01176" ref-type="bibr">84</xref>]. For example, a conductive ink composed of polyaniline and polyethylene glycol diacrylate hydrogel exhibits semiconductor characteristics in scaffolds fabricated via 3D printing. These scaffolds maintain an average pore size of approximately 300 &#956;m, offering a microenvironment suitable for nerve tissue regeneration [<xref rid="B85-pharmaceutics-17-01176" ref-type="bibr">85</xref>]. Additionally, PEDOT:PSS-based hydrogels demonstrate high conductivity and stability. These hydrogels enhance neural cell adhesion and proliferation, demonstrating effectiveness in supporting axon formation and synaptic connections [<xref rid="B86-pharmaceutics-17-01176" ref-type="bibr">86</xref>]. These findings highlight the importance of scaffold design considering both electrical conductivity and biological activity for successful neural tissue engineering applications.</p></sec></sec></sec><sec id="sec4-pharmaceutics-17-01176"><title>4. Bioengineered Platforms for Peripheral Nervous System (PNS)</title><sec id="sec4dot1-pharmaceutics-17-01176"><title>4.1. Biomaterial-Based Conduits for Peripheral Nerve Repair</title><p>The PNS exhibits inherent capacity for regeneration; however, severe or complex injuries often limit full recovery [<xref rid="B87-pharmaceutics-17-01176" ref-type="bibr">87</xref>]. Consequently, tissue engineering approaches, particularly 3D bioprinting, have attracted significant attention. Nerve guidance conduits fabricated via 3D bioprinting offer structural support, promoting cell migration, alignment, and axon regeneration [<xref rid="B88-pharmaceutics-17-01176" ref-type="bibr">88</xref>,<xref rid="B89-pharmaceutics-17-01176" ref-type="bibr">89</xref>]. However, the success of these conduits depends on their architectural design and the selection of biomaterials that support cell viability, provide biochemical cues, and replicate the mechanical and degradation properties of native nerve tissue [<xref rid="B90-pharmaceutics-17-01176" ref-type="bibr">90</xref>]. Alginate- and gelatin-based hydrogels exhibit good biocompatibility, improving cell survival and growth factor expression. Silk-based nerve conduits with hierarchical ECM-like structures effectively guide Schwann cells and neuronal axons (<xref rid="pharmaceutics-17-01176-f004" ref-type="fig">Figure 4</xref>A) [<xref rid="B91-pharmaceutics-17-01176" ref-type="bibr">91</xref>]. Additionally, composites containing conductive polymers respond to electrical signals, enhancing cellular activity and accelerating nerve repair [<xref rid="B92-pharmaceutics-17-01176" ref-type="bibr">92</xref>,<xref rid="B93-pharmaceutics-17-01176" ref-type="bibr">93</xref>]. These material-based strategies offer significant advantages, combining structural support with physiological stimulation in nerve tissue engineering.</p></sec><sec id="sec4dot2-pharmaceutics-17-01176"><title>4.2. Schwann Cell-Based Scaffolds for Nerve Regeneration</title><p>Schwann cells are the principal glial cells of the PNS, essential for axonal regeneration and myelin sheath formation following nerve injury [<xref rid="B96-pharmaceutics-17-01176" ref-type="bibr">96</xref>,<xref rid="B97-pharmaceutics-17-01176" ref-type="bibr">97</xref>]. Advances in 3D bioprinting facilitate the direct incorporation of Schwann cells into biomaterials, creating optimal cell&#8211;scaffold composites for nerve regeneration. <xref rid="pharmaceutics-17-01176-f004" ref-type="fig">Figure 4</xref>B shows that GelMA hydrogels induce the attachment and alignment of Schwann cells [<xref rid="B94-pharmaceutics-17-01176" ref-type="bibr">94</xref>]. Additionally, they enhance the secretion of nerve growth factors, such as NGF and BDNF [<xref rid="B94-pharmaceutics-17-01176" ref-type="bibr">94</xref>], supporting axonal growth and differentiation. Scaffolds containing Schwann cells form axially aligned structures, guiding regenerating nerves in the correct direction. dECM-based bioinks of peripheral nerves have been developed in recent studies. These bioinks offer tissue-specific physiological cues [<xref rid="B70-pharmaceutics-17-01176" ref-type="bibr">70</xref>,<xref rid="B98-pharmaceutics-17-01176" ref-type="bibr">98</xref>,<xref rid="B99-pharmaceutics-17-01176" ref-type="bibr">99</xref>], thereby promoting the functional maturation of both neurons and Schwann cells. </p></sec><sec id="sec4dot3-pharmaceutics-17-01176"><title>4.3. Controlled Release Systems for Peripheral Nerve Regeneration</title><p>One key advantage of 3D bioprinting in peripheral nerve regeneration is its capacity to fabricate patient-specific structures. Scaffolds designed using CT or MRI imaging data demonstrate enhanced biocompatibility and superior therapeutic outcomes compared to conventional implants [<xref rid="B100-pharmaceutics-17-01176" ref-type="bibr">100</xref>]. <xref rid="pharmaceutics-17-01176-f004" ref-type="fig">Figure 4</xref>C illustrates 3D-printed scaffolds used as drug delivery systems. These scaffolds are loaded with regeneration-promoting factors, such as NGF, GDNF, and VEGF, enabling their sustained release to support nerve regeneration [<xref rid="B21-pharmaceutics-17-01176" ref-type="bibr">21</xref>,<xref rid="B101-pharmaceutics-17-01176" ref-type="bibr">101</xref>]. Depending on the design of the scaffold, the release mechanisms may range from passive diffusion to stimuli-responsive systems activated by changes in pH, enzymatic activity, or external electrical stimulation [<xref rid="B102-pharmaceutics-17-01176" ref-type="bibr">102</xref>]. These strategies allow spatiotemporal control over therapeutic delivery, thereby more closely mimicking the natural processes of nerve repair. The sequential or combined release of multiple growth factors, such as NGF for neurite extension followed by VEGF for angiogenesis, demonstrates synergistic effects in enhancing functional recovery [<xref rid="B103-pharmaceutics-17-01176" ref-type="bibr">103</xref>]. Additionally, 3D printing technology enables the precise fabrication of multi-channel structures, promoting regeneration of different nerve types and supporting blood vessel growth [<xref rid="B104-pharmaceutics-17-01176" ref-type="bibr">104</xref>]. Incorporating conductive or composite materials further stimulates axonal growth and enhances the re-establishment of functional neural connections [<xref rid="B105-pharmaceutics-17-01176" ref-type="bibr">105</xref>].</p></sec><sec id="sec4dot4-pharmaceutics-17-01176"><title>4.4. Biophysical Gradients Platform for Axonal Guidance</title><p>Recent advances in microfabrication techniques enable the precise fabrication of microenvironments incorporating both chemical and mechanical gradients [<xref rid="B106-pharmaceutics-17-01176" ref-type="bibr">106</xref>]. These gradient signals are crucial for peripheral nerve regeneration. Spatially controlled variations influence axonal growth, modulate Schwann cell activity, and enhance the alignment and functional maturation of regenerating nerve tissue. Growth factor-generated chemical gradients, such as NGF (<xref rid="pharmaceutics-17-01176-f004" ref-type="fig">Figure 4</xref>D), facilitate axonal extension and direct Schwann cell migration [<xref rid="B95-pharmaceutics-17-01176" ref-type="bibr">95</xref>]. Consequently, Schwann cells secrete trophic molecules, including NGF and BDNF, further enhancing axonal growth [<xref rid="B107-pharmaceutics-17-01176" ref-type="bibr">107</xref>,<xref rid="B108-pharmaceutics-17-01176" ref-type="bibr">108</xref>]. Techniques such as microfluidic patterning and surface functionalization have been used to integrate these gradients into nerve conduits, thereby facilitating nerve regeneration. Peptide gradient patterns integrated into micropatterned scaffold surfaces replicate the natural ECM, enhancing functional recovery. Mechanical gradients, including variations in scaffold stiffness, influence cell adhesion, migration, and differentiation. For nerve regeneration, the optimal scaffold stiffness ranges from 0.9 kPa to 2.9 kPa [<xref rid="B109-pharmaceutics-17-01176" ref-type="bibr">109</xref>]. These gradients affect both neurons and glial cells, guiding axonal growth and promoting the formation of functional connections [<xref rid="B110-pharmaceutics-17-01176" ref-type="bibr">110</xref>]. Post-printing mechanical conditioning facilitates cell alignment and enhances scaffold integration in vivo [<xref rid="B111-pharmaceutics-17-01176" ref-type="bibr">111</xref>]. Integrating chemical and mechanical gradients produces synergistic effects, enhancing regeneration outcomes. Hydrogels engineered with bioactive gradients and structural anisotropy facilitate neurite alignment and stimulate the release of growth factors [<xref rid="B112-pharmaceutics-17-01176" ref-type="bibr">112</xref>]. Conductive polymers responsive to electrical stimulation integrate structural guidance with functional recovery, facilitating more effective nerve repair [<xref rid="B113-pharmaceutics-17-01176" ref-type="bibr">113</xref>]. High-resolution bioprinting enables the creation of dynamic, biomimetic environments essential for successful peripheral nerve regeneration.</p></sec></sec><sec id="sec5-pharmaceutics-17-01176"><title>5. Bioengineered Platforms for Central Nervous System (CNS)</title><sec id="sec5dot1-pharmaceutics-17-01176"><title>5.1. Biomaterial-Based Platforms for Central Nervous System Tissue Engineering</title><p>The CNS, comprising the brain and spinal cord, serves as the primary control center for sensory information processing, motor coordination, and homeostatic regulation [<xref rid="B114-pharmaceutics-17-01176" ref-type="bibr">114</xref>]. In contrast to the PNS, the CNS exhibits a highly complex structure, characterized by the presence of the BBB, intricate neural networks, and highly localized cellular architectures; however, its capacity for self-repair remains limited [<xref rid="B115-pharmaceutics-17-01176" ref-type="bibr">115</xref>,<xref rid="B116-pharmaceutics-17-01176" ref-type="bibr">116</xref>]. These characteristics pose significant challenges for investigating CNS disease and developing effective therapeutic strategies. The human brain comprises various cell types, including neurons, astrocytes, oligodendrocytes, and microglia, each organized into distinct regions [<xref rid="B117-pharmaceutics-17-01176" ref-type="bibr">117</xref>]. Replicating this complexity in vitro requires advanced cell technologies capable of precise spatial arrangement of cells. <xref rid="pharmaceutics-17-01176-f005" ref-type="fig">Figure 5</xref>A illustrates that a 3D bioprinted construct, comprising induced pluripotent stem cell (iPSC)-derived neural cells, was developed using extrusion-based bioprinting. The bioprinted construct was validated using immunofluorescence staining for MAP2 (neuronal marker), TBR1 (deep-layer cortical neuron marker), and GFAP (astrocytic marker), confirming the successful formation of a layered, cortex-like architecture [<xref rid="B118-pharmaceutics-17-01176" ref-type="bibr">118</xref>]. GelMA served as the primary bioink due to its high biocompatibility, tunable mechanical properties, and proven ability to support neuronal adhesion and differentiation. The GelMA hydrogel was photopolymerized to ensure structural stability, and its elastic modulus was adjusted to match that of brain tissue (~1 kPa). These biomaterial-based strategies support 3D structural integrity and offer a physiologically relevant environment that promotes neural cell maturation and the formation of functional synaptic network.</p></sec><sec id="sec5dot2-pharmaceutics-17-01176"><title>5.2. Layered Neural Constructs Using 3D Bioprinting</title><p>Traditional two-dimensional culture systems and animal models cannot sufficiently replicate the unique microenvironment of the CNS. To address these limitations, 3D bioprinting has emerged as a powerful technology for precisely depositing neural cells and biomaterials, creating models that more accurately mimic the cellular structure and functional properties of natural brain tissue (<xref rid="pharmaceutics-17-01176-f005" ref-type="fig">Figure 5</xref>B) [<xref rid="B119-pharmaceutics-17-01176" ref-type="bibr">119</xref>]. For example, when human pluripotent stem cell-derived neural progenitor cells (NPCs) are patterned using extrusion-based bioprinting with GelMA-based bioinks [<xref rid="B122-pharmaceutics-17-01176" ref-type="bibr">122</xref>], they exhibit spontaneous electrical activity and differentiate into mature neurons and astrocytes. The printed constructs self-organize into multilayered neural architectures resembling the cerebral cortex, further developing functional synaptic networks and demonstrating spontaneous calcium oscillations, indicating the formation of functional neural circuitry [<xref rid="B123-pharmaceutics-17-01176" ref-type="bibr">123</xref>].</p></sec><sec id="sec5dot3-pharmaceutics-17-01176"><title>5.3. Vascularized Central Nervous System Models Developed with Microfluidic Platforms</title><p>Beyond layered tissue models, vascularization is essential for sustaining long-term cell viability and physiological function in CNS models. <xref rid="pharmaceutics-17-01176-f005" ref-type="fig">Figure 5</xref>C illustrates a microfluidic brain-on-a-chip platform used to model the vascular architecture of the brain [<xref rid="B120-pharmaceutics-17-01176" ref-type="bibr">120</xref>]. This system integrates iPSC-derived brain microvascular endothelial cells, astrocytes, and pericytes into perfusable channels, mimicking both the structural and functional characteristics of the neurovascular unit (NVU). The model facilitates continuous perfusion, maintains oxygen and nutrient gradients, and supports long-term co-culture of neural cells with vascular networks. Functional performance was validated using transendothelial electrical resistance measurements and permeability assays, indicating the formation of a tight, selective BBB.</p></sec><sec id="sec5dot4-pharmaceutics-17-01176"><title>5.4. Developmental and Disease Models Using Bioprinted Central Nervous System Constructs</title><p>Brain development involves complex spatial and temporal signaling. Three-dimensional bioprinting models provide valuable platforms for investigating neural development and associated disorders, such as autism spectrum disorder, epilepsy, and intellectual disabilities [<xref rid="B124-pharmaceutics-17-01176" ref-type="bibr">124</xref>,<xref rid="B125-pharmaceutics-17-01176" ref-type="bibr">125</xref>,<xref rid="B126-pharmaceutics-17-01176" ref-type="bibr">126</xref>]. <xref rid="pharmaceutics-17-01176-f005" ref-type="fig">Figure 5</xref>D illustrates that extrusion-based 3D bioprinting enables the spatially controlled deposition of human iPSC-derived NPCs and astrocyte precursors within bioinks, facilitating the reproduction of key developmental processes, including neuronal differentiation, synapse formation, cortical layering, and axon guidance [<xref rid="B121-pharmaceutics-17-01176" ref-type="bibr">121</xref>]. The GelMA-based bioinks promote high cell viability and support long-term culture periods. Immunofluorescence staining confirms the formation of distinct neural layers, while calcium imaging demonstrates the development of functional synaptic activity. Additionally, iPSC-based personalized models facilitate the correlation of specific genotypes with phenotypic outcomes [<xref rid="B118-pharmaceutics-17-01176" ref-type="bibr">118</xref>]. Bioprinted construct derived from NPCs and astrocyte precursors mature into functional neurons and astrocytes, exhibiting established synaptic connectivity and dynamic calcium signaling [<xref rid="B56-pharmaceutics-17-01176" ref-type="bibr">56</xref>]. This approach enables the modeling of both developmental and pathological neural networks. Recent studies show that 3D CNS models replicate key pathological features of neurodegenerative diseases&#8212;for example, amyloid plaque formation in Alzheimer&#8217;s disease, dopamine neuron degeneration in Parkinson&#8217;s disease [<xref rid="B127-pharmaceutics-17-01176" ref-type="bibr">127</xref>], and glioma progression [<xref rid="B128-pharmaceutics-17-01176" ref-type="bibr">128</xref>]. These advances highlight the expanding range of applications, extending beyond neurodevelopmental research to include disease modeling and high-throughput drug screening.</p></sec><sec id="sec5dot5-pharmaceutics-17-01176"><title>5.5. Neural Cancer Models (e.g., Glioblastoma)</title><p>Glioblastoma multiforme (GBM) is an aggressive primary brain tumor characterized by high invasiveness and poor treatment response, largely due to its complex tumor microenvironment (TME) and the restrictive nature of the BBB [<xref rid="B129-pharmaceutics-17-01176" ref-type="bibr">129</xref>]. Conventional models often fail to accurately mimic these pathological features [<xref rid="B130-pharmaceutics-17-01176" ref-type="bibr">130</xref>]. Recent advances in 3D bioprinting have enabled the development of GBM models using ECM-mimetic bioinks combined with patient-derived GBM cells, endothelial cells, and supportive glial components [<xref rid="B131-pharmaceutics-17-01176" ref-type="bibr">131</xref>]. These bioprinted constructs replicate key features of the TME, including vascular network formation and dynamic cell&#8211;cell interactions. Compared to conventional 2D cultures, they exhibit increased drug resistance and invasiveness. Furthermore, adjusting the ECM composition and stiffness affects angiogenic processes, including VEGF expression and blood vessel formation. Integrated NVU-GBM-on-a-chip platforms combining multi-nozzle bioprinting with microfluidic systems are currently in development, offering potential for high-throughput drug screening and personalized therapeutic testing [<xref rid="B132-pharmaceutics-17-01176" ref-type="bibr">132</xref>]. However, challenges persist in the field, particularly the absence of immune components and the lack of standardized protocols [<xref rid="B133-pharmaceutics-17-01176" ref-type="bibr">133</xref>]. Recent advances in 3D bioprinting and biomaterial engineering have facilitated the development of highly sophisticated CNS models, encompassing layered neural constructs, vascularized brain-on-a-chip systems, and disease-specific or TME platforms [<xref rid="B23-pharmaceutics-17-01176" ref-type="bibr">23</xref>]. These bioengineered models closely replicate the structural, cellular, and functional characteristics of the human CNS, offering powerful tools for investigating neural development, modeling neurodegenerative and neoplastic disorders, and screening therapeutic candidates within physiologically relevant conditions.</p></sec></sec><sec id="sec6-pharmaceutics-17-01176"><title>6. Bioprinting Strategies for Central and Peripheral Nervous System Models</title><sec id="sec6dot1-pharmaceutics-17-01176"><title>6.1. Comparative Analysis of Bioprinted Models of the Central and Peripheral Nervous Systems</title><p>The Three-dimensional bioprinting for neural tissue engineering should address the unique properties of the CNS and PNS, particularly regarding printing techniques, bioink composition, and design objectives. In CNS applications, bioprinting often focuses on replicating layered cortical architectures and interconnected synaptic networks. These constructs are typically fabricated using extrusion-based techniques with soft, neurocompatible hydrogels filled with neural progenitor and glial cells [<xref rid="B66-pharmaceutics-17-01176" ref-type="bibr">66</xref>]. Achieving high spatial resolution, low shear stress, and long-term viability is crucial for neural tissue engineering. Furthermore, ongoing research focuses on implementing vascularization and synaptic functions by integrating microfluidic platforms that mimic the BBB [<xref rid="B131-pharmaceutics-17-01176" ref-type="bibr">131</xref>]. In contrast, the PNS models primarily employ multi-material or coaxial printing to fabricate NGCs that facilitate chemical signaling and axon alignment. These models often use various bioinks (e.g., alginate, silk fibroin) with increasing interest in incorporating conductive elements to facilitate electrical signal transmission and support axonal growth. The primary priorities for tissue engineering are axon regeneration, Schwann cell support, and bone marrow formation. In contrast to the CNS, these processes have a limited effect on vascular integration. Both systems require careful optimization of printing parameters, such as extrusion pressure, nozzle diameter, and crosslinking conditions, to match the target tissue type. CNS models require precise replication of layered architecture and synaptic organization, while PNS structures emphasize axonal alignment and directional growth [<xref rid="B134-pharmaceutics-17-01176" ref-type="bibr">134</xref>]. Furthermore, post-printing maturation strategies differ: CNS constructs typically undergo long-term neurotrophic culture to promote network development, while PNS constructs focus on early-stage guidance and repair processes [<xref rid="B135-pharmaceutics-17-01176" ref-type="bibr">135</xref>].</p></sec><sec id="sec6dot2-pharmaceutics-17-01176"><title>6.2. Challenges and Opportunities in Bioprinting for Peripheral and Central Nervous Systems Regeneration</title><p>Despite recent progress, bioprinted disease models of both the CNS and PNS face significant limitations. These include challenges in accurately mimicking chronic disease progression, limited integration of immune system components, and the lack of standardized fabrication protocols. While bioprinting technologies establish spatial and biochemical gradients crucial for neural tissue modeling, current platforms often struggle to generate stable, high-resolution gradients with precise mechanical and biochemical control [<xref rid="B136-pharmaceutics-17-01176" ref-type="bibr">136</xref>]. In PNS applications, significant technical challenges remain in achieving an optimal balance between bioink biocompatibility and mechanical strength [<xref rid="B11-pharmaceutics-17-01176" ref-type="bibr">11</xref>]. Most hydrogel-based materials lack sufficient robustness for long-term in vivo stability. Advances in high-resolution printing, nozzle engineering, and post-processing techniques are necessary to replicate the complexity of neural architectures. Additionally, the development of bio-conductive, biodegradable materials is essential for enabling functional regeneration and seamless integration with neural devices. However, emerging innovations, including disease-specific bioinks [<xref rid="B32-pharmaceutics-17-01176" ref-type="bibr">32</xref>], gradient-based drug delivery platforms, and organ-on-chip integrations, offer promising solutions [<xref rid="B119-pharmaceutics-17-01176" ref-type="bibr">119</xref>]. These approaches will enhance the clinical relevance of neural models and expand the translational potential of 3D bioprinting in neuroregenerative medicine.</p><p>As summarized in <xref rid="pharmaceutics-17-01176-t003" ref-type="table">Table 3</xref>, the central nervous system (CNS) and peripheral nervous system (PNS) models differ significantly in terms of bioprinting methods, cell types, bioink concentrations, tissue structure, functional verification, mechanical cues, and applications [<xref rid="B66-pharmaceutics-17-01176" ref-type="bibr">66</xref>,<xref rid="B87-pharmaceutics-17-01176" ref-type="bibr">87</xref>,<xref rid="B88-pharmaceutics-17-01176" ref-type="bibr">88</xref>,<xref rid="B89-pharmaceutics-17-01176" ref-type="bibr">89</xref>,<xref rid="B90-pharmaceutics-17-01176" ref-type="bibr">90</xref>,<xref rid="B91-pharmaceutics-17-01176" ref-type="bibr">91</xref>,<xref rid="B92-pharmaceutics-17-01176" ref-type="bibr">92</xref>,<xref rid="B131-pharmaceutics-17-01176" ref-type="bibr">131</xref>].</p></sec></sec><sec id="sec7-pharmaceutics-17-01176"><title>7. Future Directions and Challenges</title><sec id="sec7dot1-pharmaceutics-17-01176"><title>7.1. Advancing Bioprinting Hardware for Gradient Control</title><p>Although 3D bioprinting has significantly advanced the reproduction of neural tissue structures, precise control over the mechanical, biochemical, and electrical gradients crucial for neural development and regeneration remains a major challenge. Functional graded materials are crucial for replicating the heterogeneous microenvironment of neural tissue, but current bioprinting systems cannot generate such gradients continuously and accurately [<xref rid="B137-pharmaceutics-17-01176" ref-type="bibr">137</xref>]. Traditional nozzle systems are primarily designed for uniform extrusion, limiting dynamic control over bioink composition and rheological properties during printing [<xref rid="B138-pharmaceutics-17-01176" ref-type="bibr">138</xref>]. This limitation hinders the reproduction of regional microenvironments crucial for neural differentiation, synapse formation, and axonal pathfinding. To address these limitations, innovative nozzle designs have been proposed. Multi-material bioprinting platforms incorporating coaxial, triaxial, or microfluidic-integrated nozzles enable spatially controlled co-extrusion and mixing of multiple bioinks, facilitating continuous or discrete gradient formation in situ [<xref rid="B139-pharmaceutics-17-01176" ref-type="bibr">139</xref>]. This approach supports the fabrication of complex tissue interfaces and physiologically relevant segmented neural structures. However, achieving precise, reproducible, and stable gradient patterns remains technically challenging. Recent advances in closed-loop control systems incorporating machine learning (ML) algorithms offer promising solutions [<xref rid="B140-pharmaceutics-17-01176" ref-type="bibr">140</xref>]. These systems dynamically regulate key printing parameters such as pressure, flow rate, and temperature in real time to enhance gradient fidelity and consistency. However, further efforts are required to standardize these advanced hardware systems and to validate their scalability for translational and clinical applications. Moreover, translating 3D bioprinted neural constructs from bench to bedside remains a formidable challenge. Current barriers include limited batch-to-batch reproducibility, the absence of regulatory frameworks specific to bioprinted neural tissues, and difficulties in achieving stable functional integration with host tissues. Additionally, issues related to immune compatibility, long-term safety, and large-scale manufacturing capacity must be resolved to advance clinical adoption.</p></sec><sec id="sec7dot2-pharmaceutics-17-01176"><title>7.2. Advancements in Bioink Development</title><p>The performance and functionality of bioinks are crucial for successful bioprinting. Conventional hydrogel bioinks, including GelMA, alginate, and collagen, are widely used for their biocompatibility and shear-thinning properties. However, balancing mechanical strength, cellular viability, and printability remains challenging. Soft hydrogels lack sufficient mechanical integrity, whereas rigid materials compromise cell health. To address these limitations, hybrid and composite bioinks have been developed. dECM bioinks provide tissue-specific environments that promote cell differentiation and maturation [<xref rid="B141-pharmaceutics-17-01176" ref-type="bibr">141</xref>]. Conductive bioinks incorporating materials such as polypyrrole or graphene are used in neural and cardiac tissue engineering [<xref rid="B142-pharmaceutics-17-01176" ref-type="bibr">142</xref>]. These bioinks respond to electrical stimuli, facilitating signal transmission and functional restoration. Furthermore, Ongoing research is also focused on developing stimulus-responsive bioinks that react to temperature, pH, or light [<xref rid="B143-pharmaceutics-17-01176" ref-type="bibr">143</xref>,<xref rid="B144-pharmaceutics-17-01176" ref-type="bibr">144</xref>]. Recent efforts have emphasized the establishment of standardized protocols for bioink evaluation, including rheological characterization, biocompatibility analysis, and degradation assessment [<xref rid="B145-pharmaceutics-17-01176" ref-type="bibr">145</xref>].</p></sec><sec id="sec7dot3-pharmaceutics-17-01176"><title>7.3. Integration of Bioprinting with Complementary Technologies</title><p>The advancement in 3D bioprinting increasingly emphasizes its integration with complementary technologies, including artificial intelligence (AI), ML, organ-on-a-chip (OoC) [<xref rid="B146-pharmaceutics-17-01176" ref-type="bibr">146</xref>], and microchip platforms. Artificial neural networks in AI and ML can monitor and assess printing status. Deep learning models enhance scaffold design optimization, reducing printing errors and accelerating experimental timelines [<xref rid="B147-pharmaceutics-17-01176" ref-type="bibr">147</xref>,<xref rid="B148-pharmaceutics-17-01176" ref-type="bibr">148</xref>]. The integration of 3D bioprinting with OoC and microfluidic technologies is currently advancing. These technologies simulate fluid flow, shear stress, and tissue-specific microenvironments [<xref rid="B149-pharmaceutics-17-01176" ref-type="bibr">149</xref>]. Incorporating bioprinted tissues into chip-based systems sustains organ viability, maturation, and tissue functionality [<xref rid="B150-pharmaceutics-17-01176" ref-type="bibr">150</xref>,<xref rid="B151-pharmaceutics-17-01176" ref-type="bibr">151</xref>]. This hybrid technology facilitates the development of models for multi-organ interactions, personalized medicine, and high-throughput drug screening. Microfluidic chips can be coupled with Interstitial spaces or bioprinted tumor tissues. This system has been applied to investigate metabolism, cancer progression, and immune responses. Integrated biosensors for pH, oxygen, and cytokine detection enhance real-time monitoring [<xref rid="B152-pharmaceutics-17-01176" ref-type="bibr">152</xref>,<xref rid="B153-pharmaceutics-17-01176" ref-type="bibr">153</xref>]. The integration of AI and microfluidic engineering is gaining considerable attention. AI-driven control systems regulate fluid dynamics based on cellular conditions to accurately replicate biological environments. Certain systems employ machine learning-driven feedback loops to improve and adjust manufacturing processes [<xref rid="B154-pharmaceutics-17-01176" ref-type="bibr">154</xref>,<xref rid="B155-pharmaceutics-17-01176" ref-type="bibr">155</xref>]. Persistent challenges include ensuring bioink&#8211;substrate compatibility, maintaining long-term perfusion, and managing data in AI-integrated systems. Ongoing interdisciplinary collaboration is crucial to overcoming these barriers. </p></sec></sec><sec sec-type="conclusions" id="sec8-pharmaceutics-17-01176"><title>8. Conclusions</title><p>In summary, 3D bioprinting technology offers significant potential for neural tissue engineering by enabling precise replication of intricate cellular structures and circuit formation in the CNS and PNS. This approach addresses key limitations of traditional two-dimensional cultures and animal models. This review highlighted the significance of bioink properties, such as rheology, biocompatibility, bioactivity, and conductivity, in ensuring structural stability and cellular function. Furthermore, precise control of scaffold microstructure and mechanical properties, combined with the use of bifunctional materials, enhances the modulation of neuronal and Schwann cell activity. Incorporating patient-derived iPSCs for personalized disease modeling, alongside brain organoids and spatiotemporal regulation of growth factors and electrical stimulation, offers significant potential for advancing drug screening and regenerative therapies. Future research should prioritize sophisticated bioprinting techniques that enable multicellular patterning, vascularization, and electrophysiological integration. This focus will support the development of advanced neural tissue platforms for functional reconstruction and clinical application.</p></sec></body><back><fn-group><fn><p><bold>Disclaimer/Publisher&#8217;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><notes><title>Author Contributions</title><p>Conceptualization, T.C. and H.L.; literature review, T.C., J.P., S.L. and H.-J.J.; writing&#8212;original draft preparation, T.C.; writing&#8212;review and editing, T.C., J.P., S.L., H.-J.J., B.H.K., H.-O.K. and H.L.; visualization, T.C. and J.P.; supervision, H.-O.K. and H.L.; project administration, H.-O.K. and H.L.; funding acquisition, H.-O.K. and H.L. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Institutional Review Board Statement</title><p>Not applicable.</p></notes><notes><title>Informed Consent Statement</title><p>Not applicable.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>The data presented in this study are available on request from the corresponding author.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><glossary><title>Abbreviations</title><array orientation="portrait"><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">3D</td><td align="left" valign="middle" rowspan="1" colspan="1">Three-dimensional</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">4D</td><td align="left" valign="middle" rowspan="1" colspan="1">Four-dimensional (time-responsive) bioprinting</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">AI</td><td align="left" valign="middle" rowspan="1" colspan="1">Artificial intelligence</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">BBB</td><td align="left" valign="middle" rowspan="1" colspan="1">Blood&#8211;brain barrier</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">CNS</td><td align="left" valign="middle" rowspan="1" colspan="1">Central nervous system</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">DAPI</td><td align="left" valign="middle" rowspan="1" colspan="1">4&#8242;,6-diamidino-2-phenylindole</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">dECM</td><td align="left" valign="middle" rowspan="1" colspan="1">Decellularized extracellular matrix</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">DLP</td><td align="left" valign="middle" rowspan="1" colspan="1">Digital light processing</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">ECM</td><td align="left" valign="middle" rowspan="1" colspan="1">Extracellular matrix</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">EHD</td><td align="left" valign="middle" rowspan="1" colspan="1">Electrohydrodynamic</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">GelMA</td><td align="left" valign="middle" rowspan="1" colspan="1">Gelatin methacryloyl</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">GFP</td><td align="left" valign="middle" rowspan="1" colspan="1">Green fluorescent protein</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">HA</td><td align="left" valign="middle" rowspan="1" colspan="1">Hyaluronic acid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">MAP2</td><td align="left" valign="middle" rowspan="1" colspan="1">Microtubule-associated protein 2</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">NGF</td><td align="left" valign="middle" rowspan="1" colspan="1">Nerve growth factor</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">NPCs</td><td align="left" valign="middle" rowspan="1" colspan="1">Neural progenitor cells</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">NTE</td><td align="left" valign="middle" rowspan="1" colspan="1">Neural tissue engineering</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">PCL</td><td align="left" valign="middle" rowspan="1" colspan="1">Polycaprolactone</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">PEDOT:PSS</td><td align="left" valign="middle" rowspan="1" colspan="1">Poly(3,4-ethylenedioxythiophene):poly(styrenesulfonate)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">PEG</td><td align="left" valign="middle" rowspan="1" colspan="1">Polyethylene glycol</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">PLA</td><td align="left" valign="middle" rowspan="1" colspan="1">Polylactic acid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">PNS</td><td align="left" valign="middle" rowspan="1" colspan="1">Peripheral nervous system</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">PST</td><td align="left" valign="middle" rowspan="1" colspan="1">Phase separation technique</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">TBR1</td><td align="left" valign="middle" rowspan="1" colspan="1">T-box brain transcription factor 1</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">VEGF</td><td align="left" valign="middle" rowspan="1" colspan="1">Vascular endothelial growth factor</td></tr></tbody></array></glossary><ref-list><title>References</title><ref id="B1-pharmaceutics-17-01176"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Ma</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Ren</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Lu</surname><given-names>D.</given-names></name><name name-style="western"><surname>Li</surname><given-names>T.</given-names></name><name name-style="western"><surname>Li</surname><given-names>W.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Ma</surname><given-names>H.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>J.</given-names></name></person-group><article-title>Tissue Engineering Strategies for Peripheral Nerve Regeneration</article-title><source>Front. Neurol.</source><year>2021</year><volume>12</volume><elocation-id>768267</elocation-id><pub-id pub-id-type="doi">10.3389/fneur.2021.768267</pub-id><pub-id pub-id-type="pmid">34867754</pub-id><pub-id pub-id-type="pmcid">PMC8635143</pub-id></element-citation></ref><ref id="B2-pharmaceutics-17-01176"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>S.</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>A.</given-names></name><name name-style="western"><surname>Meng</surname><given-names>F.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J.</given-names></name></person-group><article-title>The Expanding Burden of Neurodegenerative Diseases: An Unmet Medical and Social Need</article-title><source>Aging Dis.</source><year>2024</year><volume>16</volume><fpage>2937</fpage><pub-id pub-id-type="doi">10.14336/AD.2024.1071</pub-id><pub-id pub-id-type="pmid">39571158</pub-id><pub-id pub-id-type="pmcid">PMC12339136</pub-id></element-citation></ref><ref id="B3-pharmaceutics-17-01176"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yokota</surname><given-names>K.</given-names></name><name name-style="western"><surname>Sakai</surname><given-names>H.</given-names></name><name name-style="western"><surname>Kawano</surname><given-names>O.</given-names></name><name name-style="western"><surname>Morishita</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Masuda</surname><given-names>M.</given-names></name><name name-style="western"><surname>Hayashi</surname><given-names>T.</given-names></name><name name-style="western"><surname>Kubota</surname><given-names>K.</given-names></name><name name-style="western"><surname>Ideta</surname><given-names>R.</given-names></name><name name-style="western"><surname>Ariji</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Koga</surname><given-names>R.</given-names></name><etal/></person-group><article-title>Changing trends in traumatic spinal cord injury in an aging society: Epidemiology of 1152 cases over 15 years from a single center in Japan</article-title><source>PLoS ONE</source><year>2024</year><volume>19</volume><elocation-id>e0298836</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0298836</pub-id><pub-id pub-id-type="pmid">38753862</pub-id><pub-id pub-id-type="pmcid">PMC11098516</pub-id></element-citation></ref><ref id="B4-pharmaceutics-17-01176"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Niu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Ganta</surname><given-names>C.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>L.D.</given-names></name></person-group><article-title>Peripheral Neuropathy in Older Adults</article-title><source>J. Electrodiagn. Neuromuscul. Dis.</source><year>2023</year><volume>25</volume><fpage>92</fpage><lpage>99</lpage><pub-id pub-id-type="doi">10.18214/jend.2023.00115</pub-id></element-citation></ref><ref id="B5-pharmaceutics-17-01176"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yuan</surname><given-names>T.Y.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Yu</surname><given-names>T.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>J.P.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Q.Y.</given-names></name></person-group><article-title>3D Bioprinting for Spinal Cord Injury Repair</article-title><source>Front. Bioeng. Biotechnol.</source><year>2022</year><volume>10</volume><elocation-id>847344</elocation-id><pub-id pub-id-type="doi">10.3389/fbioe.2022.847344</pub-id><pub-id pub-id-type="pmid">35519617</pub-id><pub-id pub-id-type="pmcid">PMC9065470</pub-id></element-citation></ref><ref id="B6-pharmaceutics-17-01176"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lu</surname><given-names>D.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>P.</given-names></name><name name-style="western"><surname>Ma</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Li</surname><given-names>W.</given-names></name><name name-style="western"><surname>Song</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Feng</surname><given-names>H.</given-names></name><name name-style="western"><surname>Yu</surname><given-names>W.</given-names></name><name name-style="western"><surname>Ren</surname><given-names>F.</given-names></name><name name-style="western"><surname>Li</surname><given-names>T.</given-names></name><etal/></person-group><article-title>Development and Application of Three-Dimensional Bioprinting Scaffold in the Repair of Spinal Cord Injury</article-title><source>Tissue Eng. Regen. Med.</source><year>2022</year><volume>19</volume><fpage>1113</fpage><lpage>1127</lpage><pub-id pub-id-type="doi">10.1007/s13770-022-00465-1</pub-id><pub-id pub-id-type="pmid">35767151</pub-id><pub-id pub-id-type="pmcid">PMC9679100</pub-id></element-citation></ref><ref id="B7-pharmaceutics-17-01176"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Boahen</surname><given-names>A.</given-names></name><name name-style="western"><surname>Hu</surname><given-names>D.</given-names></name><name name-style="western"><surname>Adams</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Nicholls</surname><given-names>P.K.</given-names></name><name name-style="western"><surname>Greene</surname><given-names>W.K.</given-names></name><name name-style="western"><surname>Ma</surname><given-names>B.</given-names></name></person-group><article-title>Bidirectional crosstalk between the peripheral nervous system and lymphoid tissues/organs</article-title><source>Front. Immunol.</source><year>2023</year><volume>14</volume><elocation-id>1254054</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2023.1254054</pub-id><pub-id pub-id-type="pmid">37767094</pub-id><pub-id pub-id-type="pmcid">PMC10520967</pub-id></element-citation></ref><ref id="B8-pharmaceutics-17-01176"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Townsend</surname><given-names>K.L.</given-names></name></person-group><article-title>One Nervous System: Critical Links Between Central and Peripheral Nervous System Health and Implications for Obesity and Diabetes</article-title><source>Diabetes</source><year>2024</year><volume>73</volume><fpage>1967</fpage><lpage>1975</lpage><pub-id pub-id-type="doi">10.2337/dbi24-0004</pub-id><pub-id pub-id-type="pmid">39401394</pub-id></element-citation></ref><ref id="B9-pharmaceutics-17-01176"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Abe</surname><given-names>N.</given-names></name><name name-style="western"><surname>Cavalli</surname><given-names>V.</given-names></name></person-group><article-title>Nerve injury signaling</article-title><source>Curr. Opin. Neurobiol.</source><year>2008</year><volume>18</volume><fpage>276</fpage><lpage>283</lpage><pub-id pub-id-type="doi">10.1016/j.conb.2008.06.005</pub-id><pub-id pub-id-type="pmid">18655834</pub-id><pub-id pub-id-type="pmcid">PMC2633416</pub-id></element-citation></ref><ref id="B10-pharmaceutics-17-01176"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>D.Y.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>G.</given-names></name><name name-style="western"><surname>An</surname><given-names>S.B.</given-names></name><name name-style="western"><surname>Han</surname><given-names>I.</given-names></name></person-group><article-title>Innovative Strategies in 3D Bioprinting for Spinal Cord Injury Repair</article-title><source>Int. J. Mol. Sci.</source><year>2024</year><volume>25</volume><elocation-id>9592</elocation-id><pub-id pub-id-type="doi">10.3390/ijms25179592</pub-id><pub-id pub-id-type="pmid">39273538</pub-id><pub-id pub-id-type="pmcid">PMC11395085</pub-id></element-citation></ref><ref id="B11-pharmaceutics-17-01176"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cadena</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ning</surname><given-names>L.</given-names></name><name name-style="western"><surname>King</surname><given-names>A.</given-names></name><name name-style="western"><surname>Hwang</surname><given-names>B.</given-names></name><name name-style="western"><surname>Jin</surname><given-names>L.</given-names></name><name name-style="western"><surname>Serpooshan</surname><given-names>V.</given-names></name><name name-style="western"><surname>Sloan</surname><given-names>S.A.</given-names></name></person-group><article-title>3D Bioprinting of Neural Tissues</article-title><source>Adv. Healthc. Mater.</source><year>2021</year><volume>10</volume><fpage>e2001600</fpage><pub-id pub-id-type="doi">10.1002/adhm.202001600</pub-id><pub-id pub-id-type="pmid">33200587</pub-id><pub-id pub-id-type="pmcid">PMC8711131</pub-id></element-citation></ref><ref id="B12-pharmaceutics-17-01176"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lv</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Dong</surname><given-names>C.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>T.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>S.</given-names></name></person-group><article-title>Hydrogels in Spinal Cord Injury Repair: A Review</article-title><source>Front. Bioeng. Biotechnol.</source><year>2022</year><volume>10</volume><elocation-id>931800</elocation-id><pub-id pub-id-type="doi">10.3389/fbioe.2022.931800</pub-id><pub-id pub-id-type="pmid">35800332</pub-id><pub-id pub-id-type="pmcid">PMC9253563</pub-id></element-citation></ref><ref id="B13-pharmaceutics-17-01176"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bektas</surname><given-names>C.K.</given-names></name><name name-style="western"><surname>Luo</surname><given-names>J.</given-names></name><name name-style="western"><surname>Conley</surname><given-names>B.</given-names></name><name name-style="western"><surname>Le</surname><given-names>K.N.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>K.B.</given-names></name></person-group><article-title>3D bioprinting approaches for enhancing stem cell-based neural tissue regeneration</article-title><source>Acta Biomater.</source><year>2025</year><volume>193</volume><fpage>20</fpage><lpage>48</lpage><pub-id pub-id-type="doi">10.1016/j.actbio.2025.01.006</pub-id><pub-id pub-id-type="pmid">39793745</pub-id></element-citation></ref><ref id="B14-pharmaceutics-17-01176"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>L.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>H.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>H.</given-names></name><name name-style="western"><surname>Guo</surname><given-names>K.</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>H.</given-names></name><name name-style="western"><surname>Li</surname><given-names>S.</given-names></name><name name-style="western"><surname>Gao</surname><given-names>F.</given-names></name><name name-style="western"><surname>Li</surname><given-names>S.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>X.</given-names></name><etal/></person-group><article-title>Fabrication of Multi-Channel Nerve Guidance Conduits Containing Schwann Cells Based on Multi-Material 3D Bioprinting</article-title><source>3D Print. Addit. Manuf.</source><year>2023</year><volume>10</volume><fpage>1046</fpage><lpage>1054</lpage><pub-id pub-id-type="doi">10.1089/3dp.2021.0203</pub-id><pub-id pub-id-type="pmid">37886409</pub-id><pub-id pub-id-type="pmcid">PMC10599437</pub-id></element-citation></ref><ref id="B15-pharmaceutics-17-01176"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dhar</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ahmad</surname><given-names>F.</given-names></name><name name-style="western"><surname>Deshpande</surname><given-names>A.</given-names></name><name name-style="western"><surname>Rana</surname><given-names>S.S.</given-names></name><name name-style="western"><surname>Ahmed</surname><given-names>A.T.</given-names></name><name name-style="western"><surname>Priyadarsini</surname><given-names>S.</given-names></name></person-group><article-title>3-Dimensional printing and bioprinting in neurological sciences: Applications in surgery, imaging, tissue engineering, and pharmacology and therapeutics</article-title><source>J. Mater. Sci. Mater. Med.</source><year>2025</year><volume>36</volume><fpage>32</fpage><pub-id pub-id-type="doi">10.1007/s10856-025-06877-4</pub-id><pub-id pub-id-type="pmid">40205004</pub-id><pub-id pub-id-type="pmcid">PMC11982170</pub-id></element-citation></ref><ref id="B16-pharmaceutics-17-01176"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gharibshahian</surname><given-names>M.</given-names></name><name name-style="western"><surname>Torkashvand</surname><given-names>M.</given-names></name><name name-style="western"><surname>Bavisi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Aldaghi</surname><given-names>N.</given-names></name><name name-style="western"><surname>Alizadeh</surname><given-names>A.</given-names></name></person-group><article-title>Recent advances in artificial intelligent strategies for tissue engineering and regenerative medicine</article-title><source>Skin Res. Technol.</source><year>2024</year><volume>30</volume><fpage>e70016</fpage><pub-id pub-id-type="doi">10.1111/srt.70016</pub-id><pub-id pub-id-type="pmid">39189880</pub-id><pub-id pub-id-type="pmcid">PMC11348508</pub-id></element-citation></ref><ref id="B17-pharmaceutics-17-01176"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xie</surname><given-names>J.</given-names></name><name name-style="western"><surname>MacEwan</surname><given-names>M.R.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>W.</given-names></name><name name-style="western"><surname>Jesuraj</surname><given-names>N.</given-names></name><name name-style="western"><surname>Li</surname><given-names>X.</given-names></name><name name-style="western"><surname>Hunter</surname><given-names>D.</given-names></name><name name-style="western"><surname>Xia</surname><given-names>Y.</given-names></name></person-group><article-title>Nerve guidance conduits based on double-layered scaffolds of electrospun nanofibers for repairing the peripheral nervous system</article-title><source>ACS Appl. Mater. Interfaces</source><year>2014</year><volume>6</volume><fpage>9472</fpage><lpage>9480</lpage><pub-id pub-id-type="doi">10.1021/am5018557</pub-id><pub-id pub-id-type="pmid">24806389</pub-id><pub-id pub-id-type="pmcid">PMC4073935</pub-id></element-citation></ref><ref id="B18-pharmaceutics-17-01176"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ning</surname><given-names>L.</given-names></name><name name-style="western"><surname>Sun</surname><given-names>H.</given-names></name><name name-style="western"><surname>Lelong</surname><given-names>T.</given-names></name><name name-style="western"><surname>Guilloteau</surname><given-names>R.</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>N.</given-names></name><name name-style="western"><surname>Schreyer</surname><given-names>D.J.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>X.</given-names></name></person-group><article-title>3D bioprinting of scaffolds with living Schwann cells for potential nerve tissue engineering applications</article-title><source>Biofabrication</source><year>2018</year><volume>10</volume><elocation-id>035014</elocation-id><pub-id pub-id-type="doi">10.1088/1758-5090/aacd30</pub-id><pub-id pub-id-type="pmid">29911990</pub-id></element-citation></ref><ref id="B19-pharmaceutics-17-01176"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Gou</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Tao</surname><given-names>J.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Kang</surname><given-names>T.</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>S.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>S.</given-names></name><name name-style="western"><surname>He</surname><given-names>J.</given-names></name><etal/></person-group><article-title>3D-engineering of Cellularized Conduits for Peripheral Nerve Regeneration</article-title><source>Sci. Rep.</source><year>2016</year><volume>6</volume><elocation-id>32184</elocation-id><pub-id pub-id-type="doi">10.1038/srep32184</pub-id><pub-id pub-id-type="pmid">27572698</pub-id><pub-id pub-id-type="pmcid">PMC5004136</pub-id></element-citation></ref><ref id="B20-pharmaceutics-17-01176"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lozano</surname><given-names>R.</given-names></name><name name-style="western"><surname>Stevens</surname><given-names>L.</given-names></name><name name-style="western"><surname>Thompson</surname><given-names>B.C.</given-names></name><name name-style="western"><surname>Gilmore</surname><given-names>K.J.</given-names></name><name name-style="western"><surname>Gorkin</surname><given-names>R.</given-names><suffix>3rd</suffix></name><name name-style="western"><surname>Stewart</surname><given-names>E.M.</given-names></name><name name-style="western"><surname>in het Panhuis</surname><given-names>M.</given-names></name><name name-style="western"><surname>Romero-Ortega</surname><given-names>M.</given-names></name><name name-style="western"><surname>Wallace</surname><given-names>G.G.</given-names></name></person-group><article-title>3D printing of layered brain-like structures using peptide modified gellan gum substrates</article-title><source>Biomaterials</source><year>2015</year><volume>67</volume><fpage>264</fpage><lpage>273</lpage><pub-id pub-id-type="doi">10.1016/j.biomaterials.2015.07.022</pub-id><pub-id pub-id-type="pmid">26231917</pub-id></element-citation></ref><ref id="B21-pharmaceutics-17-01176"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liao</surname><given-names>W.</given-names></name><name name-style="western"><surname>Shi</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Li</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Yin</surname><given-names>X.</given-names></name></person-group><article-title>MicrochannelsforNeuralTissueengineering for nerve regeneration and repair</article-title><source>J. Nanobiotechnol.</source><year>2025</year><volume>23</volume><elocation-id>5</elocation-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12951-024-03052-9</pub-id><pub-id pub-id-type="pmcid">PMC11697815</pub-id><pub-id pub-id-type="pmid">39754257</pub-id></element-citation></ref><ref id="B22-pharmaceutics-17-01176"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Logan</surname><given-names>S.</given-names></name><name name-style="western"><surname>Arzua</surname><given-names>T.</given-names></name><name name-style="western"><surname>Canfield</surname><given-names>S.G.</given-names></name><name name-style="western"><surname>Seminary</surname><given-names>E.R.</given-names></name><name name-style="western"><surname>Sison</surname><given-names>S.L.</given-names></name><name name-style="western"><surname>Ebert</surname><given-names>A.D.</given-names></name><name name-style="western"><surname>Bai</surname><given-names>X.</given-names></name></person-group><article-title>Studying Human Neurological Disorders Using Induced Pluripotent Stem Cells: From 2D Monolayer to 3D Organoid and Blood Brain Barrier Models</article-title><source>Compr. Physiol.</source><year>2019</year><volume>9</volume><fpage>565</fpage><lpage>611</lpage><pub-id pub-id-type="doi">10.1002/j.2040-4603.2019.tb00076.x</pub-id><pub-id pub-id-type="pmid">30873582</pub-id><pub-id pub-id-type="pmcid">PMC6705133</pub-id></element-citation></ref><ref id="B23-pharmaceutics-17-01176"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Traldi</surname><given-names>C.</given-names></name><name name-style="western"><surname>Chiappini</surname><given-names>V.</given-names></name><name name-style="western"><surname>Menduti</surname><given-names>G.</given-names></name><name name-style="western"><surname>Tonda-Turo</surname><given-names>C.</given-names></name><name name-style="western"><surname>Boido</surname><given-names>M.</given-names></name></person-group><article-title>Advanced materials and biofabrication technologies to design in vitro functional central nervous system models</article-title><source>Front. Med. Eng.</source><year>2023</year><volume>1</volume><elocation-id>1270943</elocation-id><pub-id pub-id-type="doi">10.3389/fmede.2023.1270943</pub-id></element-citation></ref><ref id="B24-pharmaceutics-17-01176"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhao</surname><given-names>H.H.</given-names></name><name name-style="western"><surname>Haddad</surname><given-names>G.</given-names></name></person-group><article-title>Brain organoid protocols and limitations</article-title><source>Front. Cell. Neurosci.</source><year>2024</year><volume>18</volume><elocation-id>1351734</elocation-id><pub-id pub-id-type="doi">10.3389/fncel.2024.1351734</pub-id><pub-id pub-id-type="pmid">38572070</pub-id><pub-id pub-id-type="pmcid">PMC10987830</pub-id></element-citation></ref><ref id="B25-pharmaceutics-17-01176"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shriver</surname><given-names>A.J.</given-names></name><name name-style="western"><surname>John</surname><given-names>T.M.</given-names></name></person-group><article-title>Neuroethics and Animals: Report and Recommendations From the University of Pennsylvania Animal Research Neuroethics Workshop</article-title><source>ILAR J.</source><year>2021</year><volume>60</volume><fpage>424</fpage><lpage>433</lpage><pub-id pub-id-type="doi">10.1093/ilar/ilab024</pub-id><pub-id pub-id-type="pmid">34370840</pub-id><pub-id pub-id-type="pmcid">PMC8767460</pub-id></element-citation></ref><ref id="B26-pharmaceutics-17-01176"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hogberg</surname><given-names>H.T.</given-names></name><name name-style="western"><surname>Smirnova</surname><given-names>L.</given-names></name></person-group><article-title>The Future of 3D Brain Cultures in Developmental Neurotoxicity Testing</article-title><source>Front. Toxicol.</source><year>2022</year><volume>4</volume><elocation-id>808620</elocation-id><pub-id pub-id-type="doi">10.3389/ftox.2022.808620</pub-id><pub-id pub-id-type="pmid">35295222</pub-id><pub-id pub-id-type="pmcid">PMC8915853</pub-id></element-citation></ref><ref id="B27-pharmaceutics-17-01176"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Adlakha</surname><given-names>Y.K.</given-names></name></person-group><article-title>Human 3D brain organoids: Steering the demolecularization of brain and neurological diseases</article-title><source>Cell Death Discov.</source><year>2023</year><volume>9</volume><fpage>221</fpage><pub-id pub-id-type="doi">10.1038/s41420-023-01523-w</pub-id><pub-id pub-id-type="pmid">37400464</pub-id><pub-id pub-id-type="pmcid">PMC10318057</pub-id></element-citation></ref><ref id="B28-pharmaceutics-17-01176"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Villanueva-Flores</surname><given-names>F.</given-names></name><name name-style="western"><surname>Garcia-Atutxa</surname><given-names>I.</given-names></name><name name-style="western"><surname>Santos</surname><given-names>A.</given-names></name><name name-style="western"><surname>Armendariz-Borunda</surname><given-names>J.</given-names></name></person-group><article-title>Toward a New Generation of Bio-Scaffolds for Neural Tissue Engineering: Challenges and Perspectives</article-title><source>Pharmaceutics</source><year>2023</year><volume>15</volume><elocation-id>1750</elocation-id><pub-id pub-id-type="doi">10.3390/pharmaceutics15061750</pub-id><pub-id pub-id-type="pmid">37376198</pub-id><pub-id pub-id-type="pmcid">PMC10302050</pub-id></element-citation></ref><ref id="B29-pharmaceutics-17-01176"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Katrilaka</surname><given-names>C.</given-names></name><name name-style="western"><surname>Karipidou</surname><given-names>N.</given-names></name><name name-style="western"><surname>Petrou</surname><given-names>N.</given-names></name><name name-style="western"><surname>Manglaris</surname><given-names>C.</given-names></name><name name-style="western"><surname>Katrilakas</surname><given-names>G.</given-names></name><name name-style="western"><surname>Tzavellas</surname><given-names>A.N.</given-names></name><name name-style="western"><surname>Pitou</surname><given-names>M.</given-names></name><name name-style="western"><surname>Tsiridis</surname><given-names>E.E.</given-names></name><name name-style="western"><surname>Choli-Papadopoulou</surname><given-names>T.</given-names></name><name name-style="western"><surname>Aggeli</surname><given-names>A.</given-names></name></person-group><article-title>Freeze-Drying Process for the Fabrication of Collagen-Based Sponges as Medical Devices in Biomedical Engineering</article-title><source>Materials</source><year>2023</year><volume>16</volume><elocation-id>4425</elocation-id><pub-id pub-id-type="doi">10.3390/ma16124425</pub-id><pub-id pub-id-type="pmid">37374608</pub-id><pub-id pub-id-type="pmcid">PMC10302432</pub-id></element-citation></ref><ref id="B30-pharmaceutics-17-01176"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Licciardello</surname><given-names>M.</given-names></name><name name-style="western"><surname>Traldi</surname><given-names>C.</given-names></name><name name-style="western"><surname>Bortolameazzi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Testore</surname><given-names>D.</given-names></name><name name-style="western"><surname>Ciardelli</surname><given-names>G.</given-names></name><name name-style="western"><surname>Tonda-Turo</surname><given-names>C.</given-names></name></person-group><article-title>Aligned polycaprolactone/polyaniline electrospun nanofibers for directing neural stem cell differentiation and neuron arrangement</article-title><source>Front. Biomater. Sci.</source><year>2024</year><volume>3</volume><elocation-id>1362599</elocation-id><pub-id pub-id-type="doi">10.3389/fbiom.2024.1362599</pub-id></element-citation></ref><ref id="B31-pharmaceutics-17-01176"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thomas</surname><given-names>M.</given-names></name><name name-style="western"><surname>Willerth</surname><given-names>S.M.</given-names></name></person-group><article-title>3-D Bioprinting of Neural Tissue for Applications in Cell Therapy and Drug Screening</article-title><source>Front. Bioeng. Biotechnol.</source><year>2017</year><volume>5</volume><elocation-id>69</elocation-id><pub-id pub-id-type="doi">10.3389/fbioe.2017.00069</pub-id><pub-id pub-id-type="pmid">29204424</pub-id><pub-id pub-id-type="pmcid">PMC5698280</pub-id></element-citation></ref><ref id="B32-pharmaceutics-17-01176"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Soman</surname><given-names>S.S.</given-names></name><name name-style="western"><surname>Govindraj</surname><given-names>M.</given-names></name><name name-style="western"><surname>Al Hashimi</surname><given-names>N.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>J.</given-names></name><name name-style="western"><surname>Vijayavenkataraman</surname><given-names>S.</given-names></name></person-group><article-title>Bioprinting of Human Neural Tissues Using a Sustainable Marine Tunicate-Derived Bioink for Translational Medicine Applications</article-title><source>Int. J. Bioprint.</source><year>2022</year><volume>8</volume><elocation-id>604</elocation-id><pub-id pub-id-type="doi">10.18063/ijb.v8i4.604</pub-id><pub-id pub-id-type="pmid">36404791</pub-id><pub-id pub-id-type="pmcid">PMC9668579</pub-id></element-citation></ref><ref id="B33-pharmaceutics-17-01176"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ventisette</surname><given-names>I.</given-names></name><name name-style="western"><surname>Mattii</surname><given-names>F.</given-names></name><name name-style="western"><surname>Dallari</surname><given-names>C.</given-names></name><name name-style="western"><surname>Capitini</surname><given-names>C.</given-names></name><name name-style="western"><surname>Calamai</surname><given-names>M.</given-names></name><name name-style="western"><surname>Muzzi</surname><given-names>B.</given-names></name><name name-style="western"><surname>Pavone</surname><given-names>F.S.</given-names></name><name name-style="western"><surname>Carpi</surname><given-names>F.</given-names></name><name name-style="western"><surname>Credi</surname><given-names>C.</given-names></name></person-group><article-title>Gold-Hydrogel Nanocomposites for High-Resolution Laser-Based 3D Printing of Scaffolds with SERS-Sensing Properties</article-title><source>ACS Appl. Bio Mater.</source><year>2024</year><volume>7</volume><fpage>4497</fpage><lpage>4509</lpage><pub-id pub-id-type="doi">10.1021/acsabm.4c00379</pub-id><pub-id pub-id-type="pmcid">PMC11253086</pub-id><pub-id pub-id-type="pmid">38925631</pub-id></element-citation></ref><ref id="B34-pharmaceutics-17-01176"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Carvalho</surname><given-names>C.R.</given-names></name><name name-style="western"><surname>Oliveira</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Reis</surname><given-names>R.L.</given-names></name></person-group><article-title>Modern Trends for Peripheral Nerve Repair and Regeneration: Beyond the Hollow Nerve Guidance Conduit</article-title><source>Front. Bioeng. Biotechnol.</source><year>2019</year><volume>7</volume><elocation-id>337</elocation-id><pub-id pub-id-type="doi">10.3389/fbioe.2019.00337</pub-id><pub-id pub-id-type="pmid">31824934</pub-id><pub-id pub-id-type="pmcid">PMC6882937</pub-id></element-citation></ref><ref id="B35-pharmaceutics-17-01176"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zheng</surname><given-names>S.</given-names></name><name name-style="western"><surname>Wei</surname><given-names>H.</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>H.</given-names></name><name name-style="western"><surname>Qi</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Gu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Ma</surname><given-names>X.</given-names></name><name name-style="western"><surname>Sun</surname><given-names>J.</given-names></name><name name-style="western"><surname>Ye</surname><given-names>F.</given-names></name><name name-style="western"><surname>Guo</surname><given-names>F.</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>C.</given-names></name></person-group><article-title>Advances in nerve guidance conduits for peripheral nerve repair and regeneration</article-title><source>Am. J. Stem Cells</source><year>2023</year><volume>12</volume><fpage>112</fpage><lpage>123</lpage><pub-id pub-id-type="pmid">38213640</pub-id><pub-id pub-id-type="pmcid">PMC10776341</pub-id></element-citation></ref><ref id="B36-pharmaceutics-17-01176"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>S.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Xie</surname><given-names>S.</given-names></name><name name-style="western"><surname>Shan</surname><given-names>X.</given-names></name><name name-style="western"><surname>Li</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Cai</surname><given-names>Z.</given-names></name></person-group><article-title>3D-bioprinted RGD-Alg/GelMA/PCL scaffolds laden with Schwann-like cells for peripheral nerve reconstruction</article-title><source>Int. J. Bioprint.</source><year>2024</year><volume>10</volume><elocation-id>2908</elocation-id><pub-id pub-id-type="doi">10.36922/ijb.2908</pub-id></element-citation></ref><ref id="B37-pharmaceutics-17-01176"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lai</surname><given-names>J.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Lu</surname><given-names>G.</given-names></name><name name-style="western"><surname>Yung</surname><given-names>P.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Tuan</surname><given-names>R.S.</given-names></name><name name-style="western"><surname>Li</surname><given-names>Z.A.</given-names></name></person-group><article-title>4D bioprinting of programmed dynamic tissues</article-title><source>Bioact. Mater.</source><year>2024</year><volume>37</volume><fpage>348</fpage><lpage>377</lpage><pub-id pub-id-type="doi">10.1016/j.bioactmat.2024.03.033</pub-id><pub-id pub-id-type="pmid">38694766</pub-id><pub-id pub-id-type="pmcid">PMC11061618</pub-id></element-citation></ref><ref id="B38-pharmaceutics-17-01176"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Samanipour</surname><given-names>R.</given-names></name><name name-style="western"><surname>Tahmooressi</surname><given-names>H.</given-names></name><name name-style="western"><surname>Rezaei Nejad</surname><given-names>H.</given-names></name><name name-style="western"><surname>Hirano</surname><given-names>M.</given-names></name><name name-style="western"><surname>Shin</surname><given-names>S.R.</given-names></name><name name-style="western"><surname>Hoorfar</surname><given-names>M.</given-names></name></person-group><article-title>A review on 3D printing functional brain model</article-title><source>Biomicrofluidics</source><year>2022</year><volume>16</volume><elocation-id>011501</elocation-id><pub-id pub-id-type="doi">10.1063/5.0074631</pub-id><pub-id pub-id-type="pmid">35145569</pub-id><pub-id pub-id-type="pmcid">PMC8816519</pub-id></element-citation></ref><ref id="B39-pharmaceutics-17-01176"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Fu</surname><given-names>D.</given-names></name><name name-style="western"><surname>Zha</surname><given-names>X.</given-names></name><name name-style="western"><surname>Ling</surname><given-names>T.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>J.</given-names></name></person-group><article-title>High-precision 3D printing of hydrogel: Material innovations, process breakthroughs, and translational applications in regenerative medicine</article-title><source>APL Mater.</source><year>2025</year><volume>13</volume><fpage>060605</fpage><pub-id pub-id-type="doi">10.1063/5.0278581</pub-id></element-citation></ref><ref id="B40-pharmaceutics-17-01176"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Joung</surname><given-names>D.</given-names></name><name name-style="western"><surname>Lavoie</surname><given-names>N.S.</given-names></name><name name-style="western"><surname>Guo</surname><given-names>S.Z.</given-names></name><name name-style="western"><surname>Park</surname><given-names>S.H.</given-names></name><name name-style="western"><surname>Parr</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>McAlpine</surname><given-names>M.C.</given-names></name></person-group><article-title>3D Printed Neural Regeneration Devices</article-title><source>Adv. Funct. Mater.</source><year>2020</year><volume>30</volume><fpage>1906237</fpage><pub-id pub-id-type="doi">10.1002/adfm.201906237</pub-id><pub-id pub-id-type="pmcid">PMC7007064</pub-id><pub-id pub-id-type="pmid">32038121</pub-id></element-citation></ref><ref id="B41-pharmaceutics-17-01176"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>N.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Guo</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>T.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y.</given-names></name></person-group><article-title>3D Bioprinted Scaffolds for Tissue Repair and Regeneration</article-title><source>Front. Mater.</source><year>2022</year><volume>9</volume><elocation-id>925321</elocation-id><pub-id pub-id-type="doi">10.3389/fmats.2022.925321</pub-id></element-citation></ref><ref id="B42-pharmaceutics-17-01176"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Murugan</surname><given-names>S.</given-names></name><name name-style="western"><surname>Parcha</surname><given-names>S.R.</given-names></name></person-group><article-title>Fabrication techniques involved in developing the composite scaffolds PCL/HA nanoparticles for bone tissue engineering applications</article-title><source>J. Mater. Sci. Mater. Med.</source><year>2021</year><volume>32</volume><fpage>93</fpage><pub-id pub-id-type="doi">10.1007/s10856-021-06564-0</pub-id><pub-id pub-id-type="pmid">34379204</pub-id><pub-id pub-id-type="pmcid">PMC8357662</pub-id></element-citation></ref><ref id="B43-pharmaceutics-17-01176"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ganguly</surname><given-names>S.</given-names></name><name name-style="western"><surname>Tang</surname><given-names>X.S.</given-names></name></person-group><article-title>3D Printing of High Strength Thermally Stable Sustainable Lightweight Corrosion-Resistant Nanocomposite by Solvent Exchange Postprocessing</article-title><source>ACS Sustain. Chem. Eng.</source><year>2025</year><volume>13</volume><fpage>423</fpage><lpage>435</lpage><pub-id pub-id-type="doi">10.1021/acssuschemeng.4c07940</pub-id></element-citation></ref><ref id="B44-pharmaceutics-17-01176"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shahrubudin</surname><given-names>N.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>T.C.</given-names></name><name name-style="western"><surname>Ramlan</surname><given-names>R.</given-names></name></person-group><article-title>An Overview on 3D Printing Technology: Technological, Materials, and Applications</article-title><source>Procedia Manuf.</source><year>2019</year><volume>35</volume><fpage>1286</fpage><lpage>1296</lpage><pub-id pub-id-type="doi">10.1016/j.promfg.2019.06.089</pub-id></element-citation></ref><ref id="B45-pharmaceutics-17-01176"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rossi</surname><given-names>A.</given-names></name><name name-style="western"><surname>Pescara</surname><given-names>T.</given-names></name><name name-style="western"><surname>Gambelli</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Gaggia</surname><given-names>F.</given-names></name><name name-style="western"><surname>Asthana</surname><given-names>A.</given-names></name><name name-style="western"><surname>Perrier</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Basta</surname><given-names>G.</given-names></name><name name-style="western"><surname>Moretti</surname><given-names>M.</given-names></name><name name-style="western"><surname>Senin</surname><given-names>N.</given-names></name><name name-style="western"><surname>Rossi</surname><given-names>F.</given-names></name><etal/></person-group><article-title>Biomaterials for extrusion-based bioprinting and biomedical applications</article-title><source>Front. Bioeng. Biotechnol.</source><year>2024</year><volume>12</volume><elocation-id>1393641</elocation-id><pub-id pub-id-type="doi">10.3389/fbioe.2024.1393641</pub-id><pub-id pub-id-type="pmid">38974655</pub-id><pub-id pub-id-type="pmcid">PMC11225062</pub-id></element-citation></ref><ref id="B46-pharmaceutics-17-01176"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gu</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Fu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Lin</surname><given-names>H.</given-names></name><name name-style="western"><surname>He</surname><given-names>Y.</given-names></name></person-group><article-title>Development of 3D bioprinting: From printing methods to biomedical applications</article-title><source>Asian J. Pharm. Sci.</source><year>2020</year><volume>15</volume><fpage>529</fpage><lpage>557</lpage><pub-id pub-id-type="doi">10.1016/j.ajps.2019.11.003</pub-id><pub-id pub-id-type="pmid">33193859</pub-id><pub-id pub-id-type="pmcid">PMC7610207</pub-id></element-citation></ref><ref id="B47-pharmaceutics-17-01176"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gillispie</surname><given-names>G.</given-names></name><name name-style="western"><surname>Prim</surname><given-names>P.</given-names></name><name name-style="western"><surname>Copus</surname><given-names>J.</given-names></name><name name-style="western"><surname>Fisher</surname><given-names>J.</given-names></name><name name-style="western"><surname>Mikos</surname><given-names>A.G.</given-names></name><name name-style="western"><surname>Yoo</surname><given-names>J.J.</given-names></name><name name-style="western"><surname>Atala</surname><given-names>A.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>S.J.</given-names></name></person-group><article-title>Assessment methodologies for extrusion-based bioink printability</article-title><source>Biofabrication</source><year>2020</year><volume>12</volume><elocation-id>022003</elocation-id><pub-id pub-id-type="doi">10.1088/1758-5090/ab6f0d</pub-id><pub-id pub-id-type="pmid">31972558</pub-id><pub-id pub-id-type="pmcid">PMC7039534</pub-id></element-citation></ref><ref id="B48-pharmaceutics-17-01176"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Malekpour</surname><given-names>A.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>X.</given-names></name></person-group><article-title>Printability and Cell Viability in Extrusion-Based Bioprinting from Experimental, Computational, and Machine Learning Views</article-title><source>J. Funct. Biomater.</source><year>2022</year><volume>13</volume><elocation-id>40</elocation-id><pub-id pub-id-type="doi">10.3390/jfb13020040</pub-id><pub-id pub-id-type="pmid">35466222</pub-id><pub-id pub-id-type="pmcid">PMC9036289</pub-id></element-citation></ref><ref id="B49-pharmaceutics-17-01176"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Park</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Jung</surname><given-names>S.</given-names></name></person-group><article-title>Inkjet-based bioprinting for tissue engineering</article-title><source>Organoid</source><year>2023</year><volume>3</volume><fpage>e12</fpage><pub-id pub-id-type="doi">10.51335/organoid.2023.3.e12</pub-id></element-citation></ref><ref id="B50-pharmaceutics-17-01176"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhu</surname><given-names>H.</given-names></name><name name-style="western"><surname>Li</surname><given-names>R.</given-names></name><name name-style="western"><surname>Li</surname><given-names>S.</given-names></name><name name-style="western"><surname>Guo</surname><given-names>K.</given-names></name><name name-style="western"><surname>Ji</surname><given-names>C.</given-names></name><name name-style="western"><surname>Gao</surname><given-names>F.</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>R.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>H.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>L.</given-names></name><etal/></person-group><article-title>Multi-physical field control piezoelectric inkjet bioprinting for 3D tissue-like structure manufacturing</article-title><source>Int. J. Bioprint.</source><year>2024</year><volume>10</volume><elocation-id>2120</elocation-id><pub-id pub-id-type="doi">10.36922/ijb.2120</pub-id></element-citation></ref><ref id="B51-pharmaceutics-17-01176"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>K.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>D.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>K.</given-names></name><name name-style="western"><surname>Song</surname><given-names>K.</given-names></name><name name-style="western"><surname>Liang</surname><given-names>J.</given-names></name></person-group><article-title>Electrohydrodynamic jet 3D printing of PCL/PVP composite scaffold for cell culture</article-title><source>Talanta</source><year>2020</year><volume>211</volume><fpage>120750</fpage><pub-id pub-id-type="doi">10.1016/j.talanta.2020.120750</pub-id><pub-id pub-id-type="pmid">32070610</pub-id></element-citation></ref><ref id="B52-pharmaceutics-17-01176"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kwon</surname><given-names>H.-j.</given-names></name><name name-style="western"><surname>Hong</surname><given-names>J.</given-names></name><name name-style="western"><surname>Nam</surname><given-names>S.Y.</given-names></name><name name-style="western"><surname>Choi</surname><given-names>H.H.</given-names></name><name name-style="western"><surname>Li</surname><given-names>X.</given-names></name><name name-style="western"><surname>Jeong</surname><given-names>Y.J.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>S.H.</given-names></name></person-group><article-title>Overview of recent progress in electrohydrodynamic jet printing in practical printed electronics: Focus on the variety of printable materials for each component</article-title><source>Mater. Adv.</source><year>2021</year><volume>2</volume><fpage>5593</fpage><lpage>5615</lpage><pub-id pub-id-type="doi">10.1039/D1MA00463H</pub-id></element-citation></ref><ref id="B53-pharmaceutics-17-01176"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mao</surname><given-names>M.</given-names></name><name name-style="western"><surname>Liang</surname><given-names>H.</given-names></name><name name-style="western"><surname>He</surname><given-names>J.</given-names></name><name name-style="western"><surname>Kasimu</surname><given-names>A.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>L.</given-names></name><name name-style="western"><surname>Li</surname><given-names>X.</given-names></name><name name-style="western"><surname>Li</surname><given-names>D.</given-names></name></person-group><article-title>Coaxial Electrohydrodynamic Bioprinting of Pre-vascularized Cell-laden Constructs for Tissue Engineering</article-title><source>Int. J. Bioprint.</source><year>2021</year><volume>7</volume><elocation-id>362</elocation-id><pub-id pub-id-type="doi">10.18063/ijb.v7i3.362</pub-id><pub-id pub-id-type="pmid">34286149</pub-id><pub-id pub-id-type="pmcid">PMC8287508</pub-id></element-citation></ref><ref id="B54-pharmaceutics-17-01176"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schiele</surname><given-names>N.R.</given-names></name><name name-style="western"><surname>Corr</surname><given-names>D.T.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Raof</surname><given-names>N.A.</given-names></name><name name-style="western"><surname>Xie</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Chrisey</surname><given-names>D.B.</given-names></name></person-group><article-title>Laser-based direct-write techniques for cell printing</article-title><source>Biofabrication</source><year>2010</year><volume>2</volume><elocation-id>032001</elocation-id><pub-id pub-id-type="doi">10.1088/1758-5082/2/3/032001</pub-id><pub-id pub-id-type="pmid">20814088</pub-id><pub-id pub-id-type="pmcid">PMC4887083</pub-id></element-citation></ref><ref id="B55-pharmaceutics-17-01176"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Sun</surname><given-names>X.</given-names></name></person-group><article-title>Laser-induced forward transfer based laser bioprinting in biomedical applications</article-title><source>Front. Bioeng. Biotechnol.</source><year>2023</year><volume>11</volume><elocation-id>1255782</elocation-id><pub-id pub-id-type="doi">10.3389/fbioe.2023.1255782</pub-id><pub-id pub-id-type="pmid">37671193</pub-id><pub-id pub-id-type="pmcid">PMC10475545</pub-id></element-citation></ref><ref id="B56-pharmaceutics-17-01176"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Koch</surname><given-names>L.</given-names></name><name name-style="western"><surname>Deiwick</surname><given-names>A.</given-names></name><name name-style="western"><surname>Soriano</surname><given-names>J.</given-names></name><name name-style="western"><surname>Chichkov</surname><given-names>B.</given-names></name></person-group><article-title>344Laser bioprinting of human iPSC-derived neural stem cells and neurons: Effect on cell survival, multipotency, differentiation, and neuronal activity</article-title><source>Int. J. Bioprint.</source><year>2023</year><volume>9</volume><elocation-id>672</elocation-id><pub-id pub-id-type="doi">10.18063/ijb.v9i2.672</pub-id><pub-id pub-id-type="pmid">37065669</pub-id><pub-id pub-id-type="pmcid">PMC10090817</pub-id></element-citation></ref><ref id="B57-pharmaceutics-17-01176"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Grigoryan</surname><given-names>B.</given-names></name><name name-style="western"><surname>Sazer</surname><given-names>D.W.</given-names></name><name name-style="western"><surname>Avila</surname><given-names>A.</given-names></name><name name-style="western"><surname>Albritton</surname><given-names>J.L.</given-names></name><name name-style="western"><surname>Padhye</surname><given-names>A.</given-names></name><name name-style="western"><surname>Ta</surname><given-names>A.H.</given-names></name><name name-style="western"><surname>Greenfield</surname><given-names>P.T.</given-names></name><name name-style="western"><surname>Gibbons</surname><given-names>D.L.</given-names></name><name name-style="western"><surname>Miller</surname><given-names>J.S.</given-names></name></person-group><article-title>Development, characterization, and applications of multi-material stereolithography bioprinting</article-title><source>Sci. Rep.</source><year>2021</year><volume>11</volume><elocation-id>3171</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-021-82102-w</pub-id><pub-id pub-id-type="pmid">33542283</pub-id><pub-id pub-id-type="pmcid">PMC7862383</pub-id></element-citation></ref><ref id="B58-pharmaceutics-17-01176"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kilic</surname><given-names>N.I.</given-names></name><name name-style="western"><surname>Saladino</surname><given-names>G.M.</given-names></name><name name-style="western"><surname>Johansson</surname><given-names>S.</given-names></name><name name-style="western"><surname>Shen</surname><given-names>R.</given-names></name><name name-style="western"><surname>McDorman</surname><given-names>C.</given-names></name><name name-style="western"><surname>Toprak</surname><given-names>M.S.</given-names></name><name name-style="western"><surname>Johansson</surname><given-names>S.</given-names></name></person-group><article-title>Two-Photon Polymerization Printing with High Metal Nanoparticle Loading</article-title><source>ACS Appl. Mater. Interfaces</source><year>2023</year><volume>15</volume><fpage>49794</fpage><lpage>49804</lpage><pub-id pub-id-type="doi">10.1021/acsami.3c10581</pub-id><pub-id pub-id-type="pmid">37816209</pub-id><pub-id pub-id-type="pmcid">PMC10614202</pub-id></element-citation></ref><ref id="B59-pharmaceutics-17-01176"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bercea</surname><given-names>M.</given-names></name></person-group><article-title>Rheology as a Tool for Fine-Tuning the Properties of Printable Bioinspired Gels</article-title><source>Molecules</source><year>2023</year><volume>28</volume><elocation-id>2766</elocation-id><pub-id pub-id-type="doi">10.3390/molecules28062766</pub-id><pub-id pub-id-type="pmid">36985738</pub-id><pub-id pub-id-type="pmcid">PMC10058016</pub-id></element-citation></ref><ref id="B60-pharmaceutics-17-01176"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>H.Q.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>J.C.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Z.Y.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>C.X.</given-names></name></person-group><article-title>A review on cell damage, viability, and functionality during 3D bioprinting</article-title><source>Mil. Med. Res.</source><year>2022</year><volume>9</volume><fpage>70</fpage><pub-id pub-id-type="doi">10.1186/s40779-022-00429-5</pub-id><pub-id pub-id-type="pmid">36522661</pub-id><pub-id pub-id-type="pmcid">PMC9756521</pub-id></element-citation></ref><ref id="B61-pharmaceutics-17-01176"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sanchez-Sanchez</surname><given-names>R.</given-names></name><name name-style="western"><surname>Rodriguez-Rego</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Macias-Garcia</surname><given-names>A.</given-names></name><name name-style="western"><surname>Mendoza-Cerezo</surname><given-names>L.</given-names></name><name name-style="western"><surname>Diaz-Parralejo</surname><given-names>A.</given-names></name></person-group><article-title>Relationship between shear-thinning rheological properties of bioinks and bioprinting parameters</article-title><source>Int. J. Bioprint.</source><year>2023</year><volume>9</volume><elocation-id>687</elocation-id><pub-id pub-id-type="doi">10.18063/ijb.687</pub-id><pub-id pub-id-type="pmid">37065663</pub-id><pub-id pub-id-type="pmcid">PMC10090819</pub-id></element-citation></ref><ref id="B62-pharmaceutics-17-01176"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gillispie</surname><given-names>G.J.</given-names></name><name name-style="western"><surname>Copus</surname><given-names>J.</given-names></name><name name-style="western"><surname>Uzun-Per</surname><given-names>M.</given-names></name><name name-style="western"><surname>Yoo</surname><given-names>J.J.</given-names></name><name name-style="western"><surname>Atala</surname><given-names>A.</given-names></name><name name-style="western"><surname>Niazi</surname><given-names>M.K.K.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>S.J.</given-names></name></person-group><article-title>The correlation between rheological properties and extrusion-based printability in bioink artifact quantification</article-title><source>Mater. Des.</source><year>2023</year><volume>233</volume><fpage>112237</fpage><pub-id pub-id-type="doi">10.1016/j.matdes.2023.112237</pub-id><pub-id pub-id-type="pmid">37854951</pub-id><pub-id pub-id-type="pmcid">PMC10583861</pub-id></element-citation></ref><ref id="B63-pharmaceutics-17-01176"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ashammakhi</surname><given-names>N.</given-names></name><name name-style="western"><surname>Ahadian</surname><given-names>S.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>C.</given-names></name><name name-style="western"><surname>Montazerian</surname><given-names>H.</given-names></name><name name-style="western"><surname>Ko</surname><given-names>H.</given-names></name><name name-style="western"><surname>Nasiri</surname><given-names>R.</given-names></name><name name-style="western"><surname>Barros</surname><given-names>N.</given-names></name><name name-style="western"><surname>Khademhosseini</surname><given-names>A.</given-names></name></person-group><article-title>Bioinks and bioprinting technologies to make heterogeneous and biomimetic tissue constructs</article-title><source>Mater. Today Bio</source><year>2019</year><volume>1</volume><elocation-id>100008</elocation-id><pub-id pub-id-type="doi">10.1016/j.mtbio.2019.100008</pub-id><pub-id pub-id-type="pmcid">PMC7061634</pub-id><pub-id pub-id-type="pmid">32159140</pub-id></element-citation></ref><ref id="B64-pharmaceutics-17-01176"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>W.H.</given-names></name><name name-style="western"><surname>Ding</surname><given-names>S.L.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>X.Y.</given-names></name><name name-style="western"><surname>Li</surname><given-names>K.</given-names></name><name name-style="western"><surname>Guo</surname><given-names>H.T.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>M.Z.</given-names></name><name name-style="western"><surname>Gu</surname><given-names>Q.</given-names></name></person-group><article-title>Collagen for neural tissue engineering: Materials, strategies, and challenges</article-title><source>Mater. Today Bio</source><year>2023</year><volume>20</volume><elocation-id>100639</elocation-id><pub-id pub-id-type="doi">10.1016/j.mtbio.2023.100639</pub-id><pub-id pub-id-type="pmid">37197743</pub-id><pub-id pub-id-type="pmcid">PMC10183670</pub-id></element-citation></ref><ref id="B65-pharmaceutics-17-01176"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Debnath</surname><given-names>S.</given-names></name><name name-style="western"><surname>Agrawal</surname><given-names>A.</given-names></name><name name-style="western"><surname>Jain</surname><given-names>N.</given-names></name><name name-style="western"><surname>Chatterjee</surname><given-names>K.</given-names></name><name name-style="western"><surname>Player</surname><given-names>D.J.</given-names></name></person-group><article-title>Collagen as a bio-ink for 3D printing: A critical review</article-title><source>J. Mater. Chem. B</source><year>2025</year><volume>13</volume><fpage>1890</fpage><lpage>1919</lpage><pub-id pub-id-type="doi">10.1039/D4TB01060D</pub-id><pub-id pub-id-type="pmid">39775500</pub-id></element-citation></ref><ref id="B66-pharmaceutics-17-01176"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pereira</surname><given-names>I.</given-names></name><name name-style="western"><surname>Lopez-Martinez</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Villasante</surname><given-names>A.</given-names></name><name name-style="western"><surname>Introna</surname><given-names>C.</given-names></name><name name-style="western"><surname>Tornero</surname><given-names>D.</given-names></name><name name-style="western"><surname>Canals</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Samitier</surname><given-names>J.</given-names></name></person-group><article-title>Hyaluronic acid-based bioink improves the differentiation and network formation of neural progenitor cells</article-title><source>Front. Bioeng. Biotechnol.</source><year>2023</year><volume>11</volume><elocation-id>1110547</elocation-id><pub-id pub-id-type="doi">10.3389/fbioe.2023.1110547</pub-id><pub-id pub-id-type="pmid">36937768</pub-id><pub-id pub-id-type="pmcid">PMC10020230</pub-id></element-citation></ref><ref id="B67-pharmaceutics-17-01176"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Li</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>S.</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Cao</surname><given-names>X.</given-names></name></person-group><article-title>Preparation and Properties of 3D Printed Alginate(-)Chitosan Polyion Complex Hydrogels for Tissue Engineering</article-title><source>Polymers</source><year>2018</year><volume>10</volume><elocation-id>664</elocation-id><pub-id pub-id-type="doi">10.3390/polym10060664</pub-id><pub-id pub-id-type="pmid">30966698</pub-id><pub-id pub-id-type="pmcid">PMC6404366</pub-id></element-citation></ref><ref id="B68-pharmaceutics-17-01176"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Freeman</surname><given-names>F.E.</given-names></name><name name-style="western"><surname>Kelly</surname><given-names>D.J.</given-names></name></person-group><article-title>Tuning Alginate Bioink Stiffness and Composition for Controlled Growth Factor Delivery and to Spatially Direct MSC Fate within Bioprinted Tissues</article-title><source>Sci. Rep.</source><year>2017</year><volume>7</volume><elocation-id>17042</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-017-17286-1</pub-id><pub-id pub-id-type="pmid">29213126</pub-id><pub-id pub-id-type="pmcid">PMC5719090</pub-id></element-citation></ref><ref id="B69-pharmaceutics-17-01176"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Reginensi</surname><given-names>D.</given-names></name><name name-style="western"><surname>Ortiz</surname><given-names>D.A.</given-names></name><name name-style="western"><surname>Denis</surname><given-names>B.</given-names></name><name name-style="western"><surname>Castillo</surname><given-names>S.</given-names></name><name name-style="western"><surname>Burillo</surname><given-names>A.</given-names></name><name name-style="western"><surname>Khoury</surname><given-names>N.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Dam</surname><given-names>M.L.</given-names></name><name name-style="western"><surname>Escobar</surname><given-names>A.A.H.</given-names></name><name name-style="western"><surname>Dave</surname><given-names>K.R.</given-names></name><etal/></person-group><article-title>Region-specific brain decellularized extracellular matrix promotes cell recovery in an in vitro model of stroke</article-title><source>Sci. Rep.</source><year>2025</year><volume>15</volume><elocation-id>11921</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-025-95656-w</pub-id><pub-id pub-id-type="pmid">40195414</pub-id><pub-id pub-id-type="pmcid">PMC11976941</pub-id></element-citation></ref><ref id="B70-pharmaceutics-17-01176"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kong</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>D.</given-names></name><name name-style="western"><surname>Wei</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Y.</given-names></name></person-group><article-title>Nerve Decellularized Matrix Composite Scaffold With High Antibacterial Activity for Nerve Regeneration</article-title><source>Front. Bioeng. Biotechnol.</source><year>2021</year><volume>9</volume><elocation-id>840421</elocation-id><pub-id pub-id-type="doi">10.3389/fbioe.2021.840421</pub-id><pub-id pub-id-type="pmid">35155420</pub-id><pub-id pub-id-type="pmcid">PMC8831845</pub-id></element-citation></ref><ref id="B71-pharmaceutics-17-01176"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mantec&#243;n-Oria</surname><given-names>M.</given-names></name><name name-style="western"><surname>Diban</surname><given-names>N.</given-names></name><name name-style="western"><surname>Berciano</surname><given-names>M.T.</given-names></name><name name-style="western"><surname>Rivero</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>David</surname><given-names>O.</given-names></name><name name-style="western"><surname>Lafarga</surname><given-names>M.</given-names></name><name name-style="western"><surname>Tapia</surname><given-names>O.</given-names></name><name name-style="western"><surname>Urtiaga</surname><given-names>A.</given-names></name></person-group><article-title>Hollow Fiber Membranes of PCL and PCL/Graphene as Scaffolds with Potential to Develop In Vitro Blood-Brain Barrier Models</article-title><source>Membranes</source><year>2020</year><volume>10</volume><elocation-id>161</elocation-id><pub-id pub-id-type="doi">10.3390/membranes10080161</pub-id><pub-id pub-id-type="pmid">32708027</pub-id><pub-id pub-id-type="pmcid">PMC7464335</pub-id></element-citation></ref><ref id="B72-pharmaceutics-17-01176"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>X.</given-names></name><name name-style="western"><surname>Gaihre</surname><given-names>B.</given-names></name><name name-style="western"><surname>George</surname><given-names>M.N.</given-names></name><name name-style="western"><surname>Miller</surname><given-names>A.L.</given-names><suffix>2nd</suffix></name><name name-style="western"><surname>Xu</surname><given-names>H.</given-names></name><name name-style="western"><surname>Waletzki</surname><given-names>B.E.</given-names></name><name name-style="western"><surname>Lu</surname><given-names>L.</given-names></name></person-group><article-title>3D bioprinting of oligo(poly[ethylene glycol] fumarate) for bone and nerve tissue engineering</article-title><source>J. Biomed. Mater. Res. A</source><year>2021</year><volume>109</volume><fpage>6</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1002/jbm.a.37002</pub-id><pub-id pub-id-type="pmid">32418273</pub-id><pub-id pub-id-type="pmcid">PMC8942303</pub-id></element-citation></ref><ref id="B73-pharmaceutics-17-01176"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kusen</surname><given-names>I.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>A.</given-names></name><name name-style="western"><surname>Cuttaz</surname><given-names>E.A.</given-names></name><name name-style="western"><surname>Bailey</surname><given-names>Z.K.</given-names></name><name name-style="western"><surname>Killilea</surname><given-names>J.</given-names></name><name name-style="western"><surname>Aslie</surname><given-names>S.M.</given-names></name><name name-style="western"><surname>Goding</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Green</surname><given-names>R.A.</given-names></name></person-group><article-title>Injectable conductive hydrogel electrodes for minimally invasive neural interfaces</article-title><source>J. Mater. Chem. B</source><year>2024</year><volume>12</volume><fpage>8929</fpage><lpage>8940</lpage><pub-id pub-id-type="doi">10.1039/D4TB00679H</pub-id><pub-id pub-id-type="pmid">39145569</pub-id><pub-id pub-id-type="pmcid">PMC11325676</pub-id></element-citation></ref><ref id="B74-pharmaceutics-17-01176"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kulig</surname><given-names>D.</given-names></name><name name-style="western"><surname>Zimoch-Korzycka</surname><given-names>A.</given-names></name><name name-style="western"><surname>Jarmoluk</surname><given-names>A.</given-names></name><name name-style="western"><surname>Marycz</surname><given-names>K.</given-names></name></person-group><article-title>Study on Alginate-Chitosan Complex Formed with Different Polymers Ratio</article-title><source>Polymers</source><year>2016</year><volume>8</volume><elocation-id>167</elocation-id><pub-id pub-id-type="doi">10.3390/polym8050167</pub-id><pub-id pub-id-type="pmid">30979272</pub-id><pub-id pub-id-type="pmcid">PMC6432350</pub-id></element-citation></ref><ref id="B75-pharmaceutics-17-01176"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kandhola</surname><given-names>G.</given-names></name><name name-style="western"><surname>Park</surname><given-names>S.</given-names></name><name name-style="western"><surname>Lim</surname><given-names>J.W.</given-names></name><name name-style="western"><surname>Chivers</surname><given-names>C.</given-names></name><name name-style="western"><surname>Song</surname><given-names>Y.H.</given-names></name><name name-style="western"><surname>Chung</surname><given-names>J.H.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>J.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>J.W.</given-names></name></person-group><article-title>Nanomaterial-Based Scaffolds for Tissue Engineering Applications: A Review on Graphene, Carbon Nanotubes and Nanocellulose</article-title><source>Tissue Eng. Regen. Med.</source><year>2023</year><volume>20</volume><fpage>411</fpage><lpage>433</lpage><pub-id pub-id-type="doi">10.1007/s13770-023-00530-3</pub-id><pub-id pub-id-type="pmid">37060487</pub-id><pub-id pub-id-type="pmcid">PMC10219911</pub-id></element-citation></ref><ref id="B76-pharmaceutics-17-01176"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jung</surname><given-names>K.</given-names></name><name name-style="western"><surname>Corrigan</surname><given-names>N.</given-names></name><name name-style="western"><surname>Wong</surname><given-names>E.H.H.</given-names></name><name name-style="western"><surname>Boyer</surname><given-names>C.</given-names></name></person-group><article-title>Bioactive Synthetic Polymers</article-title><source>Adv. Mater.</source><year>2022</year><volume>34</volume><fpage>e2105063</fpage><pub-id pub-id-type="doi">10.1002/adma.202105063</pub-id><pub-id pub-id-type="pmid">34611948</pub-id></element-citation></ref><ref id="B77-pharmaceutics-17-01176"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Santoro</surname><given-names>M.</given-names></name><name name-style="western"><surname>Shah</surname><given-names>S.R.</given-names></name><name name-style="western"><surname>Walker</surname><given-names>J.L.</given-names></name><name name-style="western"><surname>Mikos</surname><given-names>A.G.</given-names></name></person-group><article-title>Poly(lactic acid) nanofibrous scaffolds for tissue engineering</article-title><source>Adv. Drug. Deliv. Rev.</source><year>2016</year><volume>107</volume><fpage>206</fpage><lpage>212</lpage><pub-id pub-id-type="doi">10.1016/j.addr.2016.04.019</pub-id><pub-id pub-id-type="pmid">27125190</pub-id><pub-id pub-id-type="pmcid">PMC5081275</pub-id></element-citation></ref><ref id="B78-pharmaceutics-17-01176"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Santana</surname><given-names>M.D.V.</given-names></name><name name-style="western"><surname>Magulas</surname><given-names>M.B.S.</given-names></name><name name-style="western"><surname>Brito</surname><given-names>G.C.</given-names></name><name name-style="western"><surname>Santos</surname><given-names>M.C.</given-names></name><name name-style="western"><surname>de Oliveira</surname><given-names>T.G.</given-names></name><name name-style="western"><surname>de Melo</surname><given-names>W.G.G.</given-names></name><name name-style="western"><surname>Argolo Neto</surname><given-names>N.M.</given-names></name><name name-style="western"><surname>Marciano</surname><given-names>F.R.</given-names></name><name name-style="western"><surname>Viana</surname><given-names>B.C.</given-names></name><name name-style="western"><surname>Lobo</surname><given-names>A.O.</given-names></name></person-group><article-title>Cryogenic 3D Printing of GelMA/Graphene Bioinks: Improved Mechanical Strength and Structural Properties for Tissue Engineering</article-title><source>Int. J. Nanomed.</source><year>2024</year><volume>19</volume><fpage>10745</fpage><lpage>10765</lpage><pub-id pub-id-type="doi">10.2147/IJN.S486868</pub-id><pub-id pub-id-type="pmcid">PMC11514648</pub-id><pub-id pub-id-type="pmid">39469448</pub-id></element-citation></ref><ref id="B79-pharmaceutics-17-01176"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sadraei</surname><given-names>S.M.</given-names></name><name name-style="western"><surname>Kiani</surname><given-names>J.</given-names></name><name name-style="western"><surname>Ashtari</surname><given-names>B.</given-names></name></person-group><article-title>Gold nanorods decorated polycaprolactone/cellulose acetate hybrid scaffold for PC12 cells proliferation</article-title><source>Int. J. Biol. Macromol.</source><year>2022</year><volume>206</volume><fpage>511</fpage><lpage>520</lpage><pub-id pub-id-type="doi">10.1016/j.ijbiomac.2022.02.156</pub-id><pub-id pub-id-type="pmid">35240215</pub-id></element-citation></ref><ref id="B80-pharmaceutics-17-01176"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pillai</surname><given-names>E.K.</given-names></name><name name-style="western"><surname>Franze</surname><given-names>K.</given-names></name></person-group><article-title>Mechanics in the nervous system: From development to disease</article-title><source>Neuron</source><year>2024</year><volume>112</volume><fpage>342</fpage><lpage>361</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2023.10.005</pub-id><pub-id pub-id-type="pmid">37967561</pub-id></element-citation></ref><ref id="B81-pharmaceutics-17-01176"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhao</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Liang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Ding</surname><given-names>S.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>K.</given-names></name><name name-style="western"><surname>Mao</surname><given-names>H.Q.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Y.</given-names></name></person-group><article-title>Application of conductive PPy/SF composite scaffold and electrical stimulation for neural tissue engineering</article-title><source>Biomaterials</source><year>2020</year><volume>255</volume><elocation-id>120164</elocation-id><pub-id pub-id-type="doi">10.1016/j.biomaterials.2020.120164</pub-id><pub-id pub-id-type="pmid">32554132</pub-id></element-citation></ref><ref id="B82-pharmaceutics-17-01176"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cheng</surname><given-names>H.</given-names></name><name name-style="western"><surname>Bai</surname><given-names>J.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>X.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>N.</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Ren</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Li</surname><given-names>X.</given-names></name><name name-style="western"><surname>Su</surname><given-names>T.</given-names></name><name name-style="western"><surname>Liang</surname><given-names>L.</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>W.</given-names></name><etal/></person-group><article-title>Electrical stimulation with polypyrrole-coated polycaprolactone/silk fibroin scaffold promotes sacral nerve regeneration by modulating macrophage polarisation</article-title><source>Biomater. Transl.</source><year>2024</year><volume>5</volume><fpage>157</fpage><lpage>174</lpage><pub-id pub-id-type="pmid">39351163</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.12336/biomatertransl.2024.02.006</pub-id><pub-id pub-id-type="pmcid">PMC11438605</pub-id></element-citation></ref><ref id="B83-pharmaceutics-17-01176"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>J.</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>H.</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Xie</surname><given-names>T.</given-names></name></person-group><article-title>Promising Graphene-Based Nanomaterials and Their Biomedical Applications and Potential Risks: A Comprehensive Review</article-title><source>ACS Biomater. Sci. Eng.</source><year>2021</year><volume>7</volume><fpage>5363</fpage><lpage>5396</lpage><pub-id pub-id-type="doi">10.1021/acsbiomaterials.1c00875</pub-id><pub-id pub-id-type="pmid">34747591</pub-id></element-citation></ref><ref id="B84-pharmaceutics-17-01176"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Qiao</surname><given-names>L.</given-names></name><name name-style="western"><surname>Qiao</surname><given-names>B.</given-names></name><name name-style="western"><surname>Guo</surname><given-names>B.</given-names></name></person-group><article-title>Conductive hydrogels for tissue repair</article-title><source>Chem. Sci.</source><year>2023</year><volume>14</volume><fpage>3091</fpage><lpage>3116</lpage><pub-id pub-id-type="doi">10.1039/D3SC00145H</pub-id><pub-id pub-id-type="pmid">36970088</pub-id><pub-id pub-id-type="pmcid">PMC10034154</pub-id></element-citation></ref><ref id="B85-pharmaceutics-17-01176"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ul Haq</surname><given-names>A.</given-names></name><name name-style="western"><surname>Montaina</surname><given-names>L.</given-names></name><name name-style="western"><surname>Pescosolido</surname><given-names>F.</given-names></name><name name-style="western"><surname>Carotenuto</surname><given-names>F.</given-names></name><name name-style="western"><surname>Trovalusci</surname><given-names>F.</given-names></name><name name-style="western"><surname>De Matteis</surname><given-names>F.</given-names></name><name name-style="western"><surname>Tamburri</surname><given-names>E.</given-names></name><name name-style="western"><surname>Di Nardo</surname><given-names>P.</given-names></name></person-group><article-title>Electrically conductive scaffolds mimicking the hierarchical structure of cardiac myofibers</article-title><source>Sci. Rep.</source><year>2023</year><volume>13</volume><elocation-id>2863</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-023-29780-w</pub-id><pub-id pub-id-type="pmid">36804588</pub-id><pub-id pub-id-type="pmcid">PMC9938142</pub-id></element-citation></ref><ref id="B86-pharmaceutics-17-01176"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pisciotta</surname><given-names>A.</given-names></name><name name-style="western"><surname>Lunghi</surname><given-names>A.</given-names></name><name name-style="western"><surname>Bertani</surname><given-names>G.</given-names></name><name name-style="western"><surname>Di Tinco</surname><given-names>R.</given-names></name><name name-style="western"><surname>Bertoni</surname><given-names>L.</given-names></name><name name-style="western"><surname>Orlandi</surname><given-names>G.</given-names></name><name name-style="western"><surname>Biscarini</surname><given-names>F.</given-names></name><name name-style="western"><surname>Bianchi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Carnevale</surname><given-names>G.</given-names></name></person-group><article-title>PEDOT: PSS promotes neurogenic commitment of neural crest-derived stem cells</article-title><source>Front. Physiol.</source><year>2022</year><volume>13</volume><elocation-id>930804</elocation-id><pub-id pub-id-type="doi">10.3389/fphys.2022.930804</pub-id><pub-id pub-id-type="pmid">36060701</pub-id><pub-id pub-id-type="pmcid">PMC9428488</pub-id></element-citation></ref><ref id="B87-pharmaceutics-17-01176"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Foy</surname><given-names>C.A.</given-names></name><name name-style="western"><surname>Kuffler</surname><given-names>D.P.</given-names></name></person-group><article-title>Limitations to clinically restoring meaningful peripheral nerve function across gaps and overcoming them</article-title><source>Exp. Biol. Med.</source><year>2025</year><volume>250</volume><elocation-id>10566</elocation-id><pub-id pub-id-type="doi">10.3389/ebm.2025.10566</pub-id><pub-id pub-id-type="pmid">40495880</pub-id><pub-id pub-id-type="pmcid">PMC12150083</pub-id></element-citation></ref><ref id="B88-pharmaceutics-17-01176"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Soman</surname><given-names>S.S.</given-names></name><name name-style="western"><surname>Vijayavenkataraman</surname><given-names>S.</given-names></name></person-group><article-title>Perspectives on 3D Bioprinting of Peripheral Nerve Conduits</article-title><source>Int. J. Mol. Sci.</source><year>2020</year><volume>21</volume><elocation-id>5792</elocation-id><pub-id pub-id-type="doi">10.3390/ijms21165792</pub-id><pub-id pub-id-type="pmid">32806758</pub-id><pub-id pub-id-type="pmcid">PMC7461058</pub-id></element-citation></ref><ref id="B89-pharmaceutics-17-01176"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yu</surname><given-names>X.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>T.</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y.</given-names></name></person-group><article-title>3D Printing and Bioprinting Nerve Conduits for Neural Tissue Engineering</article-title><source>Polymers</source><year>2020</year><volume>12</volume><elocation-id>1637</elocation-id><pub-id pub-id-type="doi">10.3390/polym12081637</pub-id><pub-id pub-id-type="pmid">32717878</pub-id><pub-id pub-id-type="pmcid">PMC7465920</pub-id></element-citation></ref><ref id="B90-pharmaceutics-17-01176"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fornasari</surname><given-names>B.E.</given-names></name><name name-style="western"><surname>Carta</surname><given-names>G.</given-names></name><name name-style="western"><surname>Gambarotta</surname><given-names>G.</given-names></name><name name-style="western"><surname>Raimondo</surname><given-names>S.</given-names></name></person-group><article-title>Natural-Based Biomaterials for Peripheral Nerve Injury Repair</article-title><source>Front. Bioeng. Biotechnol.</source><year>2020</year><volume>8</volume><elocation-id>554257</elocation-id><pub-id pub-id-type="doi">10.3389/fbioe.2020.554257</pub-id><pub-id pub-id-type="pmid">33178670</pub-id><pub-id pub-id-type="pmcid">PMC7596179</pub-id></element-citation></ref><ref id="B91-pharmaceutics-17-01176"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lu</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>F.</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>W.</given-names></name><name name-style="western"><surname>Gao</surname><given-names>X.</given-names></name><name name-style="western"><surname>Ding</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Lu</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Kaplan</surname><given-names>D.L.</given-names></name></person-group><article-title>Nerve Guidance Conduits with Hierarchical Anisotropic Architecture for Peripheral Nerve Regeneration</article-title><source>Adv. Healthc. Mater.</source><year>2021</year><volume>10</volume><fpage>e2100427</fpage><pub-id pub-id-type="doi">10.1002/adhm.202100427</pub-id><pub-id pub-id-type="pmid">34038626</pub-id><pub-id pub-id-type="pmcid">PMC8295195</pub-id></element-citation></ref><ref id="B92-pharmaceutics-17-01176"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Anderson</surname><given-names>M.</given-names></name><name name-style="western"><surname>Shelke</surname><given-names>N.B.</given-names></name><name name-style="western"><surname>Manoukian</surname><given-names>O.S.</given-names></name><name name-style="western"><surname>Yu</surname><given-names>X.</given-names></name><name name-style="western"><surname>McCullough</surname><given-names>L.D.</given-names></name><name name-style="western"><surname>Kumbar</surname><given-names>S.G.</given-names></name></person-group><article-title>Peripheral Nerve Regeneration Strategies: Electrically Stimulating Polymer Based Nerve Growth Conduits</article-title><source>Crit. Rev. Biomed. Eng.</source><year>2015</year><volume>43</volume><fpage>131</fpage><lpage>159</lpage><pub-id pub-id-type="doi">10.1615/CritRevBiomedEng.2015014015</pub-id><pub-id pub-id-type="pmid">27278739</pub-id><pub-id pub-id-type="pmcid">PMC5266796</pub-id></element-citation></ref><ref id="B93-pharmaceutics-17-01176"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Manoukian</surname><given-names>O.S.</given-names></name><name name-style="western"><surname>Stratton</surname><given-names>S.</given-names></name><name name-style="western"><surname>Arul</surname><given-names>M.R.</given-names></name><name name-style="western"><surname>Moskow</surname><given-names>J.</given-names></name><name name-style="western"><surname>Sardashti</surname><given-names>N.</given-names></name><name name-style="western"><surname>Yu</surname><given-names>X.</given-names></name><name name-style="western"><surname>Rudraiah</surname><given-names>S.</given-names></name><name name-style="western"><surname>Kumbar</surname><given-names>S.G.</given-names></name></person-group><article-title>Polymeric ionically conductive composite matrices and electrical stimulation strategies for nerve regeneration: In vitro characterization</article-title><source>J. Biomed. Mater. Res. Part B Appl. Biomater.</source><year>2019</year><volume>107</volume><fpage>1792</fpage><lpage>1805</lpage><pub-id pub-id-type="doi">10.1002/jbm.b.34272</pub-id><pub-id pub-id-type="pmcid">PMC6511498</pub-id><pub-id pub-id-type="pmid">30419159</pub-id></element-citation></ref><ref id="B94-pharmaceutics-17-01176"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>K.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Dai</surname><given-names>G.</given-names></name><name name-style="western"><surname>Yin</surname><given-names>J.</given-names></name><name name-style="western"><surname>Wei</surname><given-names>P.</given-names></name></person-group><article-title>Promotion of Adrenal Pheochromocytoma (PC-12) Cell Proliferation and Outgrowth Using Schwann Cell-Laden Gelatin Methacrylate Substrate</article-title><source>Gels</source><year>2022</year><volume>8</volume><elocation-id>84</elocation-id><pub-id pub-id-type="doi">10.3390/gels8020084</pub-id><pub-id pub-id-type="pmid">35200467</pub-id><pub-id pub-id-type="pmcid">PMC8871842</pub-id></element-citation></ref><ref id="B95-pharmaceutics-17-01176"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>L.</given-names></name><name name-style="western"><surname>Gao</surname><given-names>J.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>H.</given-names></name><name name-style="western"><surname>Xia</surname><given-names>B.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>F.</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>X.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Luo</surname><given-names>Z.</given-names></name></person-group><article-title>Fabrication of 3 HierarchicalAnisotropicD Scaffolds Displaying Biochemical Gradients along Longitudinally Oriented Microchannels for Neural Tissue Engineering</article-title><source>ACS Appl. Mater. Interfaces</source><year>2020</year><volume>12</volume><fpage>48380</fpage><lpage>48394</lpage><pub-id pub-id-type="doi">10.1021/acsami.0c15185</pub-id><pub-id pub-id-type="pmid">33052661</pub-id></element-citation></ref><ref id="B96-pharmaceutics-17-01176"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>X.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>H.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>L.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>T.</given-names></name></person-group><article-title>3D bioprinted rat Schwann cell-laden structures with shape flexibility and enhanced nerve growth factor expression</article-title><source>3 Biotech</source><year>2018</year><volume>8</volume><elocation-id>342</elocation-id><pub-id pub-id-type="doi">10.1007/s13205-018-1341-9</pub-id><pub-id pub-id-type="pmcid">PMC6063810</pub-id><pub-id pub-id-type="pmid">30073127</pub-id></element-citation></ref><ref id="B97-pharmaceutics-17-01176"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rao</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Lin</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Song</surname><given-names>P.</given-names></name><name name-style="western"><surname>Quan</surname><given-names>D.</given-names></name><name name-style="western"><surname>Bai</surname><given-names>Y.</given-names></name></person-group><article-title>Biomaterial-Based Schwann Cell Transplantation and Schwann Cell-Derived Biomaterials for Nerve Regeneration</article-title><source>Front. Cell. Neurosci.</source><year>2022</year><volume>16</volume><elocation-id>926222</elocation-id><pub-id pub-id-type="doi">10.3389/fncel.2022.926222</pub-id><pub-id pub-id-type="pmid">35836742</pub-id><pub-id pub-id-type="pmcid">PMC9273721</pub-id></element-citation></ref><ref id="B98-pharmaceutics-17-01176"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>T.</given-names></name><name name-style="western"><surname>Javed</surname><given-names>R.</given-names></name><name name-style="western"><surname>Ao</surname><given-names>Q.</given-names></name></person-group><article-title>Xenogeneic Decellularized Extracellular Matrix-based Biomaterials For Peripheral Nerve Repair and Regeneration</article-title><source>Curr. Neuropharmacol.</source><year>2021</year><volume>19</volume><fpage>2152</fpage><lpage>2163</lpage><pub-id pub-id-type="doi">10.2174/1570159X18666201111103815</pub-id><pub-id pub-id-type="pmid">33176651</pub-id><pub-id pub-id-type="pmcid">PMC9185777</pub-id></element-citation></ref><ref id="B99-pharmaceutics-17-01176"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gregory</surname><given-names>E.</given-names></name><name name-style="western"><surname>Baek</surname><given-names>I.H.</given-names></name><name name-style="western"><surname>Ala-Kokko</surname><given-names>N.</given-names></name><name name-style="western"><surname>Dugan</surname><given-names>R.</given-names></name><name name-style="western"><surname>Pinzon-Herrera</surname><given-names>L.</given-names></name><name name-style="western"><surname>Almod&#243;var</surname><given-names>J.</given-names></name><name name-style="western"><surname>Song</surname><given-names>Y.H.</given-names></name></person-group><article-title>Peripheral Nerve Decellularization for In Vitro Extracellular Matrix Hydrogel Use: A Comparative Study</article-title><source>ACS Biomater. Sci. Eng.</source><year>2022</year><volume>8</volume><fpage>2574</fpage><lpage>2588</lpage><pub-id pub-id-type="doi">10.1021/acsbiomaterials.2c00034</pub-id><pub-id pub-id-type="pmid">35649243</pub-id><pub-id pub-id-type="pmcid">PMC9983633</pub-id></element-citation></ref><ref id="B100-pharmaceutics-17-01176"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>K.</given-names></name><name name-style="western"><surname>Yan</surname><given-names>L.</given-names></name><name name-style="western"><surname>Li</surname><given-names>R.</given-names></name><name name-style="western"><surname>Song</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Ding</surname><given-names>J.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>B.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>X.</given-names></name></person-group><article-title>3D Printed Personalized Nerve Guide Conduits for Precision Repair of Peripheral Nerve Defects</article-title><source>Adv. Sci.</source><year>2022</year><volume>9</volume><fpage>e2103875</fpage><pub-id pub-id-type="doi">10.1002/advs.202103875</pub-id><pub-id pub-id-type="pmcid">PMC9036027</pub-id><pub-id pub-id-type="pmid">35182046</pub-id></element-citation></ref><ref id="B101-pharmaceutics-17-01176"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>X.Y.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>C.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>H.H.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y.S.</given-names></name><name name-style="western"><surname>Zhong</surname><given-names>L.</given-names></name><name name-style="western"><surname>Hu</surname><given-names>N.</given-names></name><name name-style="western"><surname>Jia</surname><given-names>X.L.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y.W.</given-names></name><name name-style="western"><surname>Zhong</surname><given-names>K.H.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Integrated printed BDNF/collagen/chitosan scaffolds with low temperature extrusion 3D printer accelerated neural regeneration after spinal cord injury</article-title><source>Regen. Biomater.</source><year>2021</year><volume>8</volume><elocation-id>rbab047</elocation-id><pub-id pub-id-type="pmid">34513004</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/rb/rbab047</pub-id><pub-id pub-id-type="pmcid">PMC8417565</pub-id></element-citation></ref><ref id="B102-pharmaceutics-17-01176"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Manoukian</surname><given-names>O.S.</given-names></name><name name-style="western"><surname>Baker</surname><given-names>J.T.</given-names></name><name name-style="western"><surname>Rudraiah</surname><given-names>S.</given-names></name><name name-style="western"><surname>Arul</surname><given-names>M.R.</given-names></name><name name-style="western"><surname>Vella</surname><given-names>A.T.</given-names></name><name name-style="western"><surname>Domb</surname><given-names>A.J.</given-names></name><name name-style="western"><surname>Kumbar</surname><given-names>S.G.</given-names></name></person-group><article-title>Functional polymeric nerve guidance conduits and drug delivery strategies for peripheral nerve repair and regeneration</article-title><source>J Control. Release</source><year>2020</year><volume>317</volume><fpage>78</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.1016/j.jconrel.2019.11.021</pub-id><pub-id pub-id-type="pmid">31756394</pub-id></element-citation></ref><ref id="B103-pharmaceutics-17-01176"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhou</surname><given-names>J.</given-names></name><name name-style="western"><surname>Vijayavenkataraman</surname><given-names>S.</given-names></name></person-group><article-title>A &#8216;Relay&#8217;-Type Drug-Eluting Nerve Guide Conduit: Computational Fluid Dynamics Modeling of the Drug Eluting Efficiency of Various Drug Release Systems</article-title><source>Pharmaceutics</source><year>2022</year><volume>14</volume><elocation-id>230</elocation-id><pub-id pub-id-type="doi">10.3390/pharmaceutics14020230</pub-id><pub-id pub-id-type="pmid">35213963</pub-id><pub-id pub-id-type="pmcid">PMC8874367</pub-id></element-citation></ref><ref id="B104-pharmaceutics-17-01176"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>W.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>H.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Li</surname><given-names>B.</given-names></name><name name-style="western"><surname>Gou</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Li</surname><given-names>X.</given-names></name><name name-style="western"><surname>Gou</surname><given-names>M.</given-names></name></person-group><article-title>3D printing of functional nerve guide conduits</article-title><source>Burn. Trauma</source><year>2021</year><volume>9</volume><fpage>tkab011</fpage><pub-id pub-id-type="doi">10.1093/burnst/tkab011</pub-id><pub-id pub-id-type="pmid">34212061</pub-id><pub-id pub-id-type="pmcid">PMC8240533</pub-id></element-citation></ref><ref id="B105-pharmaceutics-17-01176"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yi</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Zhan</surname><given-names>F.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>R.</given-names></name><name name-style="western"><surname>Lin</surname><given-names>H.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>L.</given-names></name></person-group><article-title>An electroconductive hydrogel with injectable and self-healing properties accelerates peripheral nerve regeneration and motor functional recovery</article-title><source>Chem. Eng. J.</source><year>2023</year><volume>478</volume><fpage>147261</fpage><pub-id pub-id-type="doi">10.1016/j.cej.2023.147261</pub-id></element-citation></ref><ref id="B106-pharmaceutics-17-01176"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tang</surname><given-names>S.</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Xiang</surname><given-names>A.P.</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>M.H.</given-names></name><name name-style="western"><surname>Quan</surname><given-names>D.</given-names></name></person-group><article-title>The effects of gradients of nerve growth factor immobilized PCLA scaffolds on neurite outgrowth in vitro and peripheral nerve regeneration in rats</article-title><source>Biomaterials</source><year>2013</year><volume>34</volume><fpage>7086</fpage><lpage>7096</lpage><pub-id pub-id-type="doi">10.1016/j.biomaterials.2013.05.080</pub-id><pub-id pub-id-type="pmid">23791502</pub-id></element-citation></ref><ref id="B107-pharmaceutics-17-01176"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chan</surname><given-names>J.R.</given-names></name><name name-style="western"><surname>Watkins</surname><given-names>T.A.</given-names></name><name name-style="western"><surname>Cosgaya</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>C.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>L.</given-names></name><name name-style="western"><surname>Reichardt</surname><given-names>L.F.</given-names></name><name name-style="western"><surname>Shooter</surname><given-names>E.M.</given-names></name><name name-style="western"><surname>Barres</surname><given-names>B.A.</given-names></name></person-group><article-title>NGF controls axonal receptivity to myelination by Schwann cells or oligodendrocytes</article-title><source>Neuron</source><year>2004</year><volume>43</volume><fpage>183</fpage><lpage>191</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2004.06.024</pub-id><pub-id pub-id-type="pmid">15260955</pub-id><pub-id pub-id-type="pmcid">PMC2758239</pub-id></element-citation></ref><ref id="B108-pharmaceutics-17-01176"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wei</surname><given-names>C.</given-names></name><name name-style="western"><surname>Guo</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Ci</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Li</surname><given-names>M.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>Y.</given-names></name></person-group><article-title>Advances of Schwann cells in peripheral nerve regeneration: From mechanism to cell therapy</article-title><source>Biomed. Pharmacother.</source><year>2024</year><volume>175</volume><elocation-id>116645</elocation-id><pub-id pub-id-type="doi">10.1016/j.biopha.2024.116645</pub-id><pub-id pub-id-type="pmid">38729050</pub-id></element-citation></ref><ref id="B109-pharmaceutics-17-01176"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kong</surname><given-names>L.</given-names></name><name name-style="western"><surname>Gao</surname><given-names>X.</given-names></name><name name-style="western"><surname>Qian</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Sun</surname><given-names>W.</given-names></name><name name-style="western"><surname>You</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Fan</surname><given-names>C.</given-names></name></person-group><article-title>Biomechanical microenvironment in peripheral nerve regeneration: From pathophysiological understanding to tissue engineering development</article-title><source>Theranostics</source><year>2022</year><volume>12</volume><fpage>4993</fpage><lpage>5014</lpage><pub-id pub-id-type="doi">10.7150/thno.74571</pub-id><pub-id pub-id-type="pmid">35836812</pub-id><pub-id pub-id-type="pmcid">PMC9274750</pub-id></element-citation></ref><ref id="B110-pharmaceutics-17-01176"><label>110.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Marinval</surname><given-names>N.</given-names></name><name name-style="western"><surname>Chew</surname><given-names>S.Y.</given-names></name></person-group><article-title>Mechanotransduction assays for neural regeneration strategies: A focus on glial cells</article-title><source>APL Bioeng.</source><year>2021</year><volume>5</volume><elocation-id>021505</elocation-id><pub-id pub-id-type="doi">10.1063/5.0037814</pub-id><pub-id pub-id-type="pmid">33948526</pub-id><pub-id pub-id-type="pmcid">PMC8088332</pub-id></element-citation></ref><ref id="B111-pharmaceutics-17-01176"><label>111.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tran</surname><given-names>K.A.</given-names></name><name name-style="western"><surname>DeOre</surname><given-names>B.J.</given-names></name><name name-style="western"><surname>Ikejiani</surname><given-names>D.</given-names></name><name name-style="western"><surname>Means</surname><given-names>K.</given-names></name><name name-style="western"><surname>Paone</surname><given-names>L.S.</given-names></name><name name-style="western"><surname>De Marchi</surname><given-names>L.</given-names></name><name name-style="western"><surname>Suprewicz</surname><given-names>&#321;.</given-names></name><name name-style="western"><surname>Koziol</surname><given-names>K.</given-names></name><name name-style="western"><surname>Bouyer</surname><given-names>J.</given-names></name><name name-style="western"><surname>Byfield</surname><given-names>F.J.</given-names></name><etal/></person-group><article-title>Matching mechanical heterogeneity of the native spinal cord augments axon infiltration in 3D-printed scaffolds</article-title><source>Biomaterials</source><year>2023</year><volume>295</volume><elocation-id>122061</elocation-id><pub-id pub-id-type="doi">10.1016/j.biomaterials.2023.122061</pub-id><pub-id pub-id-type="pmid">36842339</pub-id><pub-id pub-id-type="pmcid">PMC10292106</pub-id></element-citation></ref><ref id="B112-pharmaceutics-17-01176"><label>112.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bittner</surname><given-names>S.M.</given-names></name><name name-style="western"><surname>Guo</surname><given-names>J.L.</given-names></name><name name-style="western"><surname>Mikos</surname><given-names>A.G.</given-names></name></person-group><article-title>Spatiotemporal Control of Growth Factors in Three-Dimensional Printed Scaffolds</article-title><source>Bioprinting</source><year>2018</year><volume>12</volume><elocation-id>e00032</elocation-id><pub-id pub-id-type="doi">10.1016/j.bprint.2018.e00032</pub-id><pub-id pub-id-type="pmid">31106279</pub-id><pub-id pub-id-type="pmcid">PMC6519969</pub-id></element-citation></ref><ref id="B113-pharmaceutics-17-01176"><label>113.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>K.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>X.</given-names></name><name name-style="western"><surname>Li</surname><given-names>X.</given-names></name><name name-style="western"><surname>Yin</surname><given-names>J.</given-names></name><name name-style="western"><surname>Wei</surname><given-names>P.</given-names></name><name name-style="western"><surname>Qian</surname><given-names>J.</given-names></name><name name-style="western"><surname>Sun</surname><given-names>J.</given-names></name></person-group><article-title>Effect of Electrical and Electromechanical Stimulation on PC12 Cell Proliferation and Axon Outgrowth</article-title><source>Front. Bioeng. Biotechnol.</source><year>2021</year><volume>9</volume><elocation-id>757906</elocation-id><pub-id pub-id-type="doi">10.3389/fbioe.2021.757906</pub-id><pub-id pub-id-type="pmid">34746110</pub-id><pub-id pub-id-type="pmcid">PMC8566739</pub-id></element-citation></ref><ref id="B114-pharmaceutics-17-01176"><label>114.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>S.J.</given-names></name><name name-style="western"><surname>Esworthy</surname><given-names>T.</given-names></name><name name-style="western"><surname>Stake</surname><given-names>S.</given-names></name><name name-style="western"><surname>Miao</surname><given-names>S.</given-names></name><name name-style="western"><surname>Zuo</surname><given-names>Y.Y.</given-names></name><name name-style="western"><surname>Harris</surname><given-names>B.T.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>L.G.</given-names></name></person-group><article-title>Advances in 3D Bioprinting for Neural Tissue Engineering</article-title><source>Adv. Biosyst.</source><year>2018</year><volume>2</volume><elocation-id>1700213</elocation-id><pub-id pub-id-type="doi">10.1002/adbi.201700213</pub-id></element-citation></ref><ref id="B115-pharmaceutics-17-01176"><label>115.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>D.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>X.</given-names></name><name name-style="western"><surname>Han</surname><given-names>F.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y.</given-names></name></person-group><article-title>The blood-brain barrier: Structure, regulation, and drug delivery</article-title><source>Signal Transduct. Target. Ther.</source><year>2023</year><volume>8</volume><fpage>217</fpage><pub-id pub-id-type="doi">10.1038/s41392-023-01481-w</pub-id><pub-id pub-id-type="pmid">37231000</pub-id><pub-id pub-id-type="pmcid">PMC10212980</pub-id></element-citation></ref><ref id="B116-pharmaceutics-17-01176"><label>116.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Costa</surname><given-names>G.</given-names></name><name name-style="western"><surname>Ribeiro</surname><given-names>F.F.</given-names></name><name name-style="western"><surname>Sebastiao</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Muir</surname><given-names>E.M.</given-names></name><name name-style="western"><surname>Vaz</surname><given-names>S.H.</given-names></name></person-group><article-title>Bridging the gap of axonal regeneration in the central nervous system: A state of the art review on central axonal regeneration</article-title><source>Front. Neurosci.</source><year>2022</year><volume>16</volume><elocation-id>1003145</elocation-id><pub-id pub-id-type="doi">10.3389/fnins.2022.1003145</pub-id><pub-id pub-id-type="pmid">36440273</pub-id><pub-id pub-id-type="pmcid">PMC9682039</pub-id></element-citation></ref><ref id="B117-pharmaceutics-17-01176"><label>117.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>J.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>S.W.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>K.T.</given-names></name></person-group><article-title>Region-Specific Characteristics of Astrocytes and Microglia: A Possible Involvement in Aging and Diseases</article-title><source>Cells</source><year>2022</year><volume>11</volume><elocation-id>1902</elocation-id><pub-id pub-id-type="doi">10.3390/cells11121902</pub-id><pub-id pub-id-type="pmid">35741031</pub-id><pub-id pub-id-type="pmcid">PMC9220858</pub-id></element-citation></ref><ref id="B118-pharmaceutics-17-01176"><label>118.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Salaris</surname><given-names>F.</given-names></name><name name-style="western"><surname>Colosi</surname><given-names>C.</given-names></name><name name-style="western"><surname>Brighi</surname><given-names>C.</given-names></name><name name-style="western"><surname>Soloperto</surname><given-names>A.</given-names></name><name name-style="western"><surname>Turris</surname><given-names>V.</given-names></name><name name-style="western"><surname>Benedetti</surname><given-names>M.C.</given-names></name><name name-style="western"><surname>Ghirga</surname><given-names>S.</given-names></name><name name-style="western"><surname>Rosito</surname><given-names>M.</given-names></name><name name-style="western"><surname>Di Angelantonio</surname><given-names>S.</given-names></name><name name-style="western"><surname>Rosa</surname><given-names>A.</given-names></name></person-group><article-title>3D Bioprinted Human Cortical Neural Constructs Derived from Induced Pluripotent Stem Cells</article-title><source>J. Clin. Med.</source><year>2019</year><volume>8</volume><elocation-id>1595</elocation-id><pub-id pub-id-type="doi">10.3390/jcm8101595</pub-id><pub-id pub-id-type="pmid">31581732</pub-id><pub-id pub-id-type="pmcid">PMC6832547</pub-id></element-citation></ref><ref id="B119-pharmaceutics-17-01176"><label>119.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Orr</surname><given-names>A.</given-names></name><name name-style="western"><surname>Kalantarnia</surname><given-names>F.</given-names></name><name name-style="western"><surname>Nazir</surname><given-names>S.</given-names></name><name name-style="western"><surname>Bolandi</surname><given-names>B.</given-names></name><name name-style="western"><surname>Alderson</surname><given-names>D.</given-names></name><name name-style="western"><surname>O&#8217;Grady</surname><given-names>K.</given-names></name><name name-style="western"><surname>Hoorfar</surname><given-names>M.</given-names></name><name name-style="western"><surname>Julian</surname><given-names>L.M.</given-names></name><name name-style="western"><surname>Willerth</surname><given-names>S.M.</given-names></name></person-group><article-title>Recent advances in 3D bioprinted neural models: A systematic review on the applications to drug discovery</article-title><source>Adv. Drug. Deliv. Rev.</source><year>2025</year><volume>218</volume><fpage>115524</fpage><pub-id pub-id-type="doi">10.1016/j.addr.2025.115524</pub-id><pub-id pub-id-type="pmid">39900293</pub-id></element-citation></ref><ref id="B120-pharmaceutics-17-01176"><label>120.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Salmon</surname><given-names>I.</given-names></name><name name-style="western"><surname>Grebenyuk</surname><given-names>S.</given-names></name><name name-style="western"><surname>Abdel Fattah</surname><given-names>A.R.</given-names></name><name name-style="western"><surname>Rustandi</surname><given-names>G.</given-names></name><name name-style="western"><surname>Pilkington</surname><given-names>T.</given-names></name><name name-style="western"><surname>Verfaillie</surname><given-names>C.</given-names></name><name name-style="western"><surname>Ranga</surname><given-names>A.</given-names></name></person-group><article-title>Engineering neurovascular organoids with 3D printed microfluidic chips</article-title><source>Lab A Chip</source><year>2022</year><volume>22</volume><fpage>1615</fpage><lpage>1629</lpage><pub-id pub-id-type="doi">10.1039/D1LC00535A</pub-id><pub-id pub-id-type="pmid">35333271</pub-id></element-citation></ref><ref id="B121-pharmaceutics-17-01176"><label>121.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yan</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Li</surname><given-names>X.</given-names></name><name name-style="western"><surname>Gao</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Mathivanan</surname><given-names>S.</given-names></name><name name-style="western"><surname>Kong</surname><given-names>L.</given-names></name><name name-style="western"><surname>Tao</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Dong</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Li</surname><given-names>X.</given-names></name><name name-style="western"><surname>Bhattacharyya</surname><given-names>A.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>X.</given-names></name><etal/></person-group><article-title>3D bioprinting of human neural tissues with functional connectivity</article-title><source>Cell Stem Cell</source><year>2024</year><volume>31</volume><fpage>260</fpage><lpage>274.e7</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2023.12.009</pub-id><pub-id pub-id-type="pmid">38306994</pub-id><pub-id pub-id-type="pmcid">PMC10883639</pub-id></element-citation></ref><ref id="B122-pharmaceutics-17-01176"><label>122.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Comella-Bolla</surname><given-names>A.</given-names></name><name name-style="western"><surname>Orlandi</surname><given-names>J.G.</given-names></name><name name-style="western"><surname>Miguez</surname><given-names>A.</given-names></name><name name-style="western"><surname>Straccia</surname><given-names>M.</given-names></name><name name-style="western"><surname>Garcia-Bravo</surname><given-names>M.</given-names></name><name name-style="western"><surname>Bombau</surname><given-names>G.</given-names></name><name name-style="western"><surname>Galofre</surname><given-names>M.</given-names></name><name name-style="western"><surname>Sanders</surname><given-names>P.</given-names></name><name name-style="western"><surname>Carrere</surname><given-names>J.</given-names></name><name name-style="western"><surname>Segovia</surname><given-names>J.C.</given-names></name><etal/></person-group><article-title>Human Pluripotent Stem Cell-Derived Neurons Are Functionally Mature In Vitro and Integrate into the Mouse Striatum Following Transplantation</article-title><source>Mol. Neurobiol.</source><year>2020</year><volume>57</volume><fpage>2766</fpage><lpage>2798</lpage><pub-id pub-id-type="doi">10.1007/s12035-020-01907-4</pub-id><pub-id pub-id-type="pmid">32356172</pub-id><pub-id pub-id-type="pmcid">PMC7253531</pub-id></element-citation></ref><ref id="B123-pharmaceutics-17-01176"><label>123.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jin</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Mikhailova</surname><given-names>E.</given-names></name><name name-style="western"><surname>Lei</surname><given-names>M.</given-names></name><name name-style="western"><surname>Cowley</surname><given-names>S.A.</given-names></name><name name-style="western"><surname>Sun</surname><given-names>T.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>K.</given-names></name><name name-style="western"><surname>Catarino da Silva</surname><given-names>D.</given-names></name><name name-style="western"><surname>Campos Soares</surname><given-names>L.</given-names></name><etal/></person-group><article-title>Integration of 3D-printed cerebral cortical tissue into an ex vivo lesioned brain slice</article-title><source>Nat. Commun.</source><year>2023</year><volume>14</volume><fpage>5986</fpage><pub-id pub-id-type="doi">10.1038/s41467-023-41356-w</pub-id><pub-id pub-id-type="pmid">37794031</pub-id><pub-id pub-id-type="pmcid">PMC10551017</pub-id></element-citation></ref><ref id="B124-pharmaceutics-17-01176"><label>124.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Warren</surname><given-names>D.</given-names></name><name name-style="western"><surname>Tomaskovic-Crook</surname><given-names>E.</given-names></name><name name-style="western"><surname>Wallace</surname><given-names>G.G.</given-names></name><name name-style="western"><surname>Crook</surname><given-names>J.M.</given-names></name></person-group><article-title>Engineering in vitro human neural tissue analogs by 3D bioprinting and electrostimulation</article-title><source>APL Bioeng.</source><year>2021</year><volume>5</volume><elocation-id>020901</elocation-id><pub-id pub-id-type="doi">10.1063/5.0032196</pub-id><pub-id pub-id-type="pmid">33834152</pub-id><pub-id pub-id-type="pmcid">PMC8019355</pub-id></element-citation></ref><ref id="B125-pharmaceutics-17-01176"><label>125.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Villa</surname><given-names>C.</given-names></name><name name-style="western"><surname>Combi</surname><given-names>R.</given-names></name><name name-style="western"><surname>Conconi</surname><given-names>D.</given-names></name><name name-style="western"><surname>Lavitrano</surname><given-names>M.</given-names></name></person-group><article-title>Patient-Derived Induced Pluripotent Stem Cells (iPSCs) and Cerebral Organoids for Drug Screening and Development in Autism Spectrum Disorder: Opportunities and Challenges</article-title><source>Pharmaceutics</source><year>2021</year><volume>13</volume><elocation-id>280</elocation-id><pub-id pub-id-type="doi">10.3390/pharmaceutics13020280</pub-id><pub-id pub-id-type="pmid">33669772</pub-id><pub-id pub-id-type="pmcid">PMC7922555</pub-id></element-citation></ref><ref id="B126-pharmaceutics-17-01176"><label>126.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ranjan</surname><given-names>J.</given-names></name><name name-style="western"><surname>Bhattacharya</surname><given-names>A.</given-names></name></person-group><article-title>The Evolving Landscape of Functional Models of Autism Spectrum Disorder</article-title><source>Cells</source><year>2025</year><volume>14</volume><elocation-id>908</elocation-id><pub-id pub-id-type="doi">10.3390/cells14120908</pub-id><pub-id pub-id-type="pmid">40558535</pub-id><pub-id pub-id-type="pmcid">PMC12190894</pub-id></element-citation></ref><ref id="B127-pharmaceutics-17-01176"><label>127.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>K.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Luo</surname><given-names>X.</given-names></name><name name-style="western"><surname>Ma</surname><given-names>C.</given-names></name><name name-style="western"><surname>Man</surname><given-names>W.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Cao</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Hu</surname><given-names>P.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>J.</given-names></name><etal/></person-group><article-title>3D bioprinted dynamic bioactive living construct enhances mechanotransduction-assisted rapid neural network self-organization for spinal cord injury repair</article-title><source>Bioact. Mater.</source><year>2025</year><volume>46</volume><fpage>531</fpage><lpage>554</lpage><pub-id pub-id-type="doi">10.1016/j.bioactmat.2024.12.028</pub-id><pub-id pub-id-type="pmid">39886605</pub-id><pub-id pub-id-type="pmcid">PMC11780150</pub-id></element-citation></ref><ref id="B128-pharmaceutics-17-01176"><label>128.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>H.</given-names></name><name name-style="western"><surname>Long</surname><given-names>X.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>T.</given-names></name></person-group><article-title>Three-dimensional-engineered bioprinted in vitro human neural stem cell self-assembling culture model constructs of Alzheimer&#8217;s disease</article-title><source>Bioact. Mater.</source><year>2022</year><volume>11</volume><fpage>192</fpage><lpage>205</lpage><pub-id pub-id-type="doi">10.1016/j.bioactmat.2021.09.023</pub-id><pub-id pub-id-type="pmid">34938923</pub-id><pub-id pub-id-type="pmcid">PMC8665263</pub-id></element-citation></ref><ref id="B129-pharmaceutics-17-01176"><label>129.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tung</surname><given-names>Y.T.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y.C.</given-names></name><name name-style="western"><surname>Derr</surname><given-names>K.</given-names></name><name name-style="western"><surname>Wilson</surname><given-names>K.</given-names></name><name name-style="western"><surname>Song</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Ferrer</surname><given-names>M.</given-names></name></person-group><article-title>A 3D Bioprinted Human Neurovascular Unit Model of Glioblastoma Tumor Growth</article-title><source>Adv. Healthc. Mater.</source><year>2024</year><volume>13</volume><fpage>e2302831</fpage><pub-id pub-id-type="doi">10.1002/adhm.202302831</pub-id><pub-id pub-id-type="pmid">38394389</pub-id><pub-id pub-id-type="pmcid">PMC11176035</pub-id></element-citation></ref><ref id="B130-pharmaceutics-17-01176"><label>130.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tang</surname><given-names>M.</given-names></name><name name-style="western"><surname>Rich</surname><given-names>J.N.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>S.</given-names></name></person-group><article-title>Biomaterials and 3D Bioprinting Strategies to Model Glioblastoma and the Blood-Brain Barrier</article-title><source>Adv. Mater.</source><year>2021</year><volume>33</volume><fpage>e2004776</fpage><pub-id pub-id-type="doi">10.1002/adma.202004776</pub-id><pub-id pub-id-type="pmid">33326131</pub-id><pub-id pub-id-type="pmcid">PMC7854518</pub-id></element-citation></ref><ref id="B131-pharmaceutics-17-01176"><label>131.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ozbek</surname><given-names>I.I.</given-names></name><name name-style="western"><surname>Saybasili</surname><given-names>H.</given-names></name><name name-style="western"><surname>Ulgen</surname><given-names>K.O.</given-names></name></person-group><article-title>Applications of 3D Bioprinting Technology to Brain Cells and Brain Tumor Models: Special Emphasis to Glioblastoma</article-title><source>ACS Biomater. Sci. Eng.</source><year>2024</year><volume>10</volume><fpage>2616</fpage><lpage>2635</lpage><pub-id pub-id-type="doi">10.1021/acsbiomaterials.3c01569</pub-id><pub-id pub-id-type="pmid">38664996</pub-id><pub-id pub-id-type="pmcid">PMC11094688</pub-id></element-citation></ref><ref id="B132-pharmaceutics-17-01176"><label>132.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Silvani</surname><given-names>G.</given-names></name><name name-style="western"><surname>Basirun</surname><given-names>C.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>H.</given-names></name><name name-style="western"><surname>Mehner</surname><given-names>C.</given-names></name><name name-style="western"><surname>Poole</surname><given-names>K.</given-names></name><name name-style="western"><surname>Bradbury</surname><given-names>P.</given-names></name><name name-style="western"><surname>Chou</surname><given-names>J.</given-names></name></person-group><article-title>A 3D-Bioprinted Vascularized Glioblastoma-on-a-Chip for Studying the Impact of Simulated Microgravity as a Novel Pre-Clinical Approach in Brain Tumor Therapy</article-title><source>Adv. Ther.</source><year>2021</year><volume>4</volume><fpage>2100106</fpage><pub-id pub-id-type="doi">10.1002/adtp.202100106</pub-id></element-citation></ref><ref id="B133-pharmaceutics-17-01176"><label>133.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Awuah</surname><given-names>W.A.</given-names></name><name name-style="western"><surname>Karkhanis</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ben-Jaafar</surname><given-names>A.</given-names></name><name name-style="western"><surname>Kong</surname><given-names>J.S.H.</given-names></name><name name-style="western"><surname>Mannan</surname><given-names>K.M.</given-names></name><name name-style="western"><surname>Nkrumah-Boateng</surname><given-names>P.A.</given-names></name><name name-style="western"><surname>Tan</surname><given-names>J.K.</given-names></name><name name-style="western"><surname>Dorcas</surname><given-names>A.O.</given-names></name><name name-style="western"><surname>Shet</surname><given-names>V.</given-names></name><name name-style="western"><surname>Shah</surname><given-names>M.H.</given-names></name><etal/></person-group><article-title>Recent advances in 3D printing applications for CNS tumours</article-title><source>Eur. J. Med. Res.</source><year>2025</year><volume>30</volume><fpage>251</fpage><pub-id pub-id-type="doi">10.1186/s40001-025-02483-w</pub-id><pub-id pub-id-type="pmid">40189551</pub-id><pub-id pub-id-type="pmcid">PMC11974138</pub-id></element-citation></ref><ref id="B134-pharmaceutics-17-01176"><label>134.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mota</surname><given-names>C.</given-names></name><name name-style="western"><surname>Camarero-Espinosa</surname><given-names>S.</given-names></name><name name-style="western"><surname>Baker</surname><given-names>M.B.</given-names></name><name name-style="western"><surname>Wieringa</surname><given-names>P.</given-names></name><name name-style="western"><surname>Moroni</surname><given-names>L.</given-names></name></person-group><article-title>Bioprinting: From Tissue and Organ Development to in Vitro Models</article-title><source>Chem. Rev.</source><year>2020</year><volume>120</volume><fpage>10547</fpage><lpage>10607</lpage><pub-id pub-id-type="doi">10.1021/acs.chemrev.9b00789</pub-id><pub-id pub-id-type="pmid">32407108</pub-id><pub-id pub-id-type="pmcid">PMC7564098</pub-id></element-citation></ref><ref id="B135-pharmaceutics-17-01176"><label>135.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rouleau</surname><given-names>N.</given-names></name><name name-style="western"><surname>Murugan</surname><given-names>N.J.</given-names></name><name name-style="western"><surname>Kaplan</surname><given-names>D.L.</given-names></name></person-group><article-title>Functional bioengineered models of the central nervous system</article-title><source>Nat. Rev. Bioeng.</source><year>2023</year><volume>1</volume><fpage>252</fpage><lpage>270</lpage><pub-id pub-id-type="doi">10.1038/s44222-023-00027-7</pub-id><pub-id pub-id-type="pmid">37064657</pub-id><pub-id pub-id-type="pmcid">PMC9903289</pub-id></element-citation></ref><ref id="B136-pharmaceutics-17-01176"><label>136.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kuzucu</surname><given-names>M.</given-names></name><name name-style="western"><surname>Vera</surname><given-names>G.</given-names></name><name name-style="western"><surname>Beaumont</surname><given-names>M.</given-names></name><name name-style="western"><surname>Fischer</surname><given-names>S.</given-names></name><name name-style="western"><surname>Wei</surname><given-names>P.</given-names></name><name name-style="western"><surname>Shastri</surname><given-names>V.P.</given-names></name><name name-style="western"><surname>Forget</surname><given-names>A.</given-names></name></person-group><article-title>Extrusion-Based 3D Bioprinting of Gradients of Stiffness, Cell Density, and Immobilized Peptide Using Thermogelling Hydrogels</article-title><source>ACS Biomater. Sci. Eng.</source><year>2021</year><volume>7</volume><fpage>2192</fpage><lpage>2197</lpage><pub-id pub-id-type="doi">10.1021/acsbiomaterials.1c00183</pub-id><pub-id pub-id-type="pmid">33970597</pub-id><pub-id pub-id-type="pmcid">PMC8207502</pub-id></element-citation></ref><ref id="B137-pharmaceutics-17-01176"><label>137.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lowen</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Leach</surname><given-names>J.K.</given-names></name></person-group><article-title>Functionally graded biomaterials for use as model systems and replacement tissues</article-title><source>Adv. Funct. Mater.</source><year>2020</year><volume>30</volume><fpage>1909089</fpage><pub-id pub-id-type="doi">10.1002/adfm.201909089</pub-id><pub-id pub-id-type="pmid">33456431</pub-id><pub-id pub-id-type="pmcid">PMC7810245</pub-id></element-citation></ref><ref id="B138-pharmaceutics-17-01176"><label>138.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gharraei</surname><given-names>R.</given-names></name><name name-style="western"><surname>Bergstrom</surname><given-names>D.J.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>X.</given-names></name></person-group><article-title>Extrusion bioprinting from a fluid mechanics perspective</article-title><source>Int. J. Bioprint.</source><year>2024</year><volume>10</volume><elocation-id>3973</elocation-id><pub-id pub-id-type="doi">10.36922/ijb.3973</pub-id></element-citation></ref><ref id="B139-pharmaceutics-17-01176"><label>139.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mohan</surname><given-names>T.S.</given-names></name><name name-style="western"><surname>Datta</surname><given-names>P.</given-names></name><name name-style="western"><surname>Nesaei</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ozbolat</surname><given-names>V.</given-names></name><name name-style="western"><surname>Ozbolat</surname><given-names>I.T.</given-names></name></person-group><article-title>3D Coaxial Bioprinting: Process Mechanisms, Bioinks and Applications</article-title><source>Prog. Biomed. Eng.</source><year>2022</year><volume>4</volume><elocation-id>022003</elocation-id><pub-id pub-id-type="doi">10.1088/2516-1091/ac631c</pub-id><pub-id pub-id-type="pmcid">PMC9103990</pub-id><pub-id pub-id-type="pmid">35573639</pub-id></element-citation></ref><ref id="B140-pharmaceutics-17-01176"><label>140.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mieszczanek</surname><given-names>P.</given-names></name><name name-style="western"><surname>Corke</surname><given-names>P.</given-names></name><name name-style="western"><surname>Mehanian</surname><given-names>C.</given-names></name><name name-style="western"><surname>Dalton</surname><given-names>P.D.</given-names></name><name name-style="western"><surname>Hutmacher</surname><given-names>D.W.</given-names></name></person-group><article-title>Towards industry-ready additive manufacturing: AI-enabled closed-loop control for 3D melt electrowriting</article-title><source>Commun. Eng.</source><year>2024</year><volume>3</volume><fpage>158</fpage><pub-id pub-id-type="doi">10.1038/s44172-024-00302-4</pub-id><pub-id pub-id-type="pmid">39501063</pub-id><pub-id pub-id-type="pmcid">PMC11538274</pub-id></element-citation></ref><ref id="B141-pharmaceutics-17-01176"><label>141.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pati</surname><given-names>F.</given-names></name><name name-style="western"><surname>Jang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Ha</surname><given-names>D.H.</given-names></name><name name-style="western"><surname>Won Kim</surname><given-names>S.</given-names></name><name name-style="western"><surname>Rhie</surname><given-names>J.W.</given-names></name><name name-style="western"><surname>Shim</surname><given-names>J.H.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>D.H.</given-names></name><name name-style="western"><surname>Cho</surname><given-names>D.W.</given-names></name></person-group><article-title>Printing three-dimensional tissue analogues with decellularized extracellular matrix bioink</article-title><source>Nat. Commun.</source><year>2014</year><volume>5</volume><fpage>3935</fpage><pub-id pub-id-type="doi">10.1038/ncomms4935</pub-id><pub-id pub-id-type="pmid">24887553</pub-id><pub-id pub-id-type="pmcid">PMC4059935</pub-id></element-citation></ref><ref id="B142-pharmaceutics-17-01176"><label>142.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ashtari</surname><given-names>K.</given-names></name><name name-style="western"><surname>Nazari</surname><given-names>H.</given-names></name><name name-style="western"><surname>Ko</surname><given-names>H.</given-names></name><name name-style="western"><surname>Tebon</surname><given-names>P.</given-names></name><name name-style="western"><surname>Akhshik</surname><given-names>M.</given-names></name><name name-style="western"><surname>Akbari</surname><given-names>M.</given-names></name><name name-style="western"><surname>Alhosseini</surname><given-names>S.N.</given-names></name><name name-style="western"><surname>Mozafari</surname><given-names>M.</given-names></name><name name-style="western"><surname>Mehravi</surname><given-names>B.</given-names></name><name name-style="western"><surname>Soleimani</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Electrically conductive nanomaterials for cardiac tissue engineering</article-title><source>Adv. Drug. Deliv. Rev.</source><year>2019</year><volume>144</volume><fpage>162</fpage><lpage>179</lpage><pub-id pub-id-type="doi">10.1016/j.addr.2019.06.001</pub-id><pub-id pub-id-type="pmid">31176755</pub-id><pub-id pub-id-type="pmcid">PMC6784829</pub-id></element-citation></ref><ref id="B143-pharmaceutics-17-01176"><label>143.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Xue</surname><given-names>W.</given-names></name><name name-style="western"><surname>Yun</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Sun</surname><given-names>X.</given-names></name></person-group><article-title>Biomedical applications of stimuli-responsive "smart" interpenetrating polymer network hydrogels</article-title><source>Mater. Today Bio</source><year>2024</year><volume>25</volume><elocation-id>100998</elocation-id><pub-id pub-id-type="doi">10.1016/j.mtbio.2024.100998</pub-id><pub-id pub-id-type="pmcid">PMC10882133</pub-id><pub-id pub-id-type="pmid">38390342</pub-id></element-citation></ref><ref id="B144-pharmaceutics-17-01176"><label>144.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Neumann</surname><given-names>M.</given-names></name><name name-style="western"><surname>di Marco</surname><given-names>G.</given-names></name><name name-style="western"><surname>Iudin</surname><given-names>D.</given-names></name><name name-style="western"><surname>Viola</surname><given-names>M.</given-names></name><name name-style="western"><surname>van Nostrum</surname><given-names>C.F.</given-names></name><name name-style="western"><surname>van Ravensteijn</surname><given-names>B.G.P.</given-names></name><name name-style="western"><surname>Vermonden</surname><given-names>T.</given-names></name></person-group><article-title>Stimuli-Responsive Hydrogels: The Dynamic Smart Biomaterials of Tomorrow</article-title><source>Macromolecules</source><year>2023</year><volume>56</volume><fpage>8377</fpage><lpage>8392</lpage><pub-id pub-id-type="doi">10.1021/acs.macromol.3c00967</pub-id><pub-id pub-id-type="pmid">38024154</pub-id><pub-id pub-id-type="pmcid">PMC10653276</pub-id></element-citation></ref><ref id="B145-pharmaceutics-17-01176"><label>145.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>J.</given-names></name></person-group><article-title>Characterization of Biocompatibility of Functional Bioinks for 3D Bioprinting</article-title><source>Bioengineering</source><year>2023</year><volume>10</volume><elocation-id>457</elocation-id><pub-id pub-id-type="doi">10.3390/bioengineering10040457</pub-id><pub-id pub-id-type="pmid">37106644</pub-id><pub-id pub-id-type="pmcid">PMC10135811</pub-id></element-citation></ref><ref id="B146-pharmaceutics-17-01176"><label>146.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>S.-M.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>J.-E.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>Y.-K.</given-names></name><name name-style="western"><surname>Yoo</surname><given-names>D.-A.</given-names></name><name name-style="western"><surname>Seon</surname><given-names>D.-B.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>D.-W.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>C.-B.</given-names></name><name name-style="western"><surname>Choi</surname><given-names>H.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>K.-H.</given-names></name></person-group><article-title>Thermal-Corrosion-Free Electrode-Integrated Cell Chip for Promotion of Electrically Stimulated Neurite Outgrowth</article-title><source>BioChip J.</source><year>2022</year><volume>16</volume><fpage>99</fpage><lpage>110</lpage><pub-id pub-id-type="doi">10.1007/s13206-022-00049-0</pub-id></element-citation></ref><ref id="B147-pharmaceutics-17-01176"><label>147.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>B&#322;aszczykowski</surname><given-names>M.</given-names></name><name name-style="western"><surname>Majerek</surname><given-names>D.</given-names></name><name name-style="western"><surname>S&#281;dzielewska</surname><given-names>E.</given-names></name><name name-style="western"><surname>Tomi&#322;o</surname><given-names>P.</given-names></name><name name-style="western"><surname>Pytka</surname><given-names>J.</given-names></name></person-group><article-title>A novel machine learning system for early defect detection in 3D printing</article-title><source>Adv. Sci. Technol. Res. J.</source><year>2025</year><volume>19</volume><fpage>134</fpage><lpage>143</lpage><pub-id pub-id-type="doi">10.12913/22998624/196684</pub-id></element-citation></ref><ref id="B148-pharmaceutics-17-01176"><label>148.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Limon</surname><given-names>S.M.</given-names></name><name name-style="western"><surname>Quigley</surname><given-names>C.</given-names></name><name name-style="western"><surname>Sarah</surname><given-names>R.</given-names></name><name name-style="western"><surname>Habib</surname><given-names>A.</given-names></name></person-group><article-title>Advancing scaffold porosity through a machine learning framework in extrusion based 3D bioprinting</article-title><source>Front. Mater.</source><year>2024</year><volume>10</volume><elocation-id>1337485</elocation-id><pub-id pub-id-type="doi">10.3389/fmats.2023.1337485</pub-id></element-citation></ref><ref id="B149-pharmaceutics-17-01176"><label>149.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>De Spirito</surname><given-names>M.</given-names></name><name name-style="western"><surname>Palmieri</surname><given-names>V.</given-names></name><name name-style="western"><surname>Perini</surname><given-names>G.</given-names></name><name name-style="western"><surname>Papi</surname><given-names>M.</given-names></name></person-group><article-title>Bridging the Gap: Integrating 3D Bioprinting and Microfluidics for Advanced Multi-Organ Models in Biomedical Research</article-title><source>Bioengineering</source><year>2024</year><volume>11</volume><elocation-id>664</elocation-id><pub-id pub-id-type="doi">10.3390/bioengineering11070664</pub-id><pub-id pub-id-type="pmid">39061746</pub-id><pub-id pub-id-type="pmcid">PMC11274229</pub-id></element-citation></ref><ref id="B150-pharmaceutics-17-01176"><label>150.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cereser</surname><given-names>B.</given-names></name><name name-style="western"><surname>Yiu</surname><given-names>A.</given-names></name><name name-style="western"><surname>Tabassum</surname><given-names>N.</given-names></name><name name-style="western"><surname>Del Bel Belluz</surname><given-names>L.</given-names></name><name name-style="western"><surname>Zagorac</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ancheta</surname><given-names>K.R.Z.</given-names></name><name name-style="western"><surname>Zhong</surname><given-names>R.</given-names></name><name name-style="western"><surname>Miere</surname><given-names>C.</given-names></name><name name-style="western"><surname>Jeffries-Jones</surname><given-names>A.R.</given-names></name><name name-style="western"><surname>Moderau</surname><given-names>N.</given-names></name><etal/></person-group><article-title>The mutational landscape of the adult healthy parous and nulliparous human breast</article-title><source>Nat. Commun.</source><year>2023</year><volume>14</volume><fpage>5136</fpage><pub-id pub-id-type="doi">10.1038/s41467-023-40608-z</pub-id><pub-id pub-id-type="pmid">37673861</pub-id><pub-id pub-id-type="pmcid">PMC10482899</pub-id></element-citation></ref><ref id="B151-pharmaceutics-17-01176"><label>151.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Grebenyuk</surname><given-names>S.</given-names></name><name name-style="western"><surname>Abdel Fattah</surname><given-names>A.R.</given-names></name><name name-style="western"><surname>Kumar</surname><given-names>M.</given-names></name><name name-style="western"><surname>Toprakhisar</surname><given-names>B.</given-names></name><name name-style="western"><surname>Rustandi</surname><given-names>G.</given-names></name><name name-style="western"><surname>Vananroye</surname><given-names>A.</given-names></name><name name-style="western"><surname>Salmon</surname><given-names>I.</given-names></name><name name-style="western"><surname>Verfaillie</surname><given-names>C.</given-names></name><name name-style="western"><surname>Grillo</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ranga</surname><given-names>A.</given-names></name></person-group><article-title>Large-scale perfused tissues via synthetic 3D soft microfluidics</article-title><source>Nat. Commun.</source><year>2023</year><volume>14</volume><fpage>193</fpage><pub-id pub-id-type="doi">10.1038/s41467-022-35619-1</pub-id><pub-id pub-id-type="pmid">36635264</pub-id><pub-id pub-id-type="pmcid">PMC9837048</pub-id></element-citation></ref><ref id="B152-pharmaceutics-17-01176"><label>152.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Qiu</surname><given-names>H.</given-names></name><name name-style="western"><surname>Tan</surname><given-names>C.S.</given-names></name></person-group><article-title>Microfluidic Liver-on-a-Chip for Preclinical Drug Discovery</article-title><source>Pharmaceutics</source><year>2023</year><volume>15</volume><elocation-id>1300</elocation-id><pub-id pub-id-type="doi">10.3390/pharmaceutics15041300</pub-id><pub-id pub-id-type="pmid">37111785</pub-id><pub-id pub-id-type="pmcid">PMC10141038</pub-id></element-citation></ref><ref id="B153-pharmaceutics-17-01176"><label>153.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ferrari</surname><given-names>E.</given-names></name><name name-style="western"><surname>Palma</surname><given-names>C.</given-names></name><name name-style="western"><surname>Vesentini</surname><given-names>S.</given-names></name><name name-style="western"><surname>Occhetta</surname><given-names>P.</given-names></name><name name-style="western"><surname>Rasponi</surname><given-names>M.</given-names></name></person-group><article-title>Integrating Biosensors in Organs-on-Chip Devices: A Perspective on Current Strategies to Monitor Microphysiological Systems</article-title><source>Biosensors</source><year>2020</year><volume>10</volume><elocation-id>110</elocation-id><pub-id pub-id-type="doi">10.3390/bios10090110</pub-id><pub-id pub-id-type="pmid">32872228</pub-id><pub-id pub-id-type="pmcid">PMC7558092</pub-id></element-citation></ref><ref id="B154-pharmaceutics-17-01176"><label>154.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chung</surname><given-names>T.C.</given-names></name><name name-style="western"><surname>Liang</surname><given-names>C.C.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>M.W.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>T.</given-names></name><name name-style="western"><surname>Little</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Shrestha</surname><given-names>S.</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y.C.E.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>I.C.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>P.Y.</given-names></name></person-group><article-title>Machine Learning Guided Design of Nerve-On-A-Chip Platforms with Promoted Neurite Outgrowth</article-title><source>Adv. Funct. Mater.</source><year>2025</year><fpage>2506074</fpage><pub-id pub-id-type="doi">10.1002/adfm.202506074</pub-id></element-citation></ref><ref id="B155-pharmaceutics-17-01176"><label>155.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>X.</given-names></name><name name-style="western"><surname>Fang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Xiong</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>T.</given-names></name></person-group><article-title>AI-driven 3D bioprinting for regenerative medicine: From bench to bedside</article-title><source>Bioact. Mater.</source><year>2025</year><volume>45</volume><fpage>201</fpage><lpage>230</lpage><pub-id pub-id-type="doi">10.1016/j.bioactmat.2024.11.021</pub-id><pub-id pub-id-type="pmid">39651398</pub-id><pub-id pub-id-type="pmcid">PMC11625302</pub-id></element-citation></ref></ref-list></back><floats-group><fig position="float" id="pharmaceutics-17-01176-f001" orientation="portrait"><label>Figure 1</label><caption><p>Overview of NTE and its diverse applications. (<bold>A</bold>) Representative applications of neural tissue engineering, highlighting its role in addressing CNS and PNS injuries through strategies such as neural repair, organ-on-chip models, drug screening platforms, and integration with AI. (<bold>B</bold>) Timeline of key technological advancements in NTE.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="pharmaceutics-17-01176-g001.jpg"/></fig><fig position="float" id="pharmaceutics-17-01176-f002" orientation="portrait"><label>Figure 2</label><caption><p>Timeline of key advancements in 3D bioprinting technologies applied to NTE. The timeline highlights significant milestones, beginning with early inkjet printing of viable mammalian cells, followed by developing biomaterial-based scaffolds and prototypes, laser-assisted cell printing, and cell-laden peripheral nerve conduits. Recent advances feature 4D bioprinting for dynamically adaptive neural constructs and DLP-based porous hydrogels for advanced neural tissue models suitable for disease studies.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="pharmaceutics-17-01176-g002.jpg"/></fig><fig position="float" id="pharmaceutics-17-01176-f003" orientation="portrait"><label>Figure 3</label><caption><p><bold>Overview of bioprinting technologies used in tissue engineering, illustrating five different bioprinting methods:</bold> (<bold>A</bold>) Extrusion-based bioprinting using mechanical force for cylindrical construct formation. (<bold>B</bold>) Inkjet bioprinting employing piezoelectric actuators for droplet deposition, (<bold>C</bold>) EHD bioprinting utilizing electric fields to generate ultra-fine jets or droplets for high-resolution bioink patterning. (<bold>D</bold>) Laser-assisted bioprinting involving laser-induced droplet ejection for precision cell placement. (<bold>E</bold>) Stereolithography utilizing patterned light projections to fabricate scaffolds with intricate structures. (<bold>F</bold>) Two-photon polymerization employing a femtosecond laser for highly precise, vascularized tissue models.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="pharmaceutics-17-01176-g003.jpg"/></fig><fig position="float" id="pharmaceutics-17-01176-f004" orientation="portrait"><label>Figure 4</label><caption><p><bold>Representative bioprinting strategies and scaffold designs for peripheral nerve regeneration.</bold> (<bold>A</bold>) Hierarchical anisotropic silk-based nerve guidance conduit with aligned silk nanofiber fillers. (<bold>B</bold>) Schwann cell-laden GelMA hydrogel scaffold promoting neurite outgrowth. ns: no significant, * <italic toggle="yes">p</italic> &lt; 0.05; ** <italic toggle="yes">p</italic> &lt; 0.01, **** <italic toggle="yes">p</italic> &lt; 0.0001. (<bold>C</bold>) 4D morphing scaffold using mussel-inspired adhesive chemistry for spatial growth factor patterning; black areas in the orientation histograms indicate angular ranges with no aligned fibers detected. (<bold>D</bold>) 3D printed scaffold with NGF gradient and oriented microchannels. Adapted with permission after [<xref rid="B21-pharmaceutics-17-01176" ref-type="bibr">21</xref>,<xref rid="B91-pharmaceutics-17-01176" ref-type="bibr">91</xref>,<xref rid="B94-pharmaceutics-17-01176" ref-type="bibr">94</xref>,<xref rid="B95-pharmaceutics-17-01176" ref-type="bibr">95</xref>].</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="pharmaceutics-17-01176-g004.jpg"/></fig><fig position="float" id="pharmaceutics-17-01176-f005" orientation="portrait"><label>Figure 5</label><caption><p><bold>Recent advancements in 3D bioprinted brain tissue models and CNS</bold>-<bold>on</bold>-<bold>chip platforms.</bold> (<bold>A</bold>) Three-dimensional bioprinted cortical tissue model with regionally organized neuronal and astrocytic populations forming layered cortical architecture. (<bold>B</bold>) Brain organoid-based 3D printed scaffold supporting neural network formation with spatial patterning. (<bold>C</bold>) Microfluidic CNS-on-chip platform integrating vascularized brain organoid models. (<bold>D</bold>) Three-dimensional printed multilayered neural constructs with sequential deposition of fluorescently labeled neural precursor cells. Adapted with permission after [<xref rid="B118-pharmaceutics-17-01176" ref-type="bibr">118</xref>,<xref rid="B119-pharmaceutics-17-01176" ref-type="bibr">119</xref>,<xref rid="B120-pharmaceutics-17-01176" ref-type="bibr">120</xref>,<xref rid="B121-pharmaceutics-17-01176" ref-type="bibr">121</xref>].</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="pharmaceutics-17-01176-g005.jpg"/></fig><table-wrap position="float" id="pharmaceutics-17-01176-t001" orientation="portrait"><object-id pub-id-type="pii">pharmaceutics-17-01176-t001_Table 1</object-id><label>Table 1</label><caption><p>Comparison of bioprinting techniques in neural tissue engineering.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Parameter</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Extrusion Bioprinting</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Inkjet Bioprinting</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">EHD Bioprinting</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Laser-Assisted Bioprinting</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Stereolithography</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Two-Photon Polymerization</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Speed</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Slow</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fast</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Medium&#8211;High</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Medium</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fast</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Slow</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cost</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Moderate</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Low</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">High</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">High</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Low</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Very High</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cell Viability</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">85&#8211;95%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">80&#8211;95%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&gt;90%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&lt;85%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&gt;85%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&gt;80%</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cell Density</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">High</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Low&#8211;Moderate</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Very High</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Medium</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Medium</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Medium</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Resolution</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100&#8211;500 &#181;m</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100&#8211;300 &#181;m</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">50&#8211;100 nm to 10 &#181;m</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">20&#8211;100 &#181;m</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10&#8211;50 &#956;m</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.1&#8211;1 &#956;m</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Viscosity Range</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">30&#8211;6 &#215; 10<sup>7</sup> mPa&#183;s</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&lt;10 mPa&#183;s</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1&#8211;1000 mPa&#183;s (wide range)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1&#8211;300 mPa&#183;s</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No limitation</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mo limitation</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Material Type</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hydrogels (e.g., GelMA, alginate), ECM-based materials</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Low viscosity inks (e.g., modified hydrogels)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Conductive or ECM-based hydrogels</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ECM-based, photosensitive materials</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Photocurable polymers (e.g., PEGDA, GelMA)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Photosensitive resins (e.g., acrylates, GelMA derivatives)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bioink Flexibility</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">High (multi-material, high cell load)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Moderate</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">High (nanoscale jetting of bioinks)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Moderate</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Moderate</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Low</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Application</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">General tissue models, nerve guidance conduits</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Patterning, high-throughput screening</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fine patterning, micro/nanoscale architecture</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">High precision scaffolds, neuroanatomical layering</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Vascular and neural constructs with precise geometry </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ultra&#8211;high-resolution microstructures</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Limitations</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Low resolution, nozzle clogging</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Droplet formation constraints</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">High voltage risk, complex setup</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Expensive setup, limited cell survival</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Limited cell survival, limiting of bioinks</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Very slow printing, expensive setup</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reference</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B45-pharmaceutics-17-01176" ref-type="bibr">45</xref>,<xref rid="B46-pharmaceutics-17-01176" ref-type="bibr">46</xref>,<xref rid="B47-pharmaceutics-17-01176" ref-type="bibr">47</xref>,<xref rid="B48-pharmaceutics-17-01176" ref-type="bibr">48</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B49-pharmaceutics-17-01176" ref-type="bibr">49</xref>,<xref rid="B50-pharmaceutics-17-01176" ref-type="bibr">50</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B51-pharmaceutics-17-01176" ref-type="bibr">51</xref>,<xref rid="B52-pharmaceutics-17-01176" ref-type="bibr">52</xref>,<xref rid="B53-pharmaceutics-17-01176" ref-type="bibr">53</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B54-pharmaceutics-17-01176" ref-type="bibr">54</xref>,<xref rid="B55-pharmaceutics-17-01176" ref-type="bibr">55</xref>,<xref rid="B56-pharmaceutics-17-01176" ref-type="bibr">56</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B57-pharmaceutics-17-01176" ref-type="bibr">57</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B58-pharmaceutics-17-01176" ref-type="bibr">58</xref>]</td></tr></tbody></table></table-wrap><table-wrap position="float" id="pharmaceutics-17-01176-t002" orientation="portrait"><object-id pub-id-type="pii">pharmaceutics-17-01176-t002_Table 2</object-id><label>Table 2</label><caption><p>Properties and applications of different bioinks used in neural tissue engineering.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Category</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Material</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Key Properties</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Applications</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">References</th></tr></thead><tbody><tr><td rowspan="5" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Natural<break/>Polymers</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Collagen</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Enhances cell viability and<break/>proliferation</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Peripheral nerve conduits</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B64-pharmaceutics-17-01176" ref-type="bibr">64</xref>,<xref rid="B65-pharmaceutics-17-01176" ref-type="bibr">65</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Promotes neurite outgrowth and<break/>neural differentiation</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PNS and CNS therapeutic<break/>scaffolds</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B66-pharmaceutics-17-01176" ref-type="bibr">66</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Chitosan</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Supports cell adhesion and<break/>neural regeneration</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Scaffold for PNS and<break/>CNS regeneration</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B67-pharmaceutics-17-01176" ref-type="bibr">67</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Alginate</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Facilitates scaffold development for<break/>nerve regeneration</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Blended scaffolds for<break/>nerve regeneration</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B68-pharmaceutics-17-01176" ref-type="bibr">68</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">dECM</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Enables cell-specific adhesion and<break/>functional differentiation</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bioink for CNS and PNS<break/>bioprinting</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B69-pharmaceutics-17-01176" ref-type="bibr">69</xref>,<xref rid="B70-pharmaceutics-17-01176" ref-type="bibr">70</xref>]</td></tr><tr><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Synthetic<break/>Polymers</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PLA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Biodegradable; modifiable for<break/>structural requirements</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3D printing and<break/>electrospinning</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B71-pharmaceutics-17-01176" ref-type="bibr">71</xref>,<xref rid="B72-pharmaceutics-17-01176" ref-type="bibr">72</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PCL</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">High structural stability; tunable<break/>degradation rate</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Electrospun fibers for<break/>axon guidance</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B71-pharmaceutics-17-01176" ref-type="bibr">71</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PEG</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tunable viscoelasticity, suitable<break/>for scaffold design</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hydrogels for tunable<break/>scaffold architecture</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B72-pharmaceutics-17-01176" ref-type="bibr">72</xref>]</td></tr><tr><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Hybrid<break/>Polymers</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PEDOT:PSS</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Conductive hydrogel with favorable<break/>electrical properties</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Neural scaffolds requiring<break/>electrical stimulation</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B73-pharmaceutics-17-01176" ref-type="bibr">73</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Alginate&#8211;Chitosan</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Enhanced structural stability via<break/>ionic interaction</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hybrid scaffolds for<break/>neural regeneration</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B74-pharmaceutics-17-01176" ref-type="bibr">74</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Graphene/Carbon Nanotubes/<break/>Cellulose Nanofibers</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Enhanced electrical conductivity<break/>and bioactivity</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Advanced functional bioinks for<break/>complex tissue fabrication</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B75-pharmaceutics-17-01176" ref-type="bibr">75</xref>]</td></tr></tbody></table></table-wrap><table-wrap position="float" id="pharmaceutics-17-01176-t003" orientation="portrait"><object-id pub-id-type="pii">pharmaceutics-17-01176-t003_Table 3</object-id><label>Table 3</label><caption><p>Comparative Analysis of the CNS and PNS.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Category</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">CNS Models</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">PNS Models</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bioprinting Method</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Slow</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fast</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cell Types</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NPCs, astrocytes, neurons</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PC-12, SH-SY5Y, Schwann cells, neurons</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bioink Concentration</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">85&#8211;95%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">80&#8211;95%</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tissue Architecture</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">High</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Low&#8211;Moderate</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Functional Validation</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100&#8211;500 &#181;m</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100&#8211;300 &#181;m</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mechanical Cues</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">30&#8211;6 &#215; 10<sup>7</sup> mPa&#183;s</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&lt;10 mPa&#183;s</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Applications</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hydrogels (e.g., GelMA, alginate), ECM</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Low-viscosity inks (e.g., modified hydrogels)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Vascularization</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">High (multi-material, high cell load)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Moderate</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Category</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">General tissue models, nerve guides</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Patterning, high-throughput screening</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reference</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B66-pharmaceutics-17-01176" ref-type="bibr">66</xref>,<xref rid="B131-pharmaceutics-17-01176" ref-type="bibr">131</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B87-pharmaceutics-17-01176" ref-type="bibr">87</xref>,<xref rid="B88-pharmaceutics-17-01176" ref-type="bibr">88</xref>,<xref rid="B89-pharmaceutics-17-01176" ref-type="bibr">89</xref>,<xref rid="B90-pharmaceutics-17-01176" ref-type="bibr">90</xref>,<xref rid="B91-pharmaceutics-17-01176" ref-type="bibr">91</xref>,<xref rid="B92-pharmaceutics-17-01176" ref-type="bibr">92</xref>]</td></tr></tbody></table></table-wrap></floats-group></article></pmc-articleset>